<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6540057</article-id><article-id pub-id-type="doi">10.3390/ijms20092167</article-id><article-id pub-id-type="publisher-id">ijms-20-02167</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-2314-3026</contrib-id><name><surname>Casares</surname><given-names>Doralicia</given-names></name><xref ref-type="aff" rid="af1-ijms-20-02167">1</xref><xref ref-type="aff" rid="af2-ijms-20-02167">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-9795-182X</contrib-id><name><surname>Escrib&#x000e1;</surname><given-names>Pablo V.</given-names></name><xref ref-type="aff" rid="af1-ijms-20-02167">1</xref><xref ref-type="aff" rid="af2-ijms-20-02167">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8977-607X</contrib-id><name><surname>Rossell&#x000f3;</surname><given-names>Catalina Ana</given-names></name><xref ref-type="aff" rid="af1-ijms-20-02167">1</xref><xref ref-type="aff" rid="af2-ijms-20-02167">2</xref><xref rid="c1-ijms-20-02167" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-ijms-20-02167"><label>1</label>Laboratory of Molecular Cell Biomedicine, University of the Balearic Islands, 07121 Palma de Mallorca, Spain; <email>doralicia.casares@lipopharma.com</email> (D.C.); <email>pablo.escriba@uib.es</email> (P.V.E.)</aff><aff id="af2-ijms-20-02167"><label>2</label>Lipopharma Therapeutics, Isaac Newton, 07121 Palma de Mallorca, Spain</aff><author-notes><corresp id="c1-ijms-20-02167"><label>*</label>Correspondence: <email>ca.rossello@uib.es</email>; Tel.: +34-971-173-331</corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>5</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2019</year></pub-date><volume>20</volume><issue>9</issue><elocation-id>2167</elocation-id><history><date date-type="received"><day>01</day><month>4</month><year>2019</year></date><date date-type="accepted"><day>30</day><month>4</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 by the authors.</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Biological membranes are key elements for the maintenance of cell architecture and physiology. Beyond a pure barrier separating the inner space of the cell from the outer, the plasma membrane is a scaffold and player in cell-to-cell communication and the initiation of intracellular signals among other functions. Critical to this function is the plasma membrane compartmentalization in lipid microdomains that control the localization and productive interactions of proteins involved in cell signal propagation. In addition, cells are divided into compartments limited by other membranes whose integrity and homeostasis are finely controlled, and which determine the identity and function of the different organelles. Here, we review current knowledge on membrane lipid composition in the plasma membrane and endomembrane compartments, emphasizing its role in sustaining organelle structure and function. The correct composition and structure of cell membranes define key pathophysiological aspects of cells. Therefore, we explore the therapeutic potential of manipulating membrane lipid composition with approaches like membrane lipid therapy, aiming to normalize cell functions through the modification of membrane lipid bilayers.</p></abstract><kwd-group><kwd>membrane</kwd><kwd>lipid</kwd><kwd>therapy</kwd><kwd>endomembrane</kwd><kwd>structure</kwd><kwd>composition</kwd><kwd>2OHOA</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-ijms-20-02167"><title>1. Introduction</title><p>Biological membranes define cell boundaries and internal organelles in eukaryotes. These assemblies are highly dynamic in order to allow maintenance of the integrity and identity of the enclosed structures [<xref rid="B1-ijms-20-02167" ref-type="bibr">1</xref>]. In 1972, the publication by Singer and Nicolson of the fluid mosaic model of the structure of cell membranes [<xref rid="B2-ijms-20-02167" ref-type="bibr">2</xref>] encouraged the study of membranes and the role of each of their components. Membranes are formed by a fluid lipid bilayer which confers exceptional physical properties to the cell [<xref rid="B3-ijms-20-02167" ref-type="bibr">3</xref>] and whose lipids interact with proteins by hydrophobic and Coulomb forces [<xref rid="B4-ijms-20-02167" ref-type="bibr">4</xref>]. These interactions allow membranes to create a variety of domains based on the type of lipid components [<xref rid="B5-ijms-20-02167" ref-type="bibr">5</xref>]. Those domains, in turn, conform different structures and exert specific functions, such as the propagation of different cell signals [<xref rid="B6-ijms-20-02167" ref-type="bibr">6</xref>]. To maintain their structure, membranes also interact with cytoskeleton [<xref rid="B7-ijms-20-02167" ref-type="bibr">7</xref>].</p><p>Membranes are essential for cell survival and can provide us with information about the origin of life and other events in cell history (e.g., bioenergetic organelles acquisition or endomembrane system formation) [<xref rid="B1-ijms-20-02167" ref-type="bibr">1</xref>]. However, the word evolution is not usually related to biomembranes in textbooks [<xref rid="B4-ijms-20-02167" ref-type="bibr">4</xref>], and the origins and evolution of the membrane trafficking system have not been properly addressed [<xref rid="B8-ijms-20-02167" ref-type="bibr">8</xref>]. To study the evolution of membranes, the nature optimization of biological properties has to be taken into account [<xref rid="B4-ijms-20-02167" ref-type="bibr">4</xref>]. For many years, different types of cells were distinguished by the presence (eukaryotes) or absence (prokaryotes) of a nucleus. We now know that prokaryotes can also be separated into bacteria and archaea which share many characteristics and come from a common ancestor called LUCA (last universal common ancestor) [<xref rid="B1-ijms-20-02167" ref-type="bibr">1</xref>]. One differential trait between archaea and bacteria is their different lipid membrane composition due to differences in the enzymes that synthesize them [<xref rid="B1-ijms-20-02167" ref-type="bibr">1</xref>]. Eukaryotes, which were formed later in life history, have a similar lipid biochemistry to bacteria, but not to archaea (reviewed in [<xref rid="B1-ijms-20-02167" ref-type="bibr">1</xref>]).</p><p>The first cellular systems on Earth arose from three molecular species: molecules which stored information for replication, catalysts encoded by that information and molecules which could encapsulate both previous species [<xref rid="B9-ijms-20-02167" ref-type="bibr">9</xref>]. Also, these primitive cells needed energy-storing molecules to create ordered biologically active molecules [<xref rid="B10-ijms-20-02167" ref-type="bibr">10</xref>]. In fact, as reviewed by Gould, ATP synthase is conserved in bacteria and archaea while membrane lipids are not, which points to the fact that lipid biosynthesis was a late step in the emergence of cells, but an essential trait to acquire a free-living state [<xref rid="B1-ijms-20-02167" ref-type="bibr">1</xref>]. Although we can find prokaryotes with internal compartments, none of them have developed the endomembrane system eukaryotes possess [<xref rid="B1-ijms-20-02167" ref-type="bibr">1</xref>,<xref rid="B8-ijms-20-02167" ref-type="bibr">8</xref>] and these structures are not homologous to eukaryotic structures [<xref rid="B11-ijms-20-02167" ref-type="bibr">11</xref>]. However, all three domains of life (Bacteria, Archaea and Eukarya) have replication machinery, transcription, translation and key metabolic pathways, which suggest that these systems must have been already present in proto-eukaryotes [<xref rid="B12-ijms-20-02167" ref-type="bibr">12</xref>].</p><p>Eukaryogenesis increased cell complexity by creating new membranous compartments which carry out specialized functions and vesicle trafficking with a specific source and destination [<xref rid="B1-ijms-20-02167" ref-type="bibr">1</xref>]. The development of this trafficking system, as reviewed in [<xref rid="B8-ijms-20-02167" ref-type="bibr">8</xref>], has been explained by two different hypotheses over the years: endosymbiotic theory and autogenesis. In modern studies, eukaryotes derive from the integration of proteobacterium (now mitochondria) into archaeal cells, however, the complexity of the archaeal ancestor at that time is still subject to debate [<xref rid="B1-ijms-20-02167" ref-type="bibr">1</xref>]. Evidence such as the similarity between mitochondria-derived vesicles and prokaryotes&#x02019; outer membrane vesicles support this theory [<xref rid="B1-ijms-20-02167" ref-type="bibr">1</xref>]. Another controversial point is the speed of this trafficking-system evolution. The last eukaryotic common ancestor (LECA) did probably possess an internal complexity so the evolution might have been fast [<xref rid="B8-ijms-20-02167" ref-type="bibr">8</xref>]. According to the presence of different organelles, the LECA is told to have possessed a basic membrane-trafficking system including an endoplasmic reticulum, stacked Golgi, endosomes and lysosomes, which are now shared by all studied eukaryotes [<xref rid="B8-ijms-20-02167" ref-type="bibr">8</xref>]. In fact, there is a common core of protein factors involved in transport and compartment specificity [<xref rid="B13-ijms-20-02167" ref-type="bibr">13</xref>]. Genomic studies further demonstrate these LECA features studying the members of the coat protein complex I and II (COPI, COPII) and clathrin complexes, and on the soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptor (SNARE) families, Guanosine-5&#x02019;-triphosphate hydrolases (GTPase)&#x02013;activating proteins, guanine nucleotide exchange factors (GEFs) and NSF ATPases, endosomal sorting complexes required for transport (ESCRT) complexes, GTPases and homologues of the retromer complex (reviewed in [<xref rid="B8-ijms-20-02167" ref-type="bibr">8</xref>]). Different organelles share homologous membrane-trafficking components originated from gene duplication which might have occurred simultaneously to organelle formation or might even be itself responsible for organelle development [<xref rid="B8-ijms-20-02167" ref-type="bibr">8</xref>]. In addition, other trafficking components were apparently added separately while some others were lost throughout membrane evolution in the adaptation of LECA&#x02019;s descendants to new environments [<xref rid="B8-ijms-20-02167" ref-type="bibr">8</xref>].</p><p>Four billion years of evolution that began with prokaryotic cells produced the current eukaryotic cells containing different organelles with a particular membrane composition and function. Membrane lipid composition in the plasma membrane (PM) and endomembrane compartments is responsible of sustaining organelle structure and function and is reviewed here. Studying the diversity of lipid species in membranes has become a field of research in itself. Eukaryotic cell membranes are formed by hundreds of lipid species assembled following a functional asymmetry [<xref rid="B1-ijms-20-02167" ref-type="bibr">1</xref>]. What is more, alterations in membrane lipid composition generate pathological conditions in cells and manipulating the membrane lipid composition is a therapeutic approach beginning to be exploited with strategies like membrane lipid therapy.</p></sec><sec id="sec2-ijms-20-02167"><title>2. Repertoire of Membrane Lipids</title><p>Membrane lipids are the least studied biomolecules. First, the tools for the study of lipids are not as powerful as the tools used for investigating genes and proteins. Second, lipids occur in membranes in the form of ensembles, including around tens of thousands of individual members, which in turn are representative of a variety of hundreds of different molecular species [<xref rid="B14-ijms-20-02167" ref-type="bibr">14</xref>]. Third, the high plasticity and flexibility of biological membranes allow them to maintain their bioactivity despite the effect of external insults (reviewed in [<xref rid="B15-ijms-20-02167" ref-type="bibr">15</xref>]). Nonetheless, cells depend upon lipids for three main functions, namely energy storage, compartmentalization and signaling (reviewed in [<xref rid="B16-ijms-20-02167" ref-type="bibr">16</xref>]):<list list-type="order"><list-item><p>Energy storage: lipid droplets used for this function contain mainly triacylglycerol and steryl esters thanks to their relatively reduced state. These anhydrous reservoirs are needed for the efficient storage of caloric reserves and as stores of fatty acid and sterol components for membrane biogenesis.</p></list-item><list-item><p>Compartmentalization: the milieu of cellular membranes is made of lipids of amphipathic nature, comprising both a hydrophobic and a hydrophilic portion. This amphipathic nature provides the physical basis for spontaneous membrane formation because the hydrophobic moieties are prone to self-associate when dissolved in water. This predisposition to self-associate enabled the segregation of an internal milieu from the external milieu when the first cells originated. Later on, this scheme was repeated inside the cell to generate discrete organelles allowing, first, the separation of specific chemical reactions, second, the limitation in the spreading of reaction products and, third, an improvement in biochemical efficiency. Furthermore, lipids are responsible of membrane ability of budding, tubulation, fission and fusion, all them indispensable for cell division, biological reproduction and intracellular membrane trafficking.</p></list-item><list-item><p>Signaling: in signal transduction, lipids first define membrane domains that allow the aggregation and dispersion of particular proteins, and subsequently organize secondary signaling or effector complexes; they can also act as first and second messengers. The rupture of amphipathic lipids generates bipartite signaling elements, which can be spread both within a membrane (by hydrophobic portions of the molecule) and through the cytosol (by soluble/polar portions of the molecule).</p></list-item></list></p><p>Phospholipids (PL) constitute the bulk of the membrane&#x02019;s lipid matrix (<xref ref-type="fig" rid="ijms-20-02167-f001">Figure 1</xref>). They resemble the triglycerides in being ester or amide derivatives of glycerol (glycerophospholipids, GPL) or sphingosine (Sph &#x02013;sphingolipids, SL) with fatty acids and phosphoric acid. </p><p>Glycerophospholipids (GPL) are the major structural lipids in eukaryotic membranes. They are generally composed of two fatty acids linked through two hydrophobic acyl chains and a phosphate head group ester linked to a glycerol. In GPL, the phosphate moiety of the resulting phosphatidic acid is further esterified with choline, ethanolamine, serine or inositol in the phospholipid itself. Therefore, GPL branch from phosphatidic acid (PA) and are classified upon the structure of the PL head group. Phosphatidylcholine (PtdCho) and phosphatidylethanolamine (PtdEtn) heads are zwitterionic, whereas phosphatidylserine (PtdSer) and phosphatidylinositol (PtdIns) heads are anionic (reviewed in [<xref rid="B16-ijms-20-02167" ref-type="bibr">16</xref>,<xref rid="B17-ijms-20-02167" ref-type="bibr">17</xref>]). Each of these phospholipid classes is defined by a shared structure but then includes a battery of molecular species upon the length and degree of saturation in their acyl chains. Both head group and acyl chain composition influence the physical properties of the membrane [<xref rid="B18-ijms-20-02167" ref-type="bibr">18</xref>]. </p><p>Sphingolipids (SL) are the second most abundant structural lipid. SL contain one hydrophobic acyl chains and a phosphate head group ester linked to a Sph backbone. Their hydrophobic backbone is an ester or amide derivative of Sph with fatty acids being ceramide (Cer) the simplest representative. Sphingomyelin (SM) contains a phosphorylcholine headgroup associated to the sphingoid base. SM is the more abundant SL in the plasma membrane (PM) of mammalian cells. Within the total PL fraction of the PM, SM accounts for 2%&#x02013;15% upon the cell type (reviewed in [<xref rid="B19-ijms-20-02167" ref-type="bibr">19</xref>]). Other SLs are glycosphingolipids (GSLs). GSLs are based on glucosylceramide (GlcCer) or on galactosylceramide (GalCer) and contain mono-, di- or oligosaccharides [<xref rid="B20-ijms-20-02167" ref-type="bibr">20</xref>].</p><p>GPL and SL generate comparable series of messenger lipids upon signaling-induced hydrolysis. GPL hydrolysis produces the messenger lipids: lysoPtdCho (LPC), lysoPA (LPA), PA and diacylglycerol (DAG). Whereas SL hydrolysis produces the messenger lipids: sphingosylphosphorylcholine (SPC), Sph, sphingosine-1-phosphate (S1P), ceramide-1-phosphate (C1P) and Cer (reviewed in [<xref rid="B16-ijms-20-02167" ref-type="bibr">16</xref>]).</p><p>Cholesterol (Chol) is a crucial element of mammalian cell membranes. Chol molecule involves four fused rings (steroid backbone) showing a hydroxyl group (A-ring) and a small branched hydrophobic tail (D-ring). In membranes, the rigid steroid backbone of Chol favors its interaction with SL. Chol-SL platforms are the basic element of lipid rafts. Chol content is strictly controlled by three mechanisms: de novo synthesis, uptake and esterification [<xref rid="B21-ijms-20-02167" ref-type="bibr">21</xref>].</p></sec><sec id="sec3-ijms-20-02167"><title>3. Lipids in Sustaining Organelle Structure, Function and Identity</title><p>Lipids are distributed heterogeneously in several ranges: subcellular organelles show varied lipid arrangements, furthermore PM and organelle membranes present foci of specific lipid domains, and finally lipid distribution shows lateral differences and/or transversal asymmetry, i.e., asymmetric distribution in both membrane leaflets (<xref ref-type="fig" rid="ijms-20-02167-f002">Figure 2</xref>, reviewed in [<xref rid="B22-ijms-20-02167" ref-type="bibr">22</xref>]).</p><sec id="sec3dot1-ijms-20-02167"><title>3.1. Endoplasmic Reticulum</title><p>The secretory pathway is the best characterized model of lipid localization and involves the endoplasmic reticulum (ER), Golgi apparatus, and PM. These three compartments display growing amounts of Chol and SL concentrations, with higher levels in PM. In fact, this Chol and SL gradient is responsible of the increased membrane thickness and stiffness of the PM. These two physical properties (thickness and stiffness) are crucial to determine the particular functions and identities of the different organelles. Furthermore, they might be related with the sorting of membrane proteins and lipids between the organelles. Because of this, lipid composition and, further on, membrane thickness and stiffness, must be homeostatically maintained [<xref rid="B23-ijms-20-02167" ref-type="bibr">23</xref>,<xref rid="B24-ijms-20-02167" ref-type="bibr">24</xref>,<xref rid="B25-ijms-20-02167" ref-type="bibr">25</xref>,<xref rid="B26-ijms-20-02167" ref-type="bibr">26</xref>]. The ER, for instance, maintains its membrane fluidity using sensory machinery [<xref rid="B27-ijms-20-02167" ref-type="bibr">27</xref>,<xref rid="B28-ijms-20-02167" ref-type="bibr">28</xref>], which also operates to pair the synthesis of proteins and lipids with membrane biogenesis needs [<xref rid="B29-ijms-20-02167" ref-type="bibr">29</xref>,<xref rid="B30-ijms-20-02167" ref-type="bibr">30</xref>]. </p><p>The ER produces the bulk of the structural PL and Chol, together with significant levels of triacylglycerol and cholesteryl esters with non-structural roles [<xref rid="B31-ijms-20-02167" ref-type="bibr">31</xref>]. In addition, the ER produces Cer, which is the precursor for complex SL. In the ER of myelinating and epithelial cells GalCer is produced to stabilize myelin and apical membranes [<xref rid="B32-ijms-20-02167" ref-type="bibr">32</xref>]. Chol in the ER is only about 1%&#x02013;2% of total Chol because, right after being synthesized, Chol is transferred from the ER to the PM. This ATP-dependent and non-vesicular transport is extremely rapid: in mammals, the half-life of Chol in the ER is only 10&#x02013;20 min (reviewed in [<xref rid="B22-ijms-20-02167" ref-type="bibr">22</xref>]). </p><p>The fast transport of Chol and other lipids to other organelles causes a loose arrangement of membrane lipids in ER membrane. This loose lipid organization is critical for ER function as it eases the insertion and the transport of recently synthesized lipids and proteins (reviewed in [<xref rid="B16-ijms-20-02167" ref-type="bibr">16</xref>]). Furthermore, the ER is the main supplier for a large percentage of membrane lipids in the Golgi and PM, which are distal secretory organelles with restricted or null capacity to produce their own lipids (reviewed in [<xref rid="B17-ijms-20-02167" ref-type="bibr">17</xref>]).</p><p>In addition, the ER includes minor lipids known to be both pathway intermediates and legitimate pathway end products (including DAG, cytidine diphosphoDAG, PA, lysophospholipids) and dolichol (reviewed in [<xref rid="B16-ijms-20-02167" ref-type="bibr">16</xref>]).</p><p>Finally, a subfraction of the ER, that cofractionates with mitochondria and is known as the mitochondria-associated membrane, is particularly enriched in specific lipid biosynthetic enzymes. </p></sec><sec id="sec3dot2-ijms-20-02167"><title>3.2. Golgi</title><p>Mammalian Golgi is the main producer of SL: SM, GlcCer, lactosylceramide (LacCer) and higher-order GSLs, whose final destination is the PM [<xref rid="B33-ijms-20-02167" ref-type="bibr">33</xref>]. For SL production in the lumen of the trans-Golgi, Cer issued by the ER is required [<xref rid="B34-ijms-20-02167" ref-type="bibr">34</xref>]. Later on, SL will accumulate in the PM whereas SL levels in the ER will be low. As it happens with SL, sterols are scarce in the ER, representing only 5 mol% of lipids, in contrast to the trans-Golgi and PM where sterols are abundant (30 mol%&#x02013;40 mol%) [<xref rid="B16-ijms-20-02167" ref-type="bibr">16</xref>,<xref rid="B35-ijms-20-02167" ref-type="bibr">35</xref>]. Sterols favorably interact with lipids containing large head groups and saturated fatty acyl chains, as is the case for SL [<xref rid="B36-ijms-20-02167" ref-type="bibr">36</xref>].</p><p>Both SL and sterols will eventually concentrate on the PM. This, together with a remodeling of PL acyl chains to a more saturated pattern, generates a tight lipid packing of sterols with PL. This packing is indeed responsible of the rigidity and thickness of this barrier isolating the intracellular from the extracellular milieu. The trans-Golgi is critical in the transition from the thin and loosely packed membrane found in the ER to the thick and rigid bilayer found at the PM. This transition, mediated by SL and sterols, is easily recognized following the single-spanning membrane proteins involved in the secretory pathway. Those membrane proteins contain transmembrane domains (TMDs) whose length and composition vary during the transition from the ER to the PM. Thus, for ER and Golgi-resident proteins, TMDs are considerably shorter than those for PM proteins [<xref rid="B34-ijms-20-02167" ref-type="bibr">34</xref>]. Both TMD length and volume decide the fate of these proteins, i.e., Golgi retention or export to the PM [<xref rid="B37-ijms-20-02167" ref-type="bibr">37</xref>,<xref rid="B38-ijms-20-02167" ref-type="bibr">38</xref>]. Since selective associations between matching lipids and TMDs have proven sufficient to drive their co-segregation in model membranes [<xref rid="B39-ijms-20-02167" ref-type="bibr">39</xref>], the preservation of the distinctive mixtures of membrane proteins and lipids that allow the ER and PM to execute their fundamentally unique tasks might be achieved by the Golgi exploiting physical principles such as hydrophobic mismatch and packing density. In turn, the outlined different TMD features in ER and PM exert temporal and spatial control over the main events governing the secretory pathway. Hence, early secretory organelles contain proteins bearing neutral amphipathic lipid packing sensor (ALPS) motifs. Those proteins show bulky hydrophobic residues that easily accommodate into lipid-packing imperfections. In contrast, late secretory organelles concentrate peripheral membrane proteins bearing polybasic motifs [<xref rid="B40-ijms-20-02167" ref-type="bibr">40</xref>,<xref rid="B41-ijms-20-02167" ref-type="bibr">41</xref>,<xref rid="B42-ijms-20-02167" ref-type="bibr">42</xref>,<xref rid="B43-ijms-20-02167" ref-type="bibr">43</xref>].</p></sec><sec id="sec3dot3-ijms-20-02167"><title>3.3. Plasma Membrane</title><p>Different cell types contain different lipid and protein compositions of their PM. Furthermore, PM is compartmentalized into microdomains with specific physico-chemical properties, e.g., signalosomes, the platforms where signaling partners exert productive interactions. Those microdomains are defined by the specific type and abundance of a given collection of proteins and lipids, including fatty acid specific composition of the latter. As an example, the cis-monounsaturated FA, oleic acid, leads the arrangement of nonlamellar phases in model membranes, in contrast to its saturated and trans-monounsaturated counterparts (stearic and elaidic, respectively) [<xref rid="B44-ijms-20-02167" ref-type="bibr">44</xref>]. Indeed, varied raft microdomains exist upon their specific lipid composition and subsequent biophysical properties [<xref rid="B45-ijms-20-02167" ref-type="bibr">45</xref>]. Lipid rafts are rich in SM, GSLs and Chol which arrange into rigid and liquid-ordered (Lo) microdomains. In contrast, the small polar heads of PtdEtn endow PtdEtn-rich regions with more fluidity and less surface packing density and pressure, these regions are then called liquid-disordered (Ld) microdomains [<xref rid="B46-ijms-20-02167" ref-type="bibr">46</xref>]. Lipid heterogeneous distribution gives rise to both transient and stable membrane microdomains. Transient membrane microdomains include lipid rafts, caveolae and coated pits, among others, while stable membrane microdomains involve tight junctions, synaptosomes, brush border, etc. This segregation between transient and stable membrane microdomains is led by specific proteins and remarkably by lipids such as Chol [<xref rid="B45-ijms-20-02167" ref-type="bibr">45</xref>,<xref rid="B47-ijms-20-02167" ref-type="bibr">47</xref>,<xref rid="B48-ijms-20-02167" ref-type="bibr">48</xref>]. </p><p>Furthermore, in eukaryotes, both leaflets of the PM contain specific lipid compositions. The outer leaflet of the PM contains mostly PtdCho and SLs. The inner leaflet, in contrast, involves PtdEtn, the negatively charged PtdSer, and PtdIns [<xref rid="B49-ijms-20-02167" ref-type="bibr">49</xref>]. This membrane asymmetry is created and maintained by two types of ATP-driven pumps: flippases and floppases [<xref rid="B50-ijms-20-02167" ref-type="bibr">50</xref>,<xref rid="B51-ijms-20-02167" ref-type="bibr">51</xref>,<xref rid="B52-ijms-20-02167" ref-type="bibr">52</xref>]. A rapid collapse of these pumps, called phospholipid scrambling, externalizes PtdSer allowing it to exert its effector role in many cell activities, for instance, the phagocytic clearance of apoptotic bodies and blood coagulation [<xref rid="B53-ijms-20-02167" ref-type="bibr">53</xref>,<xref rid="B54-ijms-20-02167" ref-type="bibr">54</xref>,<xref rid="B55-ijms-20-02167" ref-type="bibr">55</xref>,<xref rid="B56-ijms-20-02167" ref-type="bibr">56</xref>,<xref rid="B57-ijms-20-02167" ref-type="bibr">57</xref>,<xref rid="B58-ijms-20-02167" ref-type="bibr">58</xref>] (and reviewed in [<xref rid="B59-ijms-20-02167" ref-type="bibr">59</xref>]).</p><p>PM does not participate in autonomous synthesis of its structural lipids, as above mentioned. However, in several signaling cascades, the synthesis or degradation of lipids at the PM has been extensively reported [<xref rid="B60-ijms-20-02167" ref-type="bibr">60</xref>]. For SM turnover, for example, the PM contains sphingomyelin synthase 2 (SMS2), which allows the (re)synthesis of SM from Cer at PM and even has a partial effect on whole cell SM content [<xref rid="B61-ijms-20-02167" ref-type="bibr">61</xref>,<xref rid="B62-ijms-20-02167" ref-type="bibr">62</xref>].</p><p>The multiple functions of membranes depend on this lipid composition, which confers relevant functions to cells. Signalosomes, by instance, may mediate incomplete signaling cascades whose activation depends upon the recruitment of one further signaling entity (e.g., the receptor) to the lipid raft [<xref rid="B63-ijms-20-02167" ref-type="bibr">63</xref>]. </p><sec><title>Endosomes</title><p>PM lipid domains are indispensable for the assembly of signalosomes and subsequently play a key role in their internalization [<xref rid="B64-ijms-20-02167" ref-type="bibr">64</xref>,<xref rid="B65-ijms-20-02167" ref-type="bibr">65</xref>]. Remarkably, the role of PL in internalization and maturation is biologically so significant among different phyla that it has been conserved during evolution. In all eukaryotic organisms and their compartments, PL work as membrane identifiers, controlling the circulation of individual compartments (reviewed in [<xref rid="B66-ijms-20-02167" ref-type="bibr">66</xref>]). PL are not only bulk building units of membranes, but also operational controllers of main physiological events e.g., cytokinesis, chemotaxis and exocytosis. In addition, PL confer plasticity to biological membranes, for instance the PM continuously undergoes deformation, invagination, scission and fusion. Intracellular budding from the PM is the starting point of endocytosis (reviewed in [<xref rid="B22-ijms-20-02167" ref-type="bibr">22</xref>]). Endocytosis comprehends several unrelated internalization routes, e.g., phagocytosis, clathrin-mediated endocytosis, and macropinocytosis. PM lipids are continuously endocytosed and later recycled in return to the PM (reviewed in [<xref rid="B66-ijms-20-02167" ref-type="bibr">66</xref>]).</p><p>Together with the GPL, Chol and SL crucially participate in several routes of endocytosis, mainly the caveolae and the clathrin-independent carrier/glycosylphosphatidylinositol (GPtdIns)-anchor-enriched endocytic compartment-mediated (CLIC/GEEC) pathways (reviewed in [<xref rid="B66-ijms-20-02167" ref-type="bibr">66</xref>]).</p><p>All along the endocytic pathway, the presence and abundance of specific lipids was found to be finely tuned. While early endosome lipid composition matches pretty much that of the PM, alongside maturation to late endosomes, sterols and PtdSer are decreased in favor of a massive rise in bis(monoacylglycero)phosphate (BmP) [<xref rid="B67-ijms-20-02167" ref-type="bibr">67</xref>]. BmP is later implicated in fusion events, in production of multivesicular bodies, and in SL hydrolysis [<xref rid="B68-ijms-20-02167" ref-type="bibr">68</xref>,<xref rid="B69-ijms-20-02167" ref-type="bibr">69</xref>]. A dedicated collection of kinases and phosphatases generate and terminate specific phosphoinositides, among them phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) on plasma membranes, phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) on early endosomes, phosphatidylinositol 4,5-bisphosphate (PtdIns(3,5)P2) on late endosomes and phosphatidylinositol 4-phosphate (PtdIns4P) on the (trans)-Golgi network [<xref rid="B70-ijms-20-02167" ref-type="bibr">70</xref>]. As already mentioned, the production of SL may have an important role in the sorting of membrane proteins and lipids between the ER, the plasma membrane and endosomes, or the vacuole through lipid rafts.</p></sec></sec><sec id="sec3dot4-ijms-20-02167"><title>3.4. Mitochondria</title><p>Mitochondria rely on lipid and protein import for proper function [<xref rid="B71-ijms-20-02167" ref-type="bibr">71</xref>]. Mitochondria present an intricate structure enclosing two sheaths: the outer (OMM) and the inner mitochondrial membrane (IMM). In turn, the intensely folded cristae generate two aqueous compartments, i.e., the intermembrane space (IMS) and the matrix (reviewed in [<xref rid="B72-ijms-20-02167" ref-type="bibr">72</xref>]).</p><p>While mitochondria were shown to synthesize several lipids on their own, they pretty much rely upon the transference and gathering of lipids mostly produced in the ER (reviewed in [<xref rid="B73-ijms-20-02167" ref-type="bibr">73</xref>,<xref rid="B74-ijms-20-02167" ref-type="bibr">74</xref>,<xref rid="B75-ijms-20-02167" ref-type="bibr">75</xref>,<xref rid="B76-ijms-20-02167" ref-type="bibr">76</xref>,<xref rid="B77-ijms-20-02167" ref-type="bibr">77</xref>,<xref rid="B78-ijms-20-02167" ref-type="bibr">78</xref>,<xref rid="B79-ijms-20-02167" ref-type="bibr">79</xref>,<xref rid="B80-ijms-20-02167" ref-type="bibr">80</xref>]). Lipids autonomously synthesized by mitochondria include phosphatidylglycerol (PtdGro), cardiolipin (CL diphosphatidylglycerol) and in part PtdEtn, PA and cytidine diphosphate diacylglycerol (CDP-DAG). The major sites of lipid biosynthesis are the ER and its specific subfraction, the mitochondria associated membrane (MAM). Other mitochondrial membrane lipids such as PtdCho, PtdSer, PtdIns, sterols and SL have to be imported. The continuous supply and exchange of lipids is required for maintaining mitochondrial membrane integrity and overall cellular function (reviewed in [<xref rid="B72-ijms-20-02167" ref-type="bibr">72</xref>]).</p><p>Mitochondrial lipid composition is mostly shared by all different mammalian cells and tissues and is characterized by: (i) Low PL to protein ratio and sterol to protein ratio versus other subcellular fractions. (ii) High levels of PtdCho and PtdEtn (major PL members near 80% of total PL); (iii) High CL content (10%&#x02013;15% of total lipid composition), and (iv) Low sterols and SL amounts (reviewed in [<xref rid="B72-ijms-20-02167" ref-type="bibr">72</xref>]). The bacterial origin of this membrane is revealed by the occurrence, in the IMM, of PtdGro and of CL (up to 25 mol%) and by the high PtdEtn/PtdCho ratio. In turn, those two features might be mandatory for oxidative phosphorylation [<xref rid="B81-ijms-20-02167" ref-type="bibr">81</xref>]. Regarding the low sterol content of mitochondria, an exception is found in cells implicated in steroid hormone synthesis. The mitochondria of those cell types coordinate with the ER for the importing and metabolization of cholesterol [<xref rid="B82-ijms-20-02167" ref-type="bibr">82</xref>]. Other exceptions are mitochondria from heart, brain and other tissues which additionally contain 5%&#x02013;30% of total PL of PtdCho and PtdEtn plasmalogens [<xref rid="B83-ijms-20-02167" ref-type="bibr">83</xref>,<xref rid="B84-ijms-20-02167" ref-type="bibr">84</xref>]. Plasmalogens are a class of PL whose structure confers to them strong lipophilic properties. This feature of plasmalogens allows them to generate inverse hexagonal phase structures, which in turn promote membrane fusion [<xref rid="B85-ijms-20-02167" ref-type="bibr">85</xref>,<xref rid="B86-ijms-20-02167" ref-type="bibr">86</xref>]. Plasmalogens are the major membrane lipid in neurons [<xref rid="B86-ijms-20-02167" ref-type="bibr">86</xref>,<xref rid="B87-ijms-20-02167" ref-type="bibr">87</xref>,<xref rid="B88-ijms-20-02167" ref-type="bibr">88</xref>,<xref rid="B89-ijms-20-02167" ref-type="bibr">89</xref>] and, in specific tissues, they are crucial for the function of several transmembrane proteins and for membrane-related cholesterol transport both at the intracellular and extracellular levels [<xref rid="B86-ijms-20-02167" ref-type="bibr">86</xref>,<xref rid="B87-ijms-20-02167" ref-type="bibr">87</xref>,<xref rid="B88-ijms-20-02167" ref-type="bibr">88</xref>,<xref rid="B89-ijms-20-02167" ref-type="bibr">89</xref>].</p><p>Recent mass spectrometry-based lipidome analyses confirmed lipid species patterns described in mitochondria with earlier analysis techniques. Lipidome analyses fully recapitulate the found differences in FA composition of every lipid class, while this is only partially true for organelles. The role of mitochondrial lipids is now recognized for almost all lipid classes. Some of these lipids of mitochondrial membrane might be dispensable, but most contribute to the structural and functional characteristics of this organelle in a quite specific manner. Particularly mitochondrial lipids were shown to be a feasible target to modulate of the arrangement of mitochondrial supercomplexes (reviewed in [<xref rid="B72-ijms-20-02167" ref-type="bibr">72</xref>]).</p></sec><sec id="sec3dot5-ijms-20-02167"><title>3.5. Lysosomes</title><p>Lysosomes contain the enzymatic tools for the degradation of extracellular molecules. The transcription factor EB (TFEB) partially controls lysosome biogenesis [<xref rid="B90-ijms-20-02167" ref-type="bibr">90</xref>]. TFEB effect first enhances lysosomal exocytosis [<xref rid="B91-ijms-20-02167" ref-type="bibr">91</xref>], second promotes the degradation of autophagic substrates and third helps the clearance of lipid droplets and of mitochondria [<xref rid="B92-ijms-20-02167" ref-type="bibr">92</xref>,<xref rid="B93-ijms-20-02167" ref-type="bibr">93</xref>,<xref rid="B94-ijms-20-02167" ref-type="bibr">94</xref>]. Low amounts of cholesterol and high amounts of SL characterize the lysosomal lipid signature, indeed increased cholesterol levels in lysosomes are used as an early trait of numerous lysosomal storage diseases (LSDs) (reviewed in [<xref rid="B19-ijms-20-02167" ref-type="bibr">19</xref>,<xref rid="B95-ijms-20-02167" ref-type="bibr">95</xref>]).</p><p>Lysosomal lipids are fully obtained by lipid transport from other organelles particularly through the budding and fusion of membrane vesicles. Lysosomes form contact sites with organelles such as mitochondria, peroxisomes, and the ER. Through this contact sites Chol is transported between organelles, among other activities (reviewed in [<xref rid="B16-ijms-20-02167" ref-type="bibr">16</xref>]). The lysosome is a hub where several trafficking pathways converge. Thus, the lysosome is a key coordinator in the sorting and delivery of lipids to several membrane compartments (reviewed in [<xref rid="B96-ijms-20-02167" ref-type="bibr">96</xref>]). For instance, exogenous TG, sterols and PL transported by low-density lipoproteins (LDLs) first enter the cell through receptor-mediated endocytosis, and secondly, they are processed by the lysosome. Endogenous lipids are also sorted by the lysosome when it fuses with double-membraned autophagosomes. Hence, the role of lysosomes is well-established in lipid catabolism and in dietary lipid overload, when cellular lipid content or composition induces changes to alter autophagic activity in a tissue-specific manner (reviewed in [<xref rid="B97-ijms-20-02167" ref-type="bibr">97</xref>]).</p></sec><sec id="sec3dot6-ijms-20-02167"><title>3.6. Nuclear Membrane</title><p>Eukaryotic nucleus encloses this chromatin using a double membrane (nuclear envelope, NE). NE includes three interconnected domains with morphological differences: the inner (INM) and outer (ONM) nuclear membranes (NM) and the pore membranes. These two individual lipid bilayers are separated by a luminal space, of 30&#x02013;50 nm in human cells, named lumen or perinuclear space. Both the INM and ONM possess unique composition and metabolic/signaling patterns (reviewed in [<xref rid="B98-ijms-20-02167" ref-type="bibr">98</xref>,<xref rid="B99-ijms-20-02167" ref-type="bibr">99</xref>]).</p><p>Cell nucleus contains GPL, SL, and Chol. Major nuclear GPL include polyphosphoinositides (PPIn) including phosphatidylinositol phosphate (PInsP), phosphatidylinositol 4,5- bisphosphate (PtdIns(4,5)P2), and phosphatidylinositol 1,4,5- trisphosphate (PtdIns(1,4,5)P3), PtdChol, PtdSer, and PtdEtn. SL include SM, Cer, ceramide-1-phosphate (C1P), Sph, S1P and gangliosides as well as Chol and its hydroxyl and oxygenated derivatives. Total GPL contents of nuclei are reported as 3% by weight compared with 75% for protein and 22% for DNA. Cellular nuclei contain high levels of PtdCho and SM, which are partially linked with Chol and proteins to form lipid&#x02013;protein complexes. The most abundant nuclear SL is SM and is the most prominent member of the SL contributing to the signaling through NE [<xref rid="B100-ijms-20-02167" ref-type="bibr">100</xref>]. Gangliosides are another SL associated with the nucleus (reviewed in [<xref rid="B101-ijms-20-02167" ref-type="bibr">101</xref>,<xref rid="B102-ijms-20-02167" ref-type="bibr">102</xref>]).</p><p>SM not only occurs in the nuclear envelope, but also at intranuclear sites. Nuclear lipids exert different functions upon their localization, including the regulation of fluidity of both NM and nuclear matrix. Another function of nuclear lipids is serving as platforms in signal transduction for vitamin and hormone receptors and for anchoring active chromatin. Furthermore, nuclear lipids play a role in DNA duplication and the regulation of gene expression and transcription (reviewed in [<xref rid="B102-ijms-20-02167" ref-type="bibr">102</xref>]). The nucleus further hosts the metabolizing enzymes for gangliosides and Cer, including sphingomyelin synthase (SMS) and sphingomyelinase (SMase), ceramide kinase (CerK) and sphingosine kinase (SphK) activities (reviewed in [<xref rid="B101-ijms-20-02167" ref-type="bibr">101</xref>]). In short, the nuclear envelope contains the bulk of nuclear lipids, while the nuclear matrix contains enzymes and metabolites necessary for autonomous lipid metabolism in the nucleus [<xref rid="B103-ijms-20-02167" ref-type="bibr">103</xref>].</p><sec id="sec3dot6dot1-ijms-20-02167"><title>3.6.1. Nuclear Size</title><p>During NE reassembly after cell division, cell needs to adjust the proper nuclear size. With this aim, cells adjust the portion of ER membrane integrated into the NE (first integrated into the ONM and then integrated into the INM). A possible mechanism to adjust this integration is limiting the movement of PL from the ONM to the INM by using nuclear pore complexes (NPCs) as a steric barrier profiting from their location at the intersection of both membranes. Another possible mechanism to modulate nuclear size also involves NPCs, those structures affect PL metabolism by constraining the subcellular position of the effector enzymes. This is the case of lipin and numerous other lipid-generating proteins recognized in the NE proteome (reviewed in [<xref rid="B104-ijms-20-02167" ref-type="bibr">104</xref>]).</p></sec><sec id="sec3dot6dot2-ijms-20-02167"><title>3.6.2. Nuclear Phospholipid Regulation of Chromatin</title><p>Lipid&#x02013;nucleic acid interactions have been hypothesized to be the basis for the organization and expression of cellular genome (reviewed in [<xref rid="B105-ijms-20-02167" ref-type="bibr">105</xref>]). Around 50 years ago, a role of bacterial membrane was hypothesized in the segregation of bacterial chromosomes [<xref rid="B106-ijms-20-02167" ref-type="bibr">106</xref>]. This was the seed of subsequent studies on DNA&#x02013;membrane (DNA&#x02013;lipid) interactions, mostly in the 1970s and 1980s, and led to the isolation of DNA&#x02013;membrane complexes (DMC).</p><p>PL in the nucleus can be found far from the membranes linked to water-soluble proteins. PL&#x02019;s presence in the nucleoplasm was reported for sterols, PL, sphingosines, and very hydrophobic FA where those molecules were implicated in transcriptional regulation (reviewed in [<xref rid="B107-ijms-20-02167" ref-type="bibr">107</xref>]). Furthermore, lipids were reported to serve as hormone-like ligands within the nuclear receptor superfamily. This family involves ligand-regulated transcription factors exerting both the activation and repression of transcription. Identified ligands include some PL, hydrophobic, Chol-based molecules (e.g., steroids and oxy-sterols), and FA (reviewed in [<xref rid="B108-ijms-20-02167" ref-type="bibr">108</xref>]).</p></sec></sec></sec><sec id="sec4-ijms-20-02167"><title>4. Cellular Mechanisms of Physicochemical Membrane Homeostasis</title><p>The amphiphilic nature of PL leads their spontaneous distribution into bilayers in aqueous environments, which are the basic component of all cellular membranes. The nature of their head-group and the length and saturation of their acyl chains define the category of PL species and the structural features of the membrane, i.e., viscosity, curvature, and electrostatic charge of the bilayer (reviewed in [<xref rid="B66-ijms-20-02167" ref-type="bibr">66</xref>]). The physiological particularities of subcellular organelles are based on their membrane properties, including lipid composition which indeed needs to be homeostatically preserved to maintain the organelle&#x02019;s physiological purpose. Membrane protein abundance and composition also affect the physicochemical properties of biological membranes. The most robust demonstration of this influence comes from experiments where lipids isolated from biological membranes self-assemble into non-lamellar phases, not into bilayers as they do in their natural, protein-rich environment [<xref rid="B109-ijms-20-02167" ref-type="bibr">109</xref>].</p><p>Further focusing on PL, PtdCho amount is beyond 50% of all PL in most eukaryotes. PtdCho commonly involves one cis-unsaturated acyl chain, for instance oleic acid (C18:1). This cis-double bond makes a strong kink that undoubtedly decreases the packing compactness of the acyl chains and in turn rises membrane fluidity [<xref rid="B110-ijms-20-02167" ref-type="bibr">110</xref>]. PtdCho owes to its cylindrical shape the capability to self-assemble spontaneously (<xref ref-type="fig" rid="ijms-20-02167-f003">Figure 3</xref>). Hence, at a physiological temperature, PtdCho arranges into closed bilayers in a liquid crystalline state. All in all, PtdCho is specially endowed to keep a stable and fluid ground for cellular membranes (reviewed in [<xref rid="B17-ijms-20-02167" ref-type="bibr">17</xref>]). By contrast, the conical shape of PtdEtn, due to the relatively small polar head group, imposes negative curvature stress on the membrane. Acyl chain unsaturation in PtdEtn further increases the non-bilayer propensity of this PL, creating lipid-packing defects that facilitate membrane fusion and influence the binding and activity of peripheral membrane proteins [<xref rid="B111-ijms-20-02167" ref-type="bibr">111</xref>,<xref rid="B112-ijms-20-02167" ref-type="bibr">112</xref>]. Though in comparatively low abundance, PtdSer and PtdIns are crucial determinants of membrane surface charge and, further on, mediate operational connections with positively charged portions of membrane proteins, both peripheral and integral [<xref rid="B40-ijms-20-02167" ref-type="bibr">40</xref>,<xref rid="B41-ijms-20-02167" ref-type="bibr">41</xref>] (reviewed in [<xref rid="B17-ijms-20-02167" ref-type="bibr">17</xref>]).</p><p>As previously introduced, at least some lipids in every organelle were synthesized elsewhere and gained through transportation. Lipid transport between organelles needs to be specific in order to preserve the exclusive lipid composition of the organelles involved in the transfer (reviewed in [<xref rid="B16-ijms-20-02167" ref-type="bibr">16</xref>]). </p><p>The plasma membrane, endosomes and lysosomes depend completely on lipid transport from other organelles (reviewed in [<xref rid="B16-ijms-20-02167" ref-type="bibr">16</xref>]). Lipid transport can occur by several mechanisms. The first mechanism is diffusion: lipids can laterally diffuse through membrane continuities, such as those that exist between the ER and the ONM and INM. Membrane contact sites (MCS) with ER were reported for almost every other organelle. MCS are defined as confluence points where the membranes of two organelles are positioned close to each other so as to offer a milieu where proteins in one membrane are accessible to the opposite membrane. Indeed, MCS are the purpose-built platforms for the allocation of distinct classes of lipids from the ER to other organelles using non-vesicular transport. This transfer is mediated by lipid transfer proteins (LTPs), which, in MCS, can easily reach the lipid molecules to be transferred between organelles (reviewed in [<xref rid="B114-ijms-20-02167" ref-type="bibr">114</xref>]). Tubular connections have been observed between Golgi cisternae. On the contrary, mitochondria and peroxisomes do not take part into the vesicle transport system and lipids are probably coming in and out of these organelles as monomers, aided by both water-soluble and membrane-based proteins (revised in [<xref rid="B16-ijms-20-02167" ref-type="bibr">16</xref>]). The second mechanism is fusion: the major membrane transport pathway between cellular organelles in the secretory and endocytic pathways is through the budding and fusion of membrane vesicles. Particularly remarkable is the transport of Chol between ER and the PM. The PM concentrates 80% of total cellular cholesterol but lacks sterol regulatory element-binding proteins (SREBPs). In contrast, the ER membrane, with less than 1% of total cellular cholesterol, contains both SREBPs and the sensors controlling SREBP activation [<xref rid="B115-ijms-20-02167" ref-type="bibr">115</xref>] (reviewed in [<xref rid="B116-ijms-20-02167" ref-type="bibr">116</xref>]). Careful coordination of the lipid transport between PM and ER enables ER cholesterol sensors to continuously follow PM cholesterol content [<xref rid="B117-ijms-20-02167" ref-type="bibr">117</xref>]. Control of the carrying of cholesterol from the PM to the ER is governed by the arrangement of cholesterol in PM, which in turn is crucially restrained by the connection of cholesterol with SM [<xref rid="B118-ijms-20-02167" ref-type="bibr">118</xref>] (reviewed in [<xref rid="B116-ijms-20-02167" ref-type="bibr">116</xref>]). </p><p>The electrostatic charge of the bilayer is another element responsible for the maintenance of an organelle&#x02019;s physiological identity and function. Asymmetric distribution of PLs between both leaflets is strongly dependent upon the Golgi apparatus. In the Golgi, the precise asymmetric distribution of PLs between both leaflets of the PM is established, and therefore the corresponding effect on membrane electrostatics. On one hand, PtdSer fluctuates from a higher concentration in the luminal leaflet of the ER to an opposite distribution at the PM, where PtdSer faces the cytoplasm and contributes to the negative surface charge [<xref rid="B16-ijms-20-02167" ref-type="bibr">16</xref>,<xref rid="B119-ijms-20-02167" ref-type="bibr">119</xref>]. Type 4 P-type ATPases (P4-ATPases) in the trans-Golgi are the responsible for translocating PtdSer and other PL from the luminal to the cytoplasmic leaflet [<xref rid="B120-ijms-20-02167" ref-type="bibr">120</xref>,<xref rid="B121-ijms-20-02167" ref-type="bibr">121</xref>]. On the other hand, PtdIns restriction to highly dynamic sub-compartments of the ER further suggests that cytoplasmic surface of ER is overall relatively neutral [<xref rid="B43-ijms-20-02167" ref-type="bibr">43</xref>]. </p><p>As a reflection of physicochemical membrane homeostasis, the lipidome of cellular organelles is remodeled, and it does much faster than the proteome [<xref rid="B122-ijms-20-02167" ref-type="bibr">122</xref>,<xref rid="B123-ijms-20-02167" ref-type="bibr">123</xref>,<xref rid="B124-ijms-20-02167" ref-type="bibr">124</xref>,<xref rid="B125-ijms-20-02167" ref-type="bibr">125</xref>]. Two examples of physiological processes modulating the lipidome are metabolic challenge [<xref rid="B124-ijms-20-02167" ref-type="bibr">124</xref>] and acute stress [<xref rid="B125-ijms-20-02167" ref-type="bibr">125</xref>]. A third example is cellular differentiation [<xref rid="B122-ijms-20-02167" ref-type="bibr">122</xref>,<xref rid="B123-ijms-20-02167" ref-type="bibr">123</xref>]: dramatic lipid composition remodeling was reported in early post-natal differentiation of synaptic membranes from mammalian neurons [<xref rid="B122-ijms-20-02167" ref-type="bibr">122</xref>]. Against this lipidome flexibility, the fluidity and packaging of the membranes remained intact in this neural model, suggesting that physical homeostasis prevails over changes in lipid composition [<xref rid="B122-ijms-20-02167" ref-type="bibr">122</xref>]. A very tempting prospect might be that instead of preserving membrane lipid compositions, cells pursue the retention of their attributes by adjusting the multifactorial lipidome (reviewed in [<xref rid="B15-ijms-20-02167" ref-type="bibr">15</xref>]).</p></sec><sec id="sec5-ijms-20-02167"><title>5. Lipid Imbalances and Human Pathologies</title><p>The lipidome of cellular organelles is remodeled not only upon physiological conditions but also under pathological conditions (<xref ref-type="fig" rid="ijms-20-02167-f004">Figure 4</xref>). Those changes in the cell membrane lipid composition, in turn, affect the biophysical properties of microdomains and the ability of signal propagation by proteins and signaling lipids (reviewed in [<xref rid="B19-ijms-20-02167" ref-type="bibr">19</xref>]). For instance, several different pathologies develop with alterations in lipid raft composition and structure [<xref rid="B126-ijms-20-02167" ref-type="bibr">126</xref>,<xref rid="B127-ijms-20-02167" ref-type="bibr">127</xref>,<xref rid="B128-ijms-20-02167" ref-type="bibr">128</xref>]. With further detail, PL regulate endocytic processes which are required for properly regulated growth, immune surveillance, synaptic transmission, cell migration, and many other functions. Hence, alterations in PL metabolism during endocytosis were reported in chronic infections, metastatic tumors, and neurological disorders (reviewed in [<xref rid="B66-ijms-20-02167" ref-type="bibr">66</xref>]). A further example involves human disorders, such as Alzheimer&#x02019;s disease and type II diabetes, which develop with accumulations of peptide and protein fibrillar aggregates. In those cases, oligomer-mediated cytotoxicity does not depend simply on the protein aggregates themselves, but also on the chemical composition and physicochemical features of the cell membranes with which the oligomers interact [<xref rid="B129-ijms-20-02167" ref-type="bibr">129</xref>,<xref rid="B130-ijms-20-02167" ref-type="bibr">130</xref>,<xref rid="B131-ijms-20-02167" ref-type="bibr">131</xref>,<xref rid="B132-ijms-20-02167" ref-type="bibr">132</xref>].</p><p>Cystic fibrosis causes lipid imbalances which impair surfactant ability in the lungs and promote bacterial growth, leading to decreased breathing ability [<xref rid="B133-ijms-20-02167" ref-type="bibr">133</xref>,<xref rid="B134-ijms-20-02167" ref-type="bibr">134</xref>].</p><sec id="sec5dot1-ijms-20-02167"><title>5.1. Cancer</title><p>Cancer cells require significant cellular growth and therefore membrane biosynthesis to survive. In accordance, PL biosynthetic pathways are up-regulated in cancer [<xref rid="B102-ijms-20-02167" ref-type="bibr">102</xref>,<xref rid="B135-ijms-20-02167" ref-type="bibr">135</xref>]. Several alterations in membrane composition and PL synthesis, distribution, or catabolism reported in cancer are listed below:<list list-type="bullet"><list-item><p>PtdIns(3,4,5)P3 concentration is also elevated in numerous cancers. This example of abnormal lipid catabolism is due to ineffective degradation by the tumor suppressor phosphatase and tensin homolog (PTEN) [<xref rid="B136-ijms-20-02167" ref-type="bibr">136</xref>,<xref rid="B137-ijms-20-02167" ref-type="bibr">137</xref>].</p></list-item><list-item><p>Total SM levels are decreased and PtdEtn levels are increased in tumor cells compared to non-tumor controls [<xref rid="B138-ijms-20-02167" ref-type="bibr">138</xref>]. As a consequence, the PtdEtn:SM ratio in tumor cells is ca. 10-fold the ratio in normal cells. In fact, PtdEtn:SM ratio might work as a switch where high PtdEtn:SM ratio is a &#x02018;ON&#x02019; state allowing propagation of proliferation signals received at the PM, while a low PtdEtn:SM ratio is a &#x02018;OFF&#x02019; state where the PM is impaired for transduction of proliferative signals [<xref rid="B139-ijms-20-02167" ref-type="bibr">139</xref>].</p></list-item><list-item><p>Other SL involved in cancer pathology include Cer, Sph and S1P (reviewed in [<xref rid="B140-ijms-20-02167" ref-type="bibr">140</xref>]). Cer mediates numerous cell-stress responses, such as induction of apoptosis [<xref rid="B141-ijms-20-02167" ref-type="bibr">141</xref>] and cell senescence [<xref rid="B142-ijms-20-02167" ref-type="bibr">142</xref>], whereas S1P in contrast exerts its role in cell survival, migration, and inflammation [<xref rid="B143-ijms-20-02167" ref-type="bibr">143</xref>]. Further investigations point to an abnormal SL signaling in carcinogenesis of various types of cancer due to alterations in the activity of enzymes that participate in the metabolism of SL [<xref rid="B144-ijms-20-02167" ref-type="bibr">144</xref>].</p></list-item><list-item><p>Other lipid metabolism genes related with cancer are Oxidized Low Density Lipoprotein Receptor 1 (OLR1) and Glutaredoxin (GLRX), which are upregulated in breast and prostate cancer tissues [<xref rid="B145-ijms-20-02167" ref-type="bibr">145</xref>]. The oncogenic antigen-519, a molecular marker found in breast cancer patients with poor prognosis, was identified as FA Synthase (FASN) already twenty-five years ago [<xref rid="B146-ijms-20-02167" ref-type="bibr">146</xref>]. Other proteins related to FA biosynthesis and lipid metabolism regulation, such as acetyl-CoA carboxylase (ACC), Insulin induced gene 1 (INSIG1), and sterol regulatory element-binding protein 1 (SREBP1), are highly expressed in breast cancer tumors and associated with low patient survival [<xref rid="B147-ijms-20-02167" ref-type="bibr">147</xref>] while colorectal carcinoma risk has been associated with hepatic lipase polymorphisms [<xref rid="B148-ijms-20-02167" ref-type="bibr">148</xref>]. Alterations in lysosomal SL metabolism are another trait of many cancers [<xref rid="B149-ijms-20-02167" ref-type="bibr">149</xref>].</p></list-item></list></p><p>The above-mentioned lipid traits of tumors reflect their important roles during tumor initiation and disease progression at different points (reviewed in [<xref rid="B135-ijms-20-02167" ref-type="bibr">135</xref>]):<list list-type="simple"><list-item><label>&#x025aa;</label><p>Disruption of normal tissue architecture: The collapse of normal tissue architecture is a mark of malignancy. Polarized epithelia turn into disorganized structures that can occupy the adjacent tissues. In epithelial tissues, aberrant FA synthesis was linked to the loss of cell polarity. Also, the ordinary expression of SREBPs is needed to maintain the apical surface of normal epithelial cells and is lost in many cancers (reviewed in [<xref rid="B135-ijms-20-02167" ref-type="bibr">135</xref>])</p></list-item><list-item><label>&#x025aa;</label><p>Cancer cell migration: Cell migration stimulation by pro-migratory signaling lipids, such as DAG, LPA and prostaglandins, has been well characterized (reviewed in [<xref rid="B150-ijms-20-02167" ref-type="bibr">150</xref>]). In addition, other findings suggest that dietary-derived lipids might enlarge the overall lipid composition of malignant cells and so influence multiple signaling events within tumors [<xref rid="B151-ijms-20-02167" ref-type="bibr">151</xref>].</p></list-item><list-item><label>&#x025aa;</label><p>Interaction of cancer cells with components of the tumor stroma: This is another key element affecting tumor growth [<xref rid="B152-ijms-20-02167" ref-type="bibr">152</xref>] and lipids were also involved in this communication. Examples include the support to cancer-associated fibroblasts by the expression of FASN [<xref rid="B153-ijms-20-02167" ref-type="bibr">153</xref>], the compromise of proper macrophage functioning upon FA biosynthesis [<xref rid="B134-ijms-20-02167" ref-type="bibr">134</xref>,<xref rid="B154-ijms-20-02167" ref-type="bibr">154</xref>] and of proper immune response upon prostaglandin presence [<xref rid="B155-ijms-20-02167" ref-type="bibr">155</xref>].</p></list-item><list-item><label>&#x025aa;</label><p>Lipid metabolic reprogramming in cancer cells: cancer cells display an enlarged metabolic inventory that allows the flexibility to survive and grow in the severe tumor environment. Highly proliferative cancer cells display a strong lipid and Chol avidity, which they fulfill by raising the incorporation of exogenous (or dietary) lipids or increasing their endogenous synthesis. Excessive lipids and cholesterol in cancer cells stored in lipid droplets are considered marks of cancer aggressiveness (reviewed in [<xref rid="B156-ijms-20-02167" ref-type="bibr">156</xref>]).</p></list-item></list></p></sec><sec id="sec5dot2-ijms-20-02167"><title>5.2. Metabolic Diseases</title><p>Several lysosomal storage disorders (LSDs) affect lysosomal hydrolases, membrane transporters, accessory or trafficking proteins and derive into lipid storage disorders (sphingolipidoses, gangliosidoses, leukodystrophies) (reviewed in [<xref rid="B95-ijms-20-02167" ref-type="bibr">95</xref>]). The most common LSD is Gaucher disease (GD), which impairs the function of (lyso)glucosylceramide degrading enzyme &#x003b2;-glucocerebrosidase (EC 3.2.1.45). Fabry disease (FD), in contrast, develops with deficiency of the lysosomal &#x003b1;-galactosidase A (EC 3.2.1.22). Krabbe disease (KD) interferes with the function of the enzyme galactocerebrosidase (EC: 3.2.1.46), so that undegraded galactolipids accumulate and cause the progressive demyelination of cells in the nervous system. Niemann&#x02013;Pick type C disease originates by intralysosomal Chol and SL accumulation and develops with severe neurological and visceral pathology (reviewed in [<xref rid="B95-ijms-20-02167" ref-type="bibr">95</xref>]). Another example is Tay Sachs disease, a rare inherited disorder that progressively destroys nerve cells (neurons) in the brain and spinal cord. This disease is a type of sphingolipidosis which shows toxic accumulation of the molecule GM2 ganglioside within cells [<xref rid="B157-ijms-20-02167" ref-type="bibr">157</xref>].</p><p>Obesity is another metabolic disease initiated by a lipid imbalance. Particularly, it has been linked to the intake of saturated (or trans-monounsaturated fatty acid &#x02013;MUFA) fats (reviewed in [<xref rid="B19-ijms-20-02167" ref-type="bibr">19</xref>]). One of these saturated FA, palmitic acid, has been shown to induce of ER stress and cell death [<xref rid="B158-ijms-20-02167" ref-type="bibr">158</xref>].</p><p>Diabetes is a disease highly influenced by the dietary FA content. In diabetic patients, increased saturated:unsaturated FA ratio is found in erythrocyte membranes compared to healthy controls [<xref rid="B159-ijms-20-02167" ref-type="bibr">159</xref>]. In addition, dysregulation of PtdSer asymmetric distribution in the PM may contribute to the development of diabetes [<xref rid="B160-ijms-20-02167" ref-type="bibr">160</xref>,<xref rid="B161-ijms-20-02167" ref-type="bibr">161</xref>].</p><p>Focusing on the molecular mechanism behind the onset of lipid imbalance-driven obesity and diabetes, both lipid homeostasis and physical principles governing lipid arrangements in the membranes are involved. Two examples illustrate this mechanism in liver disease (reviewed in [<xref rid="B17-ijms-20-02167" ref-type="bibr">17</xref>]). The liver is a crucial metabolic organ in controlling body energy metabolism. It functions as a metabolic hub linking several tissues, skeletal muscle and adipose tissue included. In fat metabolism, the liver cells break down fats and produce energy (reviewed in [<xref rid="B162-ijms-20-02167" ref-type="bibr">162</xref>]).
<list list-type="simple"><list-item><label>&#x025aa;</label><p>In the first example, excessive intake of saturated FA is highly toxic for hepatocytes due to its limited capacity to integrate them into TG [<xref rid="B163-ijms-20-02167" ref-type="bibr">163</xref>]. In parallel, an elevated degree of membrane saturation disrupts calcium homeostasis and triggers liver ER stress [<xref rid="B164-ijms-20-02167" ref-type="bibr">164</xref>]. Chronic activation of ER stress dysregulates lipid homeostasis and might lead to dyslipidemia, insulin resistance, type II diabetes, and obesity [<xref rid="B163-ijms-20-02167" ref-type="bibr">163</xref>].</p></list-item><list-item><label>&#x025aa;</label><p>A second example involves the previously introduced TFEB, transcription factor partially dictating lysosome biogenesis. As above mentioned, TFEB participates in autophagy and in the clearance of lipid droplets. Furthermore, it governs liver lipid catabolism and energy metabolism interfering with peroxisome proliferator-activated receptor-&#x003b3; (PPAR-&#x003b3;) signaling [<xref rid="B165-ijms-20-02167" ref-type="bibr">165</xref>]. In obese animals, TFEB overexpression rescues obesity and associated metabolic syndrome by promoting lipophagy [<xref rid="B166-ijms-20-02167" ref-type="bibr">166</xref>].</p></list-item></list></p><p>A high fat diet can likewise obstruct the formation of lipid rafts needed for the uptake of exogenous factors such as insulin from the blood [<xref rid="B167-ijms-20-02167" ref-type="bibr">167</xref>,<xref rid="B168-ijms-20-02167" ref-type="bibr">168</xref>].</p><p>Hypercholesterolemia disease shows defective clearance of low-density lipoproteins (LDL) due to mutations in elements of the sterol and lipoprotein pathways. Furthermore, elevated plasma Chol levels associate with higher levels of Chol in the PM of cardiovascular and other cells, and in turn alter PM structure and signal transduction (reviewed in [<xref rid="B169-ijms-20-02167" ref-type="bibr">169</xref>]).</p></sec><sec id="sec5dot3-ijms-20-02167"><title>5.3. Neurological Disorders</title><p>The neural membrane lipid composition has been reported to change in neurodegeneration. Particularly, changes affected GPL, SL, and Chol levels both in acute neural trauma (head injury, ischemia, and spinal cord trauma) and in neurodegenerative diseases (Alzheimer&#x02019;s, Parkinson&#x02019;s and amyotrophic lateral sclerosis). In accordance, significant increased levels of in GPL-, SL-, and Chol-derived lipid mediators have been shown to accompany these variations in lipid composition both in the PM and in the cell nucleus (reviewed in [<xref rid="B101-ijms-20-02167" ref-type="bibr">101</xref>]).</p></sec><sec id="sec5dot4-ijms-20-02167"><title>5.4. Immunological Disorders</title><p>Anti-phospholipid syndrome (APS) is an autoimmune disease caused by the appearance of anti-PL antibodies and developed with vascular thromboembolism and miscarriages (reviewed in [<xref rid="B170-ijms-20-02167" ref-type="bibr">170</xref>]). Anti-PL involve lupus anticoagulant (LA), anti-&#x003b2;2GPI antibodies and anti-cardiolipin (anti-CL). The mechanism linking the binding of anti-PL antibodies to endothelial cells with cell activation is still under investigation. A great variety of infections are accompanied by increases in anti-PL mostly in viral infections (Hepatitis C virus, Epstein-Barr virus, Varicella virus, human immunodeficiency virus) (reviewed in [<xref rid="B171-ijms-20-02167" ref-type="bibr">171</xref>]).</p><p>The avoidance of autoreactivity to the broadly distributed self-PL is a key instrument to prevent autoimmune diseases. However, little is known on the molecular mechanisms responsible of T cell autoreactivity on lipid antigens (reviewed in [<xref rid="B172-ijms-20-02167" ref-type="bibr">172</xref>]).</p></sec><sec id="sec5dot5-ijms-20-02167"><title>5.5. Regulation of Cellular Activities by Prenylation</title><p>Protein prenylation is a ubiquitous covalent post-translational modification. It is the first critical step for membrane targeting and binding and mediates protein-protein interactions [<xref rid="B173-ijms-20-02167" ref-type="bibr">173</xref>]. This modification increases the hydrophobicity of the protein [<xref rid="B174-ijms-20-02167" ref-type="bibr">174</xref>], favors its temporary attachment to the membrane [<xref rid="B175-ijms-20-02167" ref-type="bibr">175</xref>] and is essential for a correct protein activity [<xref rid="B173-ijms-20-02167" ref-type="bibr">173</xref>]. Protein prenylation consists of the attachment of farnesyl (15 carbon) or geranylgeranyl (20 carbon) groups to the protein [<xref rid="B176-ijms-20-02167" ref-type="bibr">176</xref>]. First described in fungi [<xref rid="B177-ijms-20-02167" ref-type="bibr">177</xref>], farnesylation was described in mammals on lamin B [<xref rid="B178-ijms-20-02167" ref-type="bibr">178</xref>,<xref rid="B179-ijms-20-02167" ref-type="bibr">179</xref>]. Defective prenylation of proteins is linked to tumor pathogenesis among others [<xref rid="B180-ijms-20-02167" ref-type="bibr">180</xref>].</p><p>Three enzymes catalyze the prenylation of proteins: farnesyltransferase (FTase) and geranylgeranyltransferases type I and II (GGTase I and GGTase II). They are heterodimers recognising C-terminal consensus sequences in the target proteins. FTase and GGTase I transfer a single farnesyl or geranylgeranyl group to a cysteine residue located in the &#x0201c;CaaX box&#x0201d; (C-terminal consensus sequence in which &#x0201c;C&#x0201d; represents a cysteine, &#x0201c;a&#x0201d; is an aliphatic amino acid and &#x0201c;X&#x0201d; determines the attached isoprenoid) [<xref rid="B176-ijms-20-02167" ref-type="bibr">176</xref>]. Proteins modified by FTase or GGTase I need two additional processing steps: cleavage of &#x0201c;aaX&#x0201d; tripeptide by an endoprotease and methylation of prenylcysteine [<xref rid="B174-ijms-20-02167" ref-type="bibr">174</xref>]. The structure and enzymology of FTase and GGTase I are similar, although most studies focus on farnesylation. First, farnesyl residue binds to FTase [<xref rid="B181-ijms-20-02167" ref-type="bibr">181</xref>,<xref rid="B182-ijms-20-02167" ref-type="bibr">182</xref>], secondly the protein with a CaaX-box binds and the C-S bond is formed. While the prenylated protein remains bound to the enzyme, another prenyl group binds to the enzyme and, lastly, the product (prenylated protein) is dissociated before or while a new CaaX-box substrate binds [<xref rid="B173-ijms-20-02167" ref-type="bibr">173</xref>]. As a consequence, stereochemistry at C-1 position of the isoprenoid is inverted [<xref rid="B183-ijms-20-02167" ref-type="bibr">183</xref>,<xref rid="B184-ijms-20-02167" ref-type="bibr">184</xref>,<xref rid="B185-ijms-20-02167" ref-type="bibr">185</xref>] but this causes minimal differences in protein conformation [<xref rid="B186-ijms-20-02167" ref-type="bibr">186</xref>]. FTase and GGTase I have not mutually exclusive substrate specificity [<xref rid="B187-ijms-20-02167" ref-type="bibr">187</xref>], although there are preferences depending on the &#x0201c;X&#x0201d; aminoacid in CaaX box, as said above, so some prediction tools have been developed.</p><p>GGTase II, also called Rab GGTase, catalyzes the transference of two geranylgeranyl groups to two cysteine residues located in sequences such as CXC or CCXX close to C-terminus of Rab proteins [<xref rid="B176-ijms-20-02167" ref-type="bibr">176</xref>]. Its enzymology is more complex and needs an escort protein to catalyze the reaction [<xref rid="B188-ijms-20-02167" ref-type="bibr">188</xref>].</p><p>Although, only a few prenyltransferase substrates (e.g., Ras family GTPases and heterotrimeric G-proteins) have been identified, this modification is essential for the proper activity of some proteins which are altered in different diseases. This is the basis for the efforts made in the therapeutic targeting of protein prenylation. Inhibitors of prenylation have been tested for the treatment of cancer, parasite causing diseases, viral and bacterial infections, multiple sclerosis or progeria [<xref rid="B173-ijms-20-02167" ref-type="bibr">173</xref>].</p><p>Proteins involved in signal transduction pathways require prenylation. An interesting example of these proteins is Ras protein family. Many cancers present activating mutations in the RAS genes causing malignant activity of the protein [<xref rid="B189-ijms-20-02167" ref-type="bibr">189</xref>]. For this reason, prenyltransferase inhibitors have been tested in vitro and in animals for the inhibition of Ras proteins, showing promising results. Firstly, farnesyltransferase inhibitors (FTIs) were used to inhibit the farnesylation of proteins in cancer cells. FTIs promoted apoptosis, cell cycle arrest (mainly mitotic arrest at prometaphase) and inhibition of proliferation, cell migration and angiogenesis by affecting signal transduction pathways such as RAF-MEK-MAPK or PI3K-Akt and other oncogenic and survival pathways [<xref rid="B180-ijms-20-02167" ref-type="bibr">180</xref>]. Unfortunately, clinical studies did not show robust anticancer activity [<xref rid="B190-ijms-20-02167" ref-type="bibr">190</xref>] with only several patients responding to FTIs both alone and in combination with other agents. In sum, some tumors depend on farnesylated proteins for survival, but further development is needed to apply this knowledge to the clinic [<xref rid="B180-ijms-20-02167" ref-type="bibr">180</xref>].</p><p>More recently, geranylgeranyltranseferase inhibitors (GGTIs) were developed. Ras protein isoforms were found to be geranylgeranylated when FTase was inhibited and some pathways downstream Ras were mediated by geranylgeranylated proteins [<xref rid="B191-ijms-20-02167" ref-type="bibr">191</xref>]. In cell and animal models, GGTIs block cell cycle in the G1 phase [<xref rid="B192-ijms-20-02167" ref-type="bibr">192</xref>], induce apoptosis, and inhibit tumor cell growth [<xref rid="B180-ijms-20-02167" ref-type="bibr">180</xref>].</p><p>Other protein susceptible to be targeted by prenylation inhibitors include proteins being exclusively farnesylated (e.g., HRAS and RAS homologue enriched in brain &#x02013;RHEB) or geranylgeranylated (e.g., RHOA, RHOC, RALA and RALB); although some can be both farnesylated or geranylgeranylated (e.g., RHOB) or become geranylgeranylated when farnesylation is inhibited (e.g., KRAS, as said above, and HRAS). Other prenylation inhibitors&#x02019; targets include tumor suppressors (such as ARHI, RERG, DBC2, RIG, RRP22) and other proteins (such as CENPE, CENPF, PRL phosphatases, lamin A and B, HDJ2, RND3, PEX19, RHOD, RHO6, RHO7, TC10 and PTGIR) (reviewed in [<xref rid="B180-ijms-20-02167" ref-type="bibr">180</xref>]).</p></sec></sec><sec id="sec6-ijms-20-02167"><title>6. New Lipid-Based Therapeutic Avenues: Membrane Lipid Therapy</title><sec id="sec6dot1-ijms-20-02167"><title>6.1. Molecular Bases of Targeting the Plasma Membrane</title><p>In the above sections it was made clear that many cell functions take place in membranes and their surroundings [<xref rid="B160-ijms-20-02167" ref-type="bibr">160</xref>]. Furthermore, it was reviewed how membrane components participate in functions altered in many human diseases [<xref rid="B19-ijms-20-02167" ref-type="bibr">19</xref>]. Those functions include changing the localization of key proteins in the cell, in turn, altering key protein-protein interactions in membrane microdomains. Subsequently, signaling cascades are altered and correct functioning of the cell is compromised. Hence, the new therapeutic approach, membrane lipid therapy (MLT), aims to target membrane components to modify membrane composition or structure, i.e., the drug-induced regulation of membrane lipid composition and structure [<xref rid="B113-ijms-20-02167" ref-type="bibr">113</xref>]. This strategy has shown not only efficacy, but also higher specificity and safety, and has become a potential alternative to conventional drugs [<xref rid="B6-ijms-20-02167" ref-type="bibr">6</xref>].</p><p>The variety of membrane microdomains based on different compositions and bearing specific biological properties was already introduced [<xref rid="B45-ijms-20-02167" ref-type="bibr">45</xref>]. Furthermore, membrane microdomain composition, and subsequently function, may be modified by both lipid intake and enzymatic regulation [<xref rid="B19-ijms-20-02167" ref-type="bibr">19</xref>]. Proteins involved in cell signaling interact with these microdomains and assemble crucial signaling platforms whose alteration might be pathological [<xref rid="B126-ijms-20-02167" ref-type="bibr">126</xref>,<xref rid="B127-ijms-20-02167" ref-type="bibr">127</xref>]. Thus, MLT aims to alter this protein signaling by modifying the composition and structure of the membrane microdomains and subsequently modulate cell signaling, offering potentially effective treatments for a variety of conditions [<xref rid="B113-ijms-20-02167" ref-type="bibr">113</xref>,<xref rid="B193-ijms-20-02167" ref-type="bibr">193</xref>,<xref rid="B194-ijms-20-02167" ref-type="bibr">194</xref>,<xref rid="B195-ijms-20-02167" ref-type="bibr">195</xref>]. The overall membrane lipid composition, the composition of membrane microdomains or the composition of internal organelles can be targeted by natural or modified lipids or drugs [<xref rid="B196-ijms-20-02167" ref-type="bibr">196</xref>,<xref rid="B197-ijms-20-02167" ref-type="bibr">197</xref>,<xref rid="B198-ijms-20-02167" ref-type="bibr">198</xref>]. For instance, proteins such as G proteins or protein kinase C (PKC), as well as stress response proteins or enzymes such as SMS alter their binding to membrane according to membrane composition and structure [<xref rid="B19-ijms-20-02167" ref-type="bibr">19</xref>].</p><p>Different regulatory effects might be obtained when targeting plasma membrane for therapy (<xref ref-type="fig" rid="ijms-20-02167-f005">Figure 5</xref>):<list list-type="bullet"><list-item><p>Direct regulation through membrane structure modification: Dietary lipids and environmental changes modify cell membranes changing their properties and microdomain organization, thus controlling the localization and activity of proteins such as G proteins (interaction with membrane and downstream signaling) [<xref rid="B199-ijms-20-02167" ref-type="bibr">199</xref>,<xref rid="B200-ijms-20-02167" ref-type="bibr">200</xref>], the transcription of proteins involved in stress response such as heat shock proteins (Hsp) [<xref rid="B201-ijms-20-02167" ref-type="bibr">201</xref>], or the production of second messengers such as Cer [<xref rid="B202-ijms-20-02167" ref-type="bibr">202</xref>]. Thus, MUFA treatments can change the order of Lo and Ld microdomains.</p></list-item><list-item><p>Regulation of enzymatic activity to alter membrane lipid levels: Enzymatic activity of SMS and other enzymes from SL metabolism are altered in cancer and consequently modify membrane composition and structure. Hydroxyl-C18 unsaturated fatty acids (hydroxyoleic, hydroxilinoleic, hydroxy-&#x003b1;-linolenic and hydroxy-&#x003b3;-linolenic acids) have effects on SMS activity [<xref rid="B138-ijms-20-02167" ref-type="bibr">138</xref>].</p></list-item><list-item><p>Modification of gene expression that results in alterations of membrane lipid composition: this gene expression change might affect the activity of an enzyme, protein-lipid interactions or protein-protein interaction. DNA-associated PL are found in nuclear membrane [<xref rid="B203-ijms-20-02167" ref-type="bibr">203</xref>] and their effects on nuclear functions have been documented [<xref rid="B103-ijms-20-02167" ref-type="bibr">103</xref>]. Evidence of this type of MLT include the increased SM levels in differentiated cells in contrast to low levels of this lipid on proliferating cells [<xref rid="B138-ijms-20-02167" ref-type="bibr">138</xref>]. This increase does not take place with SM addition but for SMS increased activity [<xref rid="B138-ijms-20-02167" ref-type="bibr">138</xref>,<xref rid="B139-ijms-20-02167" ref-type="bibr">139</xref>], which supports the concept of MLT-induced gene expression alteration.</p></list-item><list-item><p>Lipid alterations that affect protein-protein interactions in specific membrane microdomains: The alteration of lipid ratios or the presence of particular lipids in membranes cause changes in protein-protein interactions. For example, low PtdEtn/SM ratios reduce Ras interactions both with membrane components and with downstream partners, in turn, inhibiting the transduction through proliferative signaling cascades and preventing proliferation in cancer cells [<xref rid="B139-ijms-20-02167" ref-type="bibr">139</xref>].</p></list-item><list-item><p>Direct MLT-drug binding to a protein that alters its membrane binding affinity or that of other signaling proteins: In that case, the MLT formulated molecule binds to a protein rather than a lipid. This is the case of prenylation inhibitors, which prevent Ras from binding to membrane and subsequently inhibit cancer cell proliferation while inducing cell differentiation and cell death [<xref rid="B139-ijms-20-02167" ref-type="bibr">139</xref>].</p></list-item></list></p></sec><sec id="sec6dot2-ijms-20-02167"><title>6.2. Development of Membrane Lipid Therapy in Different Therapeutic Areas</title><p>In MLT, synthetic fatty acids are newly designed with the aim of regulating membrane microdomain distribution mimicking natural lipids [<xref rid="B204-ijms-20-02167" ref-type="bibr">204</xref>]. Thus, MLT is a sophisticated therapeutic approach to make protein&#x02013;protein interactions targetable in an environment where those interactions are not amenable to manipulation [<xref rid="B139-ijms-20-02167" ref-type="bibr">139</xref>,<xref rid="B205-ijms-20-02167" ref-type="bibr">205</xref>,<xref rid="B206-ijms-20-02167" ref-type="bibr">206</xref>]. Many diseases are already being targeted by MLT. The most relevant fields in which MLT molecules are being developed are listed below and further reviewed in [<xref rid="B19-ijms-20-02167" ref-type="bibr">19</xref>] (<xref ref-type="fig" rid="ijms-20-02167-f006">Figure 6</xref>).<list list-type="bullet"><list-item><p>Oncology. The basis of developing MLT in oncology comes from the finding that membrane lipid composition might work as a switch allowing or compromising propagation of proliferation signals received at the PM in tumor cells [<xref rid="B196-ijms-20-02167" ref-type="bibr">196</xref>,<xref rid="B207-ijms-20-02167" ref-type="bibr">207</xref>]. Many molecules have been developed since the discovery membrane-altering mechanism of action of doxorubicin [<xref rid="B199-ijms-20-02167" ref-type="bibr">199</xref>]. One of the most promising molecules is rationally-designed 2-OHOA (2-hydroxyoleic acid) [<xref rid="B208-ijms-20-02167" ref-type="bibr">208</xref>], which is currently being tested in clinical trials for the treatment of glioma. 2-OHOA activates SMS increasing its product, SM, and decreasing its substrate PtdEtn in membranes of cancer cells but not of healthy cells because of the higher levels of SM found in tumor cells [<xref rid="B138-ijms-20-02167" ref-type="bibr">138</xref>]. 2OHOA was the first rationally designed MLT molecule to arrive clinical trials. It has shown good pharmaceutical efficacy and safety against cancer in humans (ClinicalTrials.gov identifier #NCT01792310). After a first-in-man phase I/IIA trial in patients with solid tumors, 43% glioma patients responded to treatment, although this percentage almost doubled (ca. 80%) if patients previously pretreated with avastin were disregarded [<xref rid="B6-ijms-20-02167" ref-type="bibr">6</xref>]. Other molecules being explored in oncology follow here: 2-hydroxylinoleic acid is on phase II clinical trial. This PUFA binds to membrane and inhibits the Akt/mTORC1 axis and induces specific cancer cell autophagy [<xref rid="B209-ijms-20-02167" ref-type="bibr">209</xref>]. Hydroxytriolein is a triacylglycerol mimetic synthetic lipid analogue of triolein shown to block cancer cell growth in vitro through the &#x003b2;-catenin pathway, downregulation of the MEK-ERK axis, and production of Reactive Oxygen Species and apoptosis [<xref rid="B210-ijms-20-02167" ref-type="bibr">210</xref>]. Worth mentioning are propofol-docosahexaenoic acid (P-DHA) and its analogue edelfosine (reviewed in [<xref rid="B6-ijms-20-02167" ref-type="bibr">6</xref>]). Examples of anticancer therapies based on inhibitors targeting enzyme regulators of lipid metabolism are orlistat (Roche Xenical<sup>&#x000ae;</sup>), a FASN inhibitor administered in the treatment of breast cancer [<xref rid="B211-ijms-20-02167" ref-type="bibr">211</xref>]; and ABC294640, a sphingosine kinase 2 and dihydroceramide desaturase inhibitor currently under an Ib/II clinical trial (ClinicalTrials.gov identifier #NCT02757326).</p></list-item><list-item><p>Metabolic and cardiovascular diseases: The use of dietary lipids for the treatment of diabetes or obesity is a clear case of MLT. For example, body weight reductions where achieved in rats with daily supplements of olive oil (made of 70%&#x02013;80% oleic acid) but not with supplements of its trans analogue elaidic acid, due to the different structure of both FA [<xref rid="B44-ijms-20-02167" ref-type="bibr">44</xref>,<xref rid="B212-ijms-20-02167" ref-type="bibr">212</xref>]. Furthermore, oleic acid analogues induce reduction of body weight in rats by promoting overexpression of uncoupling proteins UCP1 and UCP3 and decreasing food intake [<xref rid="B212-ijms-20-02167" ref-type="bibr">212</xref>]. A high intake of oleic acid has also been shown to improve glycemic status and reduce saturated FA levels of diabetic patients while increasing those of unsaturated FA [<xref rid="B159-ijms-20-02167" ref-type="bibr">159</xref>]. In the case of cardiovascular conditions, high oleic acid intake and &#x003c9;-3 FA consumption were linked to reduced blood pressure values [<xref rid="B213-ijms-20-02167" ref-type="bibr">213</xref>,<xref rid="B214-ijms-20-02167" ref-type="bibr">214</xref>]. This reduction is even greater with 2-hydroxioleic acid treatment [<xref rid="B215-ijms-20-02167" ref-type="bibr">215</xref>,<xref rid="B216-ijms-20-02167" ref-type="bibr">216</xref>]. Furthermore, unsaturated FA are cardioprotective [<xref rid="B217-ijms-20-02167" ref-type="bibr">217</xref>].</p></list-item><list-item><p>Neurodegenerative disorders: Behind adipose tissue, the central nervous system concentrates the largest depot of lipids in the body making it a primary target for MLT strategies. Alzheimer&#x02019;s disease risk has been inversely associated with &#x003c9;-3 polyunsaturated fatty acid (PUFA) consumption [<xref rid="B218-ijms-20-02167" ref-type="bibr">218</xref>]. In detail, the altered amyloid precursor protein (APP) proteolysis upon DHA abundance was the basis to design 2-hydroxioleic-DHA (2-OHDHA). A four-month treatment with 2-OHDHA in a severe Alzheimer&#x02019;s disease mice model (5XFAD) restored cognition to control values [<xref rid="B219-ijms-20-02167" ref-type="bibr">219</xref>,<xref rid="B220-ijms-20-02167" ref-type="bibr">220</xref>]. Spinal cord injury might also benefit from MLT approaches (reviewed in [<xref rid="B19-ijms-20-02167" ref-type="bibr">19</xref>]). Albumin-oleic acid complex induces significant motor recovery (~ 40%) in rats with spinal cord injury (SCI) [<xref rid="B221-ijms-20-02167" ref-type="bibr">221</xref>], ameliorating both spasticity and pain. The oleic acid analogue NFX88 (Neurofix) is undergoing clinical trials for the treatment of neuropathic pain in patients with SCI. Finally, a phase II/III clinical trial (ClinicalTrials.gov identifier #NCT00706147) is being developed to evaluate the efficacy of the lipid interacting hydroxylamine derivative arimoclomol in familial amyotrophic lateral sclerosis.</p></list-item><list-item><p>Other conditions that are bound to be ameliorated using MLT include infectious diseases, chemotherapeutic neuropathy, wound healing, retinopathies, nephropathies, acetaminophen liver toxicity, sunburn, ischemia reperfusion, intracranial hemorrhage, atrial fibrillation, vascular hypertension damage, and myocardial infarction as reviewed in [<xref rid="B19-ijms-20-02167" ref-type="bibr">19</xref>].</p></list-item></list></p></sec></sec><sec id="sec7-ijms-20-02167"><title>7. Future Directions and Conclusions</title><p>Initially described as pure barriers, biological membranes are currently viewed as active players in cell and organelle architecture and physiology. Lipid composition peculiarities of the different cell compartments is behind their specific structural properties and functionalities. Indeed, lipid dysregulation is a relevant factor in the etiology of many diseases. To exploit these new therapeutic avenues, lipids (both natural and synthetic) are being developed as potential drugs for different conditions using the MLT approach and are bound to constitute alternative or innovative therapies for fields in which there are no available or promising treatments.</p></sec></body><back><ack><title>Acknowledgments</title><p>We apologize to all authors whose work could not be cited due to space constraints. The authors thank C Hoffmann for editorial assistance.</p></ack><notes><title>Author Contributions</title><p>D.C. wrote and revised the manuscript. P.V.E. provided guidance and funding; C.A.R. conceived and designed the manuscript, collected the relevant references and, wrote and revised the manuscript.</p></notes><notes><title>Funding</title><p>This research was funded by Spanish Ministerio de Econom&#x000ed;a y Competitividad and European Regional Development Fund (grant numbers RTC-2015- 3542 and RTC-2015-4094), the Marathon Foundation, the European Commission H2020 Framework Programme (agreement number 755179), the Spanish research agency (grant DI-17-09187), the European Commission Seventh Framework Programme (agreement number PIEF-GA-2013-627441) and the Balearic Island Government and European Social Fund (grant number PD/036/2016).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><glossary><title>Abbreviations</title><array orientation="portrait"><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">2-OHDHA</td><td align="left" valign="top" rowspan="1" colspan="1">2-hydroxydocosahexanoic acid</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2-OHOA</td><td align="left" valign="top" rowspan="1" colspan="1">2-hydroxyoleic acid</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ACC</td><td align="left" valign="top" rowspan="1" colspan="1">acetyl-CoA carboxylase</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ALPS </td><td align="left" valign="top" rowspan="1" colspan="1">amphipathic lipid packing sensor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APP</td><td align="left" valign="top" rowspan="1" colspan="1">amyloid precursor protein</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APS</td><td align="left" valign="top" rowspan="1" colspan="1">anti-phospholipid syndrome</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BmP </td><td align="left" valign="top" rowspan="1" colspan="1">bis(monoacylglycero)phosphate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">C1P </td><td align="left" valign="top" rowspan="1" colspan="1">ceramide-1-phosphate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CLIC</td><td align="left" valign="top" rowspan="1" colspan="1">clathrin-independent carrier</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CDP-DAG</td><td align="left" valign="top" rowspan="1" colspan="1">cytidine diphosphate diacylglycerol</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cer </td><td align="left" valign="top" rowspan="1" colspan="1">ceramide</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CerK </td><td align="left" valign="top" rowspan="1" colspan="1">ceramide kinase</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chol </td><td align="left" valign="top" rowspan="1" colspan="1">cholesterol</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CL </td><td align="left" valign="top" rowspan="1" colspan="1">cardiolipin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">COP</td><td align="left" valign="top" rowspan="1" colspan="1">coat protein complex</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DAG</td><td align="left" valign="top" rowspan="1" colspan="1">diacylglycerol</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DMC</td><td align="left" valign="top" rowspan="1" colspan="1">DNA&#x02013;membrane complexes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ER</td><td align="left" valign="top" rowspan="1" colspan="1">endoplasmic reticulum</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ESCRT</td><td align="left" valign="top" rowspan="1" colspan="1">endosomal sorting complexes required for transport</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FASN </td><td align="left" valign="top" rowspan="1" colspan="1">fatty acid synthase</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FD</td><td align="left" valign="top" rowspan="1" colspan="1">Fabry disease</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FTase</td><td align="left" valign="top" rowspan="1" colspan="1">farnesyltransferase</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">FTI</td><td align="left" valign="top" rowspan="1" colspan="1">farnesyltransferase inhibitor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GalCer </td><td align="left" valign="top" rowspan="1" colspan="1">galactosylceramide</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GD</td><td align="left" valign="top" rowspan="1" colspan="1">Gaucher disease</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GEEC</td><td align="left" valign="top" rowspan="1" colspan="1">(GptdIns)-anchor-enriched endocytic compartment</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GEF</td><td align="left" valign="top" rowspan="1" colspan="1">guanine nucleotide exchange factors</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GGTase</td><td align="left" valign="top" rowspan="1" colspan="1">geranylgeranyltransferase</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GGTI</td><td align="left" valign="top" rowspan="1" colspan="1">geranylgeranyltransferase inhibitor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GlcCer </td><td align="left" valign="top" rowspan="1" colspan="1">glucosylceramide</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GLRX </td><td align="left" valign="top" rowspan="1" colspan="1">glutaredoxin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GPL </td><td align="left" valign="top" rowspan="1" colspan="1">glycerophospholipids</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GptdIns</td><td align="left" valign="top" rowspan="1" colspan="1">glycosylphosphatidylinositol</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GSL </td><td align="left" valign="top" rowspan="1" colspan="1">glycosphingolipid</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GTPase</td><td align="left" valign="top" rowspan="1" colspan="1">guanosine-5&#x02032;-triphosphate hydrolase</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hsp</td><td align="left" valign="top" rowspan="1" colspan="1">heat shock protein</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IMM </td><td align="left" valign="top" rowspan="1" colspan="1">inner mitochondrial membrane</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">IMS </td><td align="left" valign="top" rowspan="1" colspan="1">intermembrane space</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">INM </td><td align="left" valign="top" rowspan="1" colspan="1">inner nuclear membrane</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">INSIG1 </td><td align="left" valign="top" rowspan="1" colspan="1">insulin induced gene 1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">KD</td><td align="left" valign="top" rowspan="1" colspan="1">Krabbe disease</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LA </td><td align="left" valign="top" rowspan="1" colspan="1">lupus anticoagulant</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LacCer </td><td align="left" valign="top" rowspan="1" colspan="1">lactosylceramide</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ld </td><td align="left" valign="top" rowspan="1" colspan="1">Liquid-disordered</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LDL </td><td align="left" valign="top" rowspan="1" colspan="1">low-density lipoprotein</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LECA</td><td align="left" valign="top" rowspan="1" colspan="1">last eukaryotic common ancestor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lo </td><td align="left" valign="top" rowspan="1" colspan="1">Liquid-ordered</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LPA</td><td align="left" valign="top" rowspan="1" colspan="1">lysoPA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LPC </td><td align="left" valign="top" rowspan="1" colspan="1">lysoPtdCho</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LSD </td><td align="left" valign="top" rowspan="1" colspan="1">lysosomal storage disease</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LTP </td><td align="left" valign="top" rowspan="1" colspan="1">lipid transfer protein</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">LUCA</td><td align="left" valign="top" rowspan="1" colspan="1">last universal common ancestor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MAM </td><td align="left" valign="top" rowspan="1" colspan="1">mitochondria associated membrane</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MCS </td><td align="left" valign="top" rowspan="1" colspan="1">membrane contact site</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MLT </td><td align="left" valign="top" rowspan="1" colspan="1">membrane lipid therapy</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MUFA</td><td align="left" valign="top" rowspan="1" colspan="1">monounsaturated fatty acid</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NE </td><td align="left" valign="top" rowspan="1" colspan="1">nuclear envelope</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NM </td><td align="left" valign="top" rowspan="1" colspan="1">nuclear membrane</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NPC </td><td align="left" valign="top" rowspan="1" colspan="1">nuclear pore complex</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NSF</td><td align="left" valign="top" rowspan="1" colspan="1">N-ethylmaleimide-sensitive factor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">OLR1 </td><td align="left" valign="top" rowspan="1" colspan="1">oxidized low density lipoprotein receptor 1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">OMM </td><td align="left" valign="top" rowspan="1" colspan="1">outer mitochondrial membrane</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ONM </td><td align="left" valign="top" rowspan="1" colspan="1">outer nuclear membrane</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P4-ATPase </td><td align="left" valign="top" rowspan="1" colspan="1">type 4 P-type ATPases</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P-DHA</td><td align="left" valign="top" rowspan="1" colspan="1">propofol-docosahexaenoic acid</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PA </td><td align="left" valign="top" rowspan="1" colspan="1">phosphatidic acid</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PKC</td><td align="left" valign="top" rowspan="1" colspan="1">protein kinase C</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PL </td><td align="left" valign="top" rowspan="1" colspan="1">phospholipids</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PM </td><td align="left" valign="top" rowspan="1" colspan="1">plasma membrane</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PPAR-&#x003b3; </td><td align="left" valign="top" rowspan="1" colspan="1">peroxisome proliferator-activated receptor-&#x003b3;</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PPIn </td><td align="left" valign="top" rowspan="1" colspan="1">polyphosphoinositides</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PtdCho </td><td align="left" valign="top" rowspan="1" colspan="1">phosphatidylcholine</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PtdEtn </td><td align="left" valign="top" rowspan="1" colspan="1">phosphatidylethanolamine</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PtdGro </td><td align="left" valign="top" rowspan="1" colspan="1">phosphatidylglycerol</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PtdIns </td><td align="left" valign="top" rowspan="1" colspan="1">phosphatidylinositol</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PtdIns(1,4,5)P3</td><td align="left" valign="top" rowspan="1" colspan="1">phosphatidylinositol 1,4,5- trisphosphate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PtdIns(3,4,5)P3</td><td align="left" valign="top" rowspan="1" colspan="1">phosphatidylinositol 3,4,5-trisphosphate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PtdIns(4,5)P2</td><td align="left" valign="top" rowspan="1" colspan="1">phosphatidylinositol 4,5- bisphosphate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PtdIns4P</td><td align="left" valign="top" rowspan="1" colspan="1">phosphatidylinositol 4-phosphate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PtdInsP</td><td align="left" valign="top" rowspan="1" colspan="1">phosphatidylinositol phosphate</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PtdSer</td><td align="left" valign="top" rowspan="1" colspan="1">phosphatidylserine</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SL </td><td align="left" valign="top" rowspan="1" colspan="1">sphingolipids</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SM </td><td align="left" valign="top" rowspan="1" colspan="1">sphingomyelin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SMase </td><td align="left" valign="top" rowspan="1" colspan="1">sphingomyelinase</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SMS </td><td align="left" valign="top" rowspan="1" colspan="1">sphingomyelin synthase</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SNARE</td><td align="left" valign="top" rowspan="1" colspan="1">soluble N-ethylmaleimide-sensitive factor attachment protein receptor</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SPC </td><td align="left" valign="top" rowspan="1" colspan="1">sphingosylphosphorylcholine</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sph </td><td align="left" valign="top" rowspan="1" colspan="1">sphingosine</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SphK </td><td align="left" valign="top" rowspan="1" colspan="1">sphingosine kinase</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SREBP </td><td align="left" valign="top" rowspan="1" colspan="1">sterol regulatory element-binding protein</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TFEB </td><td align="left" valign="top" rowspan="1" colspan="1">transcription factor EB</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TMDs </td><td align="left" valign="top" rowspan="1" colspan="1">transmembrane domains</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">UCP</td><td align="left" valign="top" rowspan="1" colspan="1">uncoupling protein</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-ijms-20-02167"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>S.B.</given-names></name></person-group><article-title>Membranes and evolution</article-title><source>Curr. Biol.</source><year>2018</year><volume>28</volume><fpage>R381</fpage><lpage>R385</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2018.01.086</pub-id><?supplied-pmid 29689219?><pub-id pub-id-type="pmid">29689219</pub-id></element-citation></ref><ref id="B2-ijms-20-02167"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singer</surname><given-names>S.J.</given-names></name><name><surname>Nicolson</surname><given-names>G.L.</given-names></name></person-group><article-title>The Fluid Mosaic Model of the Structure of Cell Membranes</article-title><source>Science</source><year>1972</year><volume>175</volume><fpage>720</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.1126/science.175.4023.720</pub-id><?supplied-pmid 4333397?><pub-id pub-id-type="pmid">4333397</pub-id></element-citation></ref><ref id="B3-ijms-20-02167"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>M.</given-names></name><name><surname>Evans</surname><given-names>E.</given-names></name><name><surname>Mouritsen</surname><given-names>O.G.</given-names></name></person-group><article-title>Physical properties of the fluid lipid-bilayer component of cell membranes: a perspective</article-title><source>Q. Rev. Biophys.</source><year>1991</year><volume>24</volume><fpage>293</fpage><pub-id pub-id-type="doi">10.1017/S0033583500003735</pub-id><pub-id pub-id-type="pmid">1749824</pub-id></element-citation></ref><ref id="B4-ijms-20-02167"><label>4.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>M.</given-names></name><name><surname>Mouritsen</surname><given-names>O.G.</given-names></name></person-group><article-title>The Evolution of Membranes</article-title><source>Handbook of Biological Physics</source><publisher-name>Elsevier BV</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>1995</year><volume>Vol. 1</volume><fpage>65</fpage><lpage>95</lpage><isbn>0008-4042</isbn></element-citation></ref><ref id="B5-ijms-20-02167"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karnovsky</surname><given-names>M.J.</given-names></name></person-group><article-title>The concept of lipid domains in membranes</article-title><source>J. Cell Biol.</source><year>1982</year><volume>94</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1083/jcb.94.1.1</pub-id><?supplied-pmid 6889603?><pub-id pub-id-type="pmid">6889603</pub-id></element-citation></ref><ref id="B6-ijms-20-02167"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name></person-group><article-title>Membrane-lipid therapy: A historical perspective of membrane-targeted therapies &#x02014; From lipid bilayer structure to the pathophysiological regulation of cells</article-title><source>Biochim. Biophys. Acta BBA - Biomembr.</source><year>2017</year><volume>1859</volume><fpage>1493</fpage><lpage>1506</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2017.05.017</pub-id><?supplied-pmid 28577973?><pub-id pub-id-type="pmid">28577973</pub-id></element-citation></ref><ref id="B7-ijms-20-02167"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sackmann</surname><given-names>E.</given-names></name></person-group><article-title>Molecular and global structure and dynamics of membranes and lipid bilayers</article-title><source>Can. J. Phys.</source><year>1990</year><volume>68</volume><fpage>999</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.1139/p90-142</pub-id></element-citation></ref><ref id="B8-ijms-20-02167"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dacks</surname><given-names>J.B.</given-names></name><name><surname>Field</surname><given-names>M.C.</given-names></name></person-group><article-title>Evolution of the eukaryotic membrane-trafficking system: origin, tempo and mode</article-title><source>J. Cell Sci.</source><year>2007</year><volume>120</volume><fpage>2977</fpage><lpage>2985</lpage><pub-id pub-id-type="doi">10.1242/jcs.013250</pub-id><?supplied-pmid 17715154?><pub-id pub-id-type="pmid">17715154</pub-id></element-citation></ref><ref id="B9-ijms-20-02167"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deamer</surname><given-names>D.W.</given-names></name></person-group><article-title>Boundary structures are formed by organic components of the Murchison carbonaceous chondrite</article-title><source>Nature</source><year>1985</year><volume>317</volume><fpage>792</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.1038/317792a0</pub-id></element-citation></ref><ref id="B10-ijms-20-02167"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morowitz</surname><given-names>H.J.</given-names></name><name><surname>Heinz</surname><given-names>B.</given-names></name><name><surname>Deamer</surname><given-names>D.W.</given-names></name></person-group><article-title>The chemical logic of a minimum protocell</article-title><source>Orig. Life Evol. Biosph.</source><year>1988</year><volume>18</volume><fpage>281</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1007/BF01804674</pub-id><pub-id pub-id-type="pmid">3226720</pub-id></element-citation></ref><ref id="B11-ijms-20-02167"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gl&#x000f6;ckner</surname><given-names>F.O.</given-names></name><name><surname>Kube</surname><given-names>M.</given-names></name><name><surname>Bauer</surname><given-names>M.</given-names></name><name><surname>Teeling</surname><given-names>H.</given-names></name><name><surname>Lombardot</surname><given-names>T.</given-names></name><name><surname>Ludwig</surname><given-names>W.</given-names></name><name><surname>Gade</surname><given-names>D.</given-names></name><name><surname>Beck</surname><given-names>A.</given-names></name><name><surname>Borzym</surname><given-names>K.</given-names></name><name><surname>Heitmann</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Complete genome sequence of the marine planctomycete Pirellula sp. strain 1</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2003</year><volume>100</volume><fpage>8298</fpage><lpage>8303</lpage><pub-id pub-id-type="doi">10.1073/pnas.1431443100</pub-id><pub-id pub-id-type="pmid">12835416</pub-id></element-citation></ref><ref id="B12-ijms-20-02167"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranea</surname><given-names>J.A.G.</given-names></name><name><surname>Sillero</surname><given-names>A.</given-names></name><name><surname>Thornton</surname><given-names>J.M.</given-names></name><name><surname>Orengo</surname><given-names>C.A.</given-names></name></person-group><article-title>Protein Superfamily Evolution and the Last Universal Common Ancestor (LUCA)</article-title><source>J. Mol. Evol.</source><year>2006</year><volume>63</volume><fpage>513</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1007/s00239-005-0289-7</pub-id><?supplied-pmid 17021929?><pub-id pub-id-type="pmid">17021929</pub-id></element-citation></ref><ref id="B13-ijms-20-02167"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonifacino</surname><given-names>J.S.</given-names></name><name><surname>Glick</surname><given-names>B.S.</given-names></name></person-group><article-title>The Mechanisms of Vesicle Budding and Fusion</article-title><source>Cell</source><year>2004</year><volume>116</volume><fpage>153</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(03)01079-1</pub-id><pub-id pub-id-type="pmid">14744428</pub-id></element-citation></ref><ref id="B14-ijms-20-02167"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shevchenko</surname><given-names>A.</given-names></name><name><surname>Simons</surname><given-names>K.</given-names></name></person-group><article-title>Lipidomics: coming to grips with lipid diversity</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2010</year><volume>11</volume><fpage>593</fpage><lpage>598</lpage><pub-id pub-id-type="doi">10.1038/nrm2934</pub-id><pub-id pub-id-type="pmid">20606693</pub-id></element-citation></ref><ref id="B15-ijms-20-02167"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>R.</given-names></name><name><surname>Ballweg</surname><given-names>S.</given-names></name><name><surname>Levental</surname><given-names>I.</given-names></name></person-group><article-title>Cellular mechanisms of physicochemical membrane homeostasis</article-title><source>Curr. Opin. Cell Biol.</source><year>2018</year><volume>53</volume><fpage>44</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2018.04.013</pub-id><?supplied-pmid 29787971?><pub-id pub-id-type="pmid">29787971</pub-id></element-citation></ref><ref id="B16-ijms-20-02167"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Meer</surname><given-names>G.</given-names></name><name><surname>Voelker</surname><given-names>D.R.</given-names></name><name><surname>Feigenson</surname><given-names>G.W.</given-names></name></person-group><article-title>Membrane lipids: where they are and how they behave</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2008</year><volume>9</volume><fpage>112</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1038/nrm2330</pub-id><pub-id pub-id-type="pmid">18216768</pub-id></element-citation></ref><ref id="B17-ijms-20-02167"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holthuis</surname><given-names>J.C.M.</given-names></name><name><surname>Menon</surname><given-names>A.K.</given-names></name></person-group><article-title>Lipid landscapes and pipelines in membrane homeostasis</article-title><source>Nature</source><year>2014</year><volume>510</volume><fpage>48</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nature13474</pub-id><pub-id pub-id-type="pmid">24899304</pub-id></element-citation></ref><ref id="B18-ijms-20-02167"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Kroon</surname><given-names>A.I.P.M.</given-names></name><name><surname>Rijken</surname><given-names>P.J.</given-names></name><name><surname>De Smet</surname><given-names>C.H.</given-names></name></person-group><article-title>Checks and balances in membrane phospholipid class and acyl chain homeostasis, the yeast perspective</article-title><source>Prog. Lipid Res.</source><year>2013</year><volume>52</volume><fpage>374</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/j.plipres.2013.04.006</pub-id><?supplied-pmid 23631861?><pub-id pub-id-type="pmid">23631861</pub-id></element-citation></ref><ref id="B19-ijms-20-02167"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name><name><surname>Busquets</surname><given-names>X.</given-names></name><name><surname>Inokuchi</surname><given-names>J.</given-names></name><name><surname>Balogh</surname><given-names>G.</given-names></name><name><surname>T&#x000f6;r&#x000f6;k</surname><given-names>Z.</given-names></name><name><surname>Horv&#x000e1;th</surname><given-names>I.</given-names></name><name><surname>Harwood</surname><given-names>J.L.</given-names></name><name><surname>V&#x000ed;gh</surname><given-names>L.</given-names></name></person-group><article-title>Membrane lipid therapy: Modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment</article-title><source>Prog. Lipid Res.</source><year>2015</year><volume>59</volume><fpage>38</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.plipres.2015.04.003</pub-id><pub-id pub-id-type="pmid">25969421</pub-id></element-citation></ref><ref id="B20-ijms-20-02167"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Meer</surname><given-names>G.</given-names></name><name><surname>Lisman</surname><given-names>Q.</given-names></name></person-group><article-title>Sphingolipid Transport: Rafts and Translocators</article-title><source>J. Biol. Chem.</source><year>2002</year><volume>277</volume><fpage>25855</fpage><lpage>25858</lpage><pub-id pub-id-type="doi">10.1074/jbc.R200010200</pub-id><pub-id pub-id-type="pmid">12011105</pub-id></element-citation></ref><ref id="B21-ijms-20-02167"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikonen</surname><given-names>E.</given-names></name></person-group><article-title>Cellular cholesterol trafficking and compartmentalization</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2008</year><volume>9</volume><fpage>125</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1038/nrm2336</pub-id><pub-id pub-id-type="pmid">18216769</pub-id></element-citation></ref><ref id="B22-ijms-20-02167"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hullin-Matsuda</surname><given-names>F.</given-names></name><name><surname>Taguchi</surname><given-names>T.</given-names></name><name><surname>Greimel</surname><given-names>P.</given-names></name><name><surname>Kobayashi</surname><given-names>T.</given-names></name></person-group><article-title>Lipid compartmentalization in the endosome system</article-title><source>Semin. Cell Dev. Biol.</source><year>2014</year><volume>31</volume><fpage>48</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2014.04.010</pub-id><pub-id pub-id-type="pmid">24747366</pub-id></element-citation></ref><ref id="B23-ijms-20-02167"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz-Rohrer</surname><given-names>B.B.</given-names></name><name><surname>Levental</surname><given-names>K.R.</given-names></name><name><surname>Simons</surname><given-names>K.</given-names></name><name><surname>Levental</surname><given-names>I.</given-names></name></person-group><article-title>Membrane raft association is a determinant of plasma membrane localization</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2014</year><volume>111</volume><fpage>8500</fpage><lpage>8505</lpage><pub-id pub-id-type="doi">10.1073/pnas.1404582111</pub-id><pub-id pub-id-type="pmid">24912166</pub-id></element-citation></ref><ref id="B24-ijms-20-02167"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz-Rohrer</surname><given-names>B.</given-names></name><name><surname>Levental</surname><given-names>K.R.</given-names></name><name><surname>Levental</surname><given-names>I.</given-names></name></person-group><article-title>Rafting through traffic: Membrane domains in cellular logistics</article-title><source>Biochim. Biophys. Acta BBA - Biomembr.</source><year>2014</year><volume>1838</volume><fpage>3003</fpage><lpage>3013</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2014.07.029</pub-id></element-citation></ref><ref id="B25-ijms-20-02167"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharpe</surname><given-names>H.J.</given-names></name><name><surname>Stevens</surname><given-names>T.J.</given-names></name><name><surname>Munro</surname><given-names>S.</given-names></name></person-group><article-title>A Comprehensive Comparison of Transmembrane Domains Reveals Organelle-Specific Properties</article-title><source>Cell</source><year>2010</year><volume>142</volume><fpage>158</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.05.037</pub-id><pub-id pub-id-type="pmid">20603021</pub-id></element-citation></ref><ref id="B26-ijms-20-02167"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorent</surname><given-names>J.H.</given-names></name><name><surname>Diaz-Rohrer</surname><given-names>B.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Spring</surname><given-names>K.</given-names></name><name><surname>Gorfe</surname><given-names>A.A.</given-names></name><name><surname>Levental</surname><given-names>K.R.</given-names></name><name><surname>Levental</surname><given-names>I.</given-names></name></person-group><article-title>Structural determinants and functional consequences of protein affinity for membrane rafts</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>1219</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-01328-3</pub-id><pub-id pub-id-type="pmid">29089556</pub-id></element-citation></ref><ref id="B27-ijms-20-02167"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covino</surname><given-names>R.</given-names></name><name><surname>Ballweg</surname><given-names>S.</given-names></name><name><surname>Stordeur</surname><given-names>C.</given-names></name><name><surname>Michaelis</surname><given-names>J.B.</given-names></name><name><surname>Puth</surname><given-names>K.</given-names></name><name><surname>Wernig</surname><given-names>F.</given-names></name><name><surname>Bahrami</surname><given-names>A.</given-names></name><name><surname>Ernst</surname><given-names>A.M.</given-names></name><name><surname>Hummer</surname><given-names>G.</given-names></name><name><surname>Ernst</surname><given-names>R.</given-names></name></person-group><article-title>A Eukaryotic Sensor for Membrane Lipid Saturation</article-title><source>Mol. Cell</source><year>2016</year><volume>63</volume><fpage>49</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.05.015</pub-id><pub-id pub-id-type="pmid">27320200</pub-id></element-citation></ref><ref id="B28-ijms-20-02167"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballweg</surname><given-names>S.</given-names></name><name><surname>Ernst</surname><given-names>R.</given-names></name></person-group><article-title>Control of membrane fluidity: the OLE pathway in focus</article-title><source>Biol. Chem.</source><year>2017</year><volume>398</volume><pub-id pub-id-type="doi">10.1515/hsz-2016-0277</pub-id><?supplied-pmid 27787227?><pub-id pub-id-type="pmid">27787227</pub-id></element-citation></ref><ref id="B29-ijms-20-02167"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loewen</surname><given-names>C.J.R.</given-names></name></person-group><article-title>Phospholipid Metabolism Regulated by a Transcription Factor Sensing Phosphatidic Acid</article-title><source>Science</source><year>2004</year><volume>304</volume><fpage>1644</fpage><lpage>1647</lpage><pub-id pub-id-type="doi">10.1126/science.1096083</pub-id><pub-id pub-id-type="pmid">15192221</pub-id></element-citation></ref><ref id="B30-ijms-20-02167"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halbleib</surname><given-names>K.</given-names></name><name><surname>Pesek</surname><given-names>K.</given-names></name><name><surname>Covino</surname><given-names>R.</given-names></name><name><surname>Hofbauer</surname><given-names>H.F.</given-names></name><name><surname>Wunnicke</surname><given-names>D.</given-names></name><name><surname>H&#x000e4;nelt</surname><given-names>I.</given-names></name><name><surname>Hummer</surname><given-names>G.</given-names></name><name><surname>Ernst</surname><given-names>R.</given-names></name></person-group><article-title>Activation of the Unfolded Protein Response by Lipid Bilayer Stress</article-title><source>Mol. Cell</source><year>2017</year><volume>67</volume><fpage>673</fpage><lpage>684.e8</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.06.012</pub-id><?supplied-pmid 28689662?><pub-id pub-id-type="pmid">28689662</pub-id></element-citation></ref><ref id="B31-ijms-20-02167"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>R.M.</given-names></name><name><surname>Ballas</surname><given-names>L.M.</given-names></name><name><surname>Coleman</surname><given-names>R.A.</given-names></name></person-group><article-title>Lipid topogenesis</article-title><source>J. Lipid Res.</source><year>1981</year><volume>22</volume><fpage>391</fpage><lpage>403</lpage><?supplied-pmid 7017050?><pub-id pub-id-type="pmid">7017050</pub-id></element-citation></ref><ref id="B32-ijms-20-02167"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sprong</surname><given-names>H.</given-names></name><name><surname>Kruithof</surname><given-names>B.</given-names></name><name><surname>Leijendekker</surname><given-names>R.</given-names></name><name><surname>Slot</surname><given-names>J.W.</given-names></name><name><surname>van Meer</surname><given-names>G.</given-names></name><name><surname>van der Sluijs</surname><given-names>P.</given-names></name></person-group><article-title>UDP-Galactose:Ceramide Galactosyltransferase Is a Class I Integral Membrane Protein of the Endoplasmic Reticulum</article-title><source>J. Biol. Chem.</source><year>1998</year><volume>273</volume><fpage>25880</fpage><lpage>25888</lpage><pub-id pub-id-type="doi">10.1074/jbc.273.40.25880</pub-id><pub-id pub-id-type="pmid">9748263</pub-id></element-citation></ref><ref id="B33-ijms-20-02167"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Futerman</surname><given-names>A.H.</given-names></name><name><surname>Riezman</surname><given-names>H.</given-names></name></person-group><article-title>The ins and outs of sphingolipid synthesis</article-title><source>Trends Cell Biol.</source><year>2005</year><volume>15</volume><fpage>312</fpage><lpage>318</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2005.04.006</pub-id><pub-id pub-id-type="pmid">15953549</pub-id></element-citation></ref><ref id="B34-ijms-20-02167"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holthuis</surname><given-names>J.C.M.</given-names></name><name><surname>Pomorski</surname><given-names>T.</given-names></name><name><surname>Raggers</surname><given-names>R.J.</given-names></name><name><surname>Sprong</surname><given-names>H.</given-names></name><name><surname>Van Meer</surname><given-names>G.</given-names></name></person-group><article-title>The Organizing Potential of Sphingolipids in Intracellular Membrane Transport</article-title><source>Physiol. Rev.</source><year>2001</year><volume>81</volume><fpage>1689</fpage><lpage>1723</lpage><pub-id pub-id-type="doi">10.1152/physrev.2001.81.4.1689</pub-id><pub-id pub-id-type="pmid">11581500</pub-id></element-citation></ref><ref id="B35-ijms-20-02167"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radhakrishnan</surname><given-names>A.</given-names></name><name><surname>Goldstein</surname><given-names>J.L.</given-names></name><name><surname>McDonald</surname><given-names>J.G.</given-names></name><name><surname>Brown</surname><given-names>M.S.</given-names></name></person-group><article-title>Switch-like Control of SREBP-2 Transport Triggered by Small Changes in ER Cholesterol: A Delicate Balance</article-title><source>Cell Metab.</source><year>2008</year><volume>8</volume><fpage>512</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2008.10.008</pub-id><pub-id pub-id-type="pmid">19041766</pub-id></element-citation></ref><ref id="B36-ijms-20-02167"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slotte</surname><given-names>J.P.</given-names></name></person-group><article-title>Biological functions of sphingomyelins</article-title><source>Prog. Lipid Res.</source><year>2013</year><volume>52</volume><fpage>424</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1016/j.plipres.2013.05.001</pub-id><pub-id pub-id-type="pmid">23684760</pub-id></element-citation></ref><ref id="B37-ijms-20-02167"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munro</surname><given-names>S.</given-names></name></person-group><article-title>An investigation of the role of transmembrane domains in Golgi protein retention</article-title><source>EMBO J.</source><year>1995</year><volume>14</volume><fpage>4695</fpage><lpage>4704</lpage><pub-id pub-id-type="doi">10.1002/j.1460-2075.1995.tb00151.x</pub-id><?supplied-pmid 7588599?><pub-id pub-id-type="pmid">7588599</pub-id></element-citation></ref><ref id="B38-ijms-20-02167"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quiroga</surname><given-names>R.</given-names></name><name><surname>Trenchi</surname><given-names>A.</given-names></name><name><surname>Gonzalez Montoro</surname><given-names>A.</given-names></name><name><surname>Valdez Taubas</surname><given-names>J.</given-names></name><name><surname>Maccioni</surname><given-names>H.J.F.</given-names></name></person-group><article-title>Short transmembrane domains with high-volume exoplasmic halves determine retention of Type II membrane proteins in the Golgi complex</article-title><source>J. Cell Sci.</source><year>2013</year><volume>126</volume><fpage>5344</fpage><lpage>5349</lpage><pub-id pub-id-type="doi">10.1242/jcs.130658</pub-id><pub-id pub-id-type="pmid">24105265</pub-id></element-citation></ref><ref id="B39-ijms-20-02167"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiser</surname><given-names>H.-J.</given-names></name><name><surname>Orlowski</surname><given-names>A.</given-names></name><name><surname>Rog</surname><given-names>T.</given-names></name><name><surname>Nyholm</surname><given-names>T.K.M.</given-names></name><name><surname>Chai</surname><given-names>W.</given-names></name><name><surname>Feizi</surname><given-names>T.</given-names></name><name><surname>Lingwood</surname><given-names>D.</given-names></name><name><surname>Vattulainen</surname><given-names>I.</given-names></name><name><surname>Simons</surname><given-names>K.</given-names></name></person-group><article-title>Lateral sorting in model membranes by cholesterol-mediated hydrophobic matching</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>16628</fpage><lpage>16633</lpage><pub-id pub-id-type="doi">10.1073/pnas.1103742108</pub-id><?supplied-pmid 21930944?><pub-id pub-id-type="pmid">21930944</pub-id></element-citation></ref><ref id="B40-ijms-20-02167"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magalhaes</surname><given-names>M.A.O.</given-names></name><name><surname>Glogauer</surname><given-names>M.</given-names></name></person-group><article-title>Pivotal Advance: Phospholipids determine net membrane surface charge resulting in differential localization of active Rac1 and Rac2</article-title><source>J. Leukoc. Biol.</source><year>2010</year><volume>87</volume><fpage>545</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1189/jlb.0609390</pub-id><pub-id pub-id-type="pmid">19955208</pub-id></element-citation></ref><ref id="B41-ijms-20-02167"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grinstein</surname><given-names>S.</given-names></name></person-group><article-title>Imaging signal transduction during phagocytosis: phospholipids, surface charge, and electrostatic interactions</article-title><source>Am. J. Physiol.-Cell Physiol.</source><year>2010</year><volume>299</volume><fpage>C876</fpage><lpage>C881</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00342.2010</pub-id><pub-id pub-id-type="pmid">20739621</pub-id></element-citation></ref><ref id="B42-ijms-20-02167"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigay</surname><given-names>J.</given-names></name><name><surname>Antonny</surname><given-names>B.</given-names></name></person-group><article-title>Curvature, Lipid Packing, and Electrostatics of Membrane Organelles: Defining Cellular Territories in Determining Specificity</article-title><source>Dev. Cell</source><year>2012</year><volume>23</volume><fpage>886</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2012.10.009</pub-id><?supplied-pmid 23153485?><pub-id pub-id-type="pmid">23153485</pub-id></element-citation></ref><ref id="B43-ijms-20-02167"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanni</surname><given-names>S.</given-names></name><name><surname>Vamparys</surname><given-names>L.</given-names></name><name><surname>Gautier</surname><given-names>R.</given-names></name><name><surname>Drin</surname><given-names>G.</given-names></name><name><surname>Etchebest</surname><given-names>C.</given-names></name><name><surname>Fuchs</surname><given-names>P.F.J.</given-names></name><name><surname>Antonny</surname><given-names>B.</given-names></name></person-group><article-title>Amphipathic Lipid Packing Sensor Motifs: Probing Bilayer Defects with Hydrophobic Residues</article-title><source>Biophys. J.</source><year>2013</year><volume>104</volume><fpage>575</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2012.11.3837</pub-id><?supplied-pmid 23442908?><pub-id pub-id-type="pmid">23442908</pub-id></element-citation></ref><ref id="B44-ijms-20-02167"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Funari</surname><given-names>S.S.</given-names></name><name><surname>Barcel&#x000f3;</surname><given-names>F.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name></person-group><article-title>Effects of oleic acid and its congeners, elaidic and stearic acids, on the structural properties of phosphatidylethanolamine membranes</article-title><source>J. Lipid Res.</source><year>2003</year><volume>44</volume><fpage>567</fpage><lpage>575</lpage><pub-id pub-id-type="doi">10.1194/jlr.M200356-JLR200</pub-id><?supplied-pmid 12562874?><pub-id pub-id-type="pmid">12562874</pub-id></element-citation></ref><ref id="B45-ijms-20-02167"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindner</surname><given-names>R.</given-names></name><name><surname>Naim</surname><given-names>H.Y.</given-names></name></person-group><article-title>Domains in biological membranes</article-title><source>Exp. Cell Res.</source><year>2009</year><volume>315</volume><fpage>2871</fpage><lpage>2878</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2009.07.020</pub-id><pub-id pub-id-type="pmid">19632223</pub-id></element-citation></ref><ref id="B46-ijms-20-02167"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibarguren</surname><given-names>M.</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>D.J.</given-names></name><name><surname>Encinar</surname><given-names>J.A.</given-names></name><name><surname>Gonz&#x000e1;lez-Ros</surname><given-names>J.M.</given-names></name><name><surname>Busquets</surname><given-names>X.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name></person-group><article-title>Partitioning of liquid-ordered/liquid-disordered membrane microdomains induced by the fluidifying effect of 2-hydroxylated fatty acid derivatives</article-title><source>Biochim. Biophys. Acta BBA - Biomembr.</source><year>2013</year><volume>1828</volume><fpage>2553</fpage><lpage>2563</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2013.06.014</pub-id></element-citation></ref><ref id="B47-ijms-20-02167"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epand</surname><given-names>R.M.</given-names></name></person-group><article-title>Proteins and cholesterol-rich domains</article-title><source>Biochim. Biophys. Acta (BBA)-Biomembr.</source><year>2008</year><volume>1778</volume><fpage>1576</fpage><lpage>1582</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2008.03.016</pub-id><?supplied-pmid 18423371?><pub-id pub-id-type="pmid">18423371</pub-id></element-citation></ref><ref id="B48-ijms-20-02167"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mabrey</surname><given-names>S.</given-names></name><name><surname>Mateo</surname><given-names>P.L.</given-names></name><name><surname>Sturtevant</surname><given-names>J.M.</given-names></name></person-group><article-title>High-sensitivity scanning calorimetric study of mixtures of cholesterol with dimyristoyl- and dipalmitoylphosphatidylcholines</article-title><source>Biochemistry</source><year>1978</year><volume>17</volume><fpage>2464</fpage><lpage>2468</lpage><pub-id pub-id-type="doi">10.1021/bi00605a034</pub-id><?supplied-pmid 581060?><pub-id pub-id-type="pmid">581060</pub-id></element-citation></ref><ref id="B49-ijms-20-02167"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>T.</given-names></name><name><surname>Menon</surname><given-names>A.K.</given-names></name></person-group><article-title>Transbilayer lipid asymmetry</article-title><source>Curr. Biol.</source><year>2018</year><volume>28</volume><fpage>R386</fpage><lpage>R391</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2018.01.007</pub-id><?supplied-pmid 29689220?><pub-id pub-id-type="pmid">29689220</pub-id></element-citation></ref><ref id="B50-ijms-20-02167"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pomorski</surname><given-names>T.</given-names></name><name><surname>Menon</surname><given-names>A.K.</given-names></name></person-group><article-title>Lipid flippases and their biological functions</article-title><source>Cell. Mol. Life Sci.</source><year>2006</year><volume>63</volume><fpage>2908</fpage><lpage>2921</lpage><pub-id pub-id-type="doi">10.1007/s00018-006-6167-7</pub-id><pub-id pub-id-type="pmid">17103115</pub-id></element-citation></ref><ref id="B51-ijms-20-02167"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daleke</surname><given-names>D.L.</given-names></name></person-group><article-title>Phospholipid Flippases</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>821</fpage><lpage>825</lpage><pub-id pub-id-type="doi">10.1074/jbc.R600035200</pub-id><pub-id pub-id-type="pmid">17130120</pub-id></element-citation></ref><ref id="B52-ijms-20-02167"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sebastian</surname><given-names>T.T.</given-names></name><name><surname>Baldridge</surname><given-names>R.D.</given-names></name><name><surname>Xu</surname><given-names>P.</given-names></name><name><surname>Graham</surname><given-names>T.R.</given-names></name></person-group><article-title>Phospholipid flippases: building asymmetric membranes and transport vesicles</article-title><source>Biochim. Biophys. Acta</source><year>2012</year><volume>1821</volume><fpage>1068</fpage><lpage>1077</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2011.12.007</pub-id><pub-id pub-id-type="pmid">22234261</pub-id></element-citation></ref><ref id="B53-ijms-20-02167"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bevers</surname><given-names>E.M.</given-names></name><name><surname>Williamson</surname><given-names>P.L.</given-names></name></person-group><article-title>Getting to the Outer Leaflet: Physiology of Phosphatidylserine Exposure at the Plasma Membrane</article-title><source>Physiol. Rev.</source><year>2016</year><volume>96</volume><fpage>605</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1152/physrev.00020.2015</pub-id><pub-id pub-id-type="pmid">26936867</pub-id></element-citation></ref><ref id="B54-ijms-20-02167"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kruchten</surname><given-names>R.</given-names></name><name><surname>Mattheij</surname><given-names>N.J.A.</given-names></name><name><surname>Saunders</surname><given-names>C.</given-names></name><name><surname>Feijge</surname><given-names>M.A.H.</given-names></name><name><surname>Swieringa</surname><given-names>F.</given-names></name><name><surname>Wolfs</surname><given-names>J.L.N.</given-names></name><name><surname>Collins</surname><given-names>P.W.</given-names></name><name><surname>Heemskerk</surname><given-names>J.W.M.</given-names></name><name><surname>Bevers</surname><given-names>E.M.</given-names></name></person-group><article-title>Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation</article-title><source>Blood</source><year>2013</year><volume>121</volume><fpage>1850</fpage><lpage>1857</lpage><pub-id pub-id-type="doi">10.1182/blood-2012-09-454314</pub-id><pub-id pub-id-type="pmid">23303820</pub-id></element-citation></ref><ref id="B55-ijms-20-02167"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hochreiter-Hufford</surname><given-names>A.E.</given-names></name><name><surname>Lee</surname><given-names>C.S.</given-names></name><name><surname>Kinchen</surname><given-names>J.M.</given-names></name><name><surname>Sokolowski</surname><given-names>J.D.</given-names></name><name><surname>Arandjelovic</surname><given-names>S.</given-names></name><name><surname>Call</surname><given-names>J.A.</given-names></name><name><surname>Klibanov</surname><given-names>A.L.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Mandell</surname><given-names>J.W.</given-names></name><name><surname>Ravichandran</surname><given-names>K.S.</given-names></name></person-group><article-title>Phosphatidylserine receptor BAI1 and apoptotic cells as new promoters of myoblast fusion</article-title><source>Nature</source><year>2013</year><volume>497</volume><fpage>263</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1038/nature12135</pub-id><?supplied-pmid 23615608?><pub-id pub-id-type="pmid">23615608</pub-id></element-citation></ref><ref id="B56-ijms-20-02167"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segawa</surname><given-names>K.</given-names></name><name><surname>Suzuki</surname><given-names>J.</given-names></name><name><surname>Nagata</surname><given-names>S.</given-names></name></person-group><article-title>Constitutive exposure of phosphatidylserine on viable cells</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>19246</fpage><lpage>19251</lpage><pub-id pub-id-type="doi">10.1073/pnas.1114799108</pub-id><?supplied-pmid 22084121?><pub-id pub-id-type="pmid">22084121</pub-id></element-citation></ref><ref id="B57-ijms-20-02167"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeung</surname><given-names>T.</given-names></name><name><surname>Gilbert</surname><given-names>G.E.</given-names></name><name><surname>Shi</surname><given-names>J.</given-names></name><name><surname>Silvius</surname><given-names>J.</given-names></name><name><surname>Kapus</surname><given-names>A.</given-names></name><name><surname>Grinstein</surname><given-names>S.</given-names></name></person-group><article-title>Membrane Phosphatidylserine Regulates Surface Charge and Protein Localization</article-title><source>Science</source><year>2008</year><volume>319</volume><fpage>210</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1126/science.1152066</pub-id><?supplied-pmid 18187657?><pub-id pub-id-type="pmid">18187657</pub-id></element-citation></ref><ref id="B58-ijms-20-02167"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanderley</surname><given-names>J.L.M.</given-names></name><name><surname>Moreira</surname><given-names>M.E.C.</given-names></name><name><surname>Benjamin</surname><given-names>A.</given-names></name><name><surname>Bonomo</surname><given-names>A.C.</given-names></name><name><surname>Barcinski</surname><given-names>M.A.</given-names></name></person-group><article-title>Mimicry of apoptotic cells by exposing phosphatidylserine participates in the establishment of amastigotes of Leishmania (L) amazonensis in mammalian hosts</article-title><source>J. Immunol. Baltim. Md 1950</source><year>2006</year><volume>176</volume><fpage>1834</fpage><lpage>1839</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.176.3.1834</pub-id></element-citation></ref><ref id="B59-ijms-20-02167"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>B.-C.</given-names></name><name><surname>Khelashvili</surname><given-names>G.</given-names></name><name><surname>Falzone</surname><given-names>M.</given-names></name><name><surname>Menon</surname><given-names>A.K.</given-names></name><name><surname>Weinstein</surname><given-names>H.</given-names></name><name><surname>Accardi</surname><given-names>A.</given-names></name></person-group><article-title>Gating mechanism of the extracellular entry to the lipid pathway in a TMEM16 scramblase</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>3251</fpage><pub-id pub-id-type="doi">10.1038/s41467-018-05724-1</pub-id><?supplied-pmid 30108217?><pub-id pub-id-type="pmid">30108217</pub-id></element-citation></ref><ref id="B60-ijms-20-02167"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Paolo</surname><given-names>G.</given-names></name><name><surname>De Camilli</surname><given-names>P.</given-names></name></person-group><article-title>Phosphoinositides in cell regulation and membrane dynamics</article-title><source>Nature</source><year>2006</year><volume>443</volume><fpage>651</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1038/nature05185</pub-id><pub-id pub-id-type="pmid">17035995</pub-id></element-citation></ref><ref id="B61-ijms-20-02167"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tafesse</surname><given-names>F.G.</given-names></name><name><surname>Huitema</surname><given-names>K.</given-names></name><name><surname>Hermansson</surname><given-names>M.</given-names></name><name><surname>van der Poel</surname><given-names>S.</given-names></name><name><surname>van den Dikkenberg</surname><given-names>J.</given-names></name><name><surname>Uphoff</surname><given-names>A.</given-names></name><name><surname>Somerharju</surname><given-names>P.</given-names></name><name><surname>Holthuis</surname><given-names>J.C.M.</given-names></name></person-group><article-title>Both Sphingomyelin Synthases SMS1 and SMS2 Are Required for Sphingomyelin Homeostasis and Growth in Human HeLa Cells</article-title><source>J. Biol. Chem.</source><year>2007</year><volume>282</volume><fpage>17537</fpage><lpage>17547</lpage><pub-id pub-id-type="doi">10.1074/jbc.M702423200</pub-id><pub-id pub-id-type="pmid">17449912</pub-id></element-citation></ref><ref id="B62-ijms-20-02167"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Hailemariam</surname><given-names>T.K.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Duckworth</surname><given-names>D.C.</given-names></name><name><surname>Peake</surname><given-names>D.A.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Kuo</surname><given-names>M.-S.</given-names></name><name><surname>Cao</surname><given-names>G.</given-names></name><name><surname>Jiang</surname><given-names>X.-C.</given-names></name></person-group><article-title>Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization</article-title><source>Biochim. Biophys. Acta BBA - Mol. Cell Biol. Lipids</source><year>2007</year><volume>1771</volume><fpage>1186</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1016/j.bbalip.2007.05.007</pub-id><?supplied-pmid 17616479?><pub-id pub-id-type="pmid">17616479</pub-id></element-citation></ref><ref id="B63-ijms-20-02167"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pike</surname><given-names>L.J.</given-names></name></person-group><article-title>Lipid rafts: bringing order to chaos</article-title><source>J. Lipid Res.</source><year>2003</year><volume>44</volume><fpage>655</fpage><lpage>667</lpage><pub-id pub-id-type="doi">10.1194/jlr.R200021-JLR200</pub-id><pub-id pub-id-type="pmid">12562849</pub-id></element-citation></ref><ref id="B64-ijms-20-02167"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippincott-Schwartz</surname><given-names>J.</given-names></name><name><surname>Phair</surname><given-names>R.D.</given-names></name></person-group><article-title>Lipids and Cholesterol as Regulators of Traffic in the Endomembrane System</article-title><source>Annu. Rev. Biophys.</source><year>2010</year><volume>39</volume><fpage>559</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1146/annurev.biophys.093008.131357</pub-id><pub-id pub-id-type="pmid">20192772</pub-id></element-citation></ref><ref id="B65-ijms-20-02167"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lingwood</surname><given-names>D.</given-names></name><name><surname>Simons</surname><given-names>K.</given-names></name></person-group><article-title>Lipid Rafts As a Membrane-Organizing Principle</article-title><source>Science</source><year>2010</year><volume>327</volume><fpage>46</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1126/science.1174621</pub-id><pub-id pub-id-type="pmid">20044567</pub-id></element-citation></ref><ref id="B66-ijms-20-02167"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohdanowicz</surname><given-names>M.</given-names></name><name><surname>Grinstein</surname><given-names>S.</given-names></name></person-group><article-title>Role of Phospholipids in Endocytosis, Phagocytosis, and Macropinocytosis</article-title><source>Physiol. Rev.</source><year>2013</year><volume>93</volume><fpage>69</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1152/physrev.00002.2012</pub-id><?supplied-pmid 23303906?><pub-id pub-id-type="pmid">23303906</pub-id></element-citation></ref><ref id="B67-ijms-20-02167"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dove</surname><given-names>S.K.</given-names></name><name><surname>Cooke</surname><given-names>F.T.</given-names></name><name><surname>Douglas</surname><given-names>M.R.</given-names></name><name><surname>Sayers</surname><given-names>L.G.</given-names></name><name><surname>Parker</surname><given-names>P.J.</given-names></name><name><surname>Michell</surname><given-names>R.H.</given-names></name></person-group><article-title>Osmotic stress activates phosphatidylinositol-3,5-bisphosphate synthesis</article-title><source>Nature</source><year>1997</year><volume>390</volume><fpage>187</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1038/36613</pub-id><?supplied-pmid 9367158?><pub-id pub-id-type="pmid">9367158</pub-id></element-citation></ref><ref id="B68-ijms-20-02167"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odorizzi</surname><given-names>G.</given-names></name><name><surname>Babst</surname><given-names>M.</given-names></name><name><surname>Emr</surname><given-names>S.D.</given-names></name></person-group><article-title>Fab1p PtdIns(3)P 5-Kinase Function Essential for Protein Sorting in the Multivesicular Body</article-title><source>Cell</source><year>1998</year><volume>95</volume><fpage>847</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81707-9</pub-id><pub-id pub-id-type="pmid">9865702</pub-id></element-citation></ref><ref id="B69-ijms-20-02167"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sbrissa</surname><given-names>D.</given-names></name><name><surname>Ikonomov</surname><given-names>O.C.</given-names></name><name><surname>Shisheva</surname><given-names>A.</given-names></name></person-group><article-title>PIKfyve, a Mammalian Ortholog of Yeast Fab1p Lipid Kinase, Synthesizes 5-Phosphoinositides</article-title><source>J. Biol. Chem.</source><year>1999</year><volume>274</volume><fpage>21589</fpage><lpage>21597</lpage><pub-id pub-id-type="doi">10.1074/jbc.274.31.21589</pub-id><?supplied-pmid 10419465?><pub-id pub-id-type="pmid">10419465</pub-id></element-citation></ref><ref id="B70-ijms-20-02167"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platta</surname><given-names>H.W.</given-names></name><name><surname>Stenmark</surname><given-names>H.</given-names></name></person-group><article-title>Endocytosis and signaling</article-title><source>Curr. Opin. Cell Biol.</source><year>2011</year><volume>23</volume><fpage>393</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2011.03.008</pub-id><pub-id pub-id-type="pmid">21474295</pub-id></element-citation></ref><ref id="B71-ijms-20-02167"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tatsuta</surname><given-names>T.</given-names></name><name><surname>Scharwey</surname><given-names>M.</given-names></name><name><surname>Langer</surname><given-names>T.</given-names></name></person-group><article-title>Mitochondrial lipid trafficking</article-title><source>Trends Cell Biol.</source><year>2014</year><volume>24</volume><fpage>44</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2013.07.011</pub-id><pub-id pub-id-type="pmid">24001776</pub-id></element-citation></ref><ref id="B72-ijms-20-02167"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horvath</surname><given-names>S.E.</given-names></name><name><surname>Daum</surname><given-names>G.</given-names></name></person-group><article-title>Lipids of mitochondria</article-title><source>Prog. Lipid Res.</source><year>2013</year><volume>52</volume><fpage>590</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1016/j.plipres.2013.07.002</pub-id><pub-id pub-id-type="pmid">24007978</pub-id></element-citation></ref><ref id="B73-ijms-20-02167"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannella</surname><given-names>C.A.</given-names></name><name><surname>Buttle</surname><given-names>K.</given-names></name><name><surname>Rath</surname><given-names>B.K.</given-names></name><name><surname>Marko</surname><given-names>M.</given-names></name></person-group><article-title>Electron microscopic tomography of rat-liver mitochondria and their interactions with the endoplasmic reticulum</article-title><source>BioFactors</source><year>1998</year><volume>8</volume><fpage>225</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1002/biof.5520080309</pub-id><pub-id pub-id-type="pmid">9914823</pub-id></element-citation></ref><ref id="B74-ijms-20-02167"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daum</surname><given-names>G.</given-names></name><name><surname>Vance</surname><given-names>J.E.</given-names></name></person-group><article-title>Import of lipids into mitochondria</article-title><source>Prog. Lipid Res.</source><year>1997</year><volume>36</volume><fpage>103</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/S0163-7827(97)00006-4</pub-id><pub-id pub-id-type="pmid">9624424</pub-id></element-citation></ref><ref id="B75-ijms-20-02167"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voelker</surname><given-names>D.R.</given-names></name></person-group><article-title>Bridging gaps in phospholipid transport</article-title><source>Trends Biochem. Sci.</source><year>2005</year><volume>30</volume><fpage>396</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2005.05.008</pub-id><pub-id pub-id-type="pmid">15951180</pub-id></element-citation></ref><ref id="B76-ijms-20-02167"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raturi</surname><given-names>A.</given-names></name><name><surname>Simmen</surname><given-names>T.</given-names></name></person-group><article-title>Where the endoplasmic reticulum and the mitochondrion tie the knot: The mitochondria-associated membrane (MAM)</article-title><source>Biochim. Biophys. Acta BBA - Mol. Cell Res.</source><year>2013</year><volume>1833</volume><fpage>213</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1016/j.bbamcr.2012.04.013</pub-id></element-citation></ref><ref id="B77-ijms-20-02167"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowland</surname><given-names>A.A.</given-names></name><name><surname>Voeltz</surname><given-names>G.K.</given-names></name></person-group><article-title>Endoplasmic reticulum&#x02013;mitochondria contacts: function of the junction</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2012</year><volume>13</volume><fpage>607</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1038/nrm3440</pub-id><?supplied-pmid 22992592?><pub-id pub-id-type="pmid">22992592</pub-id></element-citation></ref><ref id="B78-ijms-20-02167"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osman</surname><given-names>C.</given-names></name><name><surname>Voelker</surname><given-names>D.R.</given-names></name><name><surname>Langer</surname><given-names>T.</given-names></name></person-group><article-title>Making heads or tails of phospholipids in mitochondria</article-title><source>J. Cell Biol.</source><year>2011</year><volume>192</volume><fpage>7</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1083/jcb.201006159</pub-id><pub-id pub-id-type="pmid">21220505</pub-id></element-citation></ref><ref id="B79-ijms-20-02167"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voelker</surname><given-names>D.R.</given-names></name></person-group><article-title>Genetic analysis of intracellular aminoglycerophospholipid traffic</article-title><source>Biochem. Cell Biol.</source><year>2004</year><volume>82</volume><fpage>156</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1139/o03-075</pub-id><?supplied-pmid 15052335?><pub-id pub-id-type="pmid">15052335</pub-id></element-citation></ref><ref id="B80-ijms-20-02167"><label>80.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Vance</surname><given-names>J.E.</given-names></name></person-group><article-title>Molecular and Cell Biology of Phosphatidylserine and Phosphatidylethanolamine Metabolism</article-title><source>Progress in Nucleic Acid Research and Molecular Biology</source><publisher-name>Elsevier BV</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2003</year><fpage>69</fpage><lpage>111</lpage><isbn>0-12-540075-6</isbn></element-citation></ref><ref id="B81-ijms-20-02167"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daum</surname><given-names>G.</given-names></name></person-group><article-title>Lipids of mitochondria</article-title><source>Biochim. Biophys. Acta</source><year>1985</year><volume>822</volume><fpage>1</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/0304-4157(85)90002-4</pub-id><pub-id pub-id-type="pmid">2408671</pub-id></element-citation></ref><ref id="B82-ijms-20-02167"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname><given-names>J.F.</given-names></name><name><surname>Kishida</surname><given-names>T.</given-names></name><name><surname>Christenson</surname><given-names>L.K.</given-names></name><name><surname>Fujimoto</surname><given-names>T.</given-names></name><name><surname>Hiroi</surname><given-names>H.</given-names></name></person-group><article-title>START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells</article-title><source>Mol. Cell. Endocrinol.</source><year>2003</year><volume>202</volume><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/S0303-7207(03)00063-7</pub-id><pub-id pub-id-type="pmid">12770731</pub-id></element-citation></ref><ref id="B83-ijms-20-02167"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>T.W.</given-names></name><name><surname>Buffenstein</surname><given-names>R.</given-names></name><name><surname>Hulbert</surname><given-names>A.J.</given-names></name></person-group><article-title>Membrane phospholipid composition may contribute to exceptional longevity of the naked mole-rat (Heterocephalus glaber): A comparative study using shotgun lipidomics</article-title><source>Exp. Gerontol.</source><year>2007</year><volume>42</volume><fpage>1053</fpage><lpage>1062</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2007.09.004</pub-id><pub-id pub-id-type="pmid">18029129</pub-id></element-citation></ref><ref id="B84-ijms-20-02167"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>C.J.</given-names></name><name><surname>Anbukumar</surname><given-names>D.S.</given-names></name><name><surname>Monda</surname><given-names>J.K.</given-names></name><name><surname>Eckelkamp</surname><given-names>J.T.</given-names></name><name><surname>Ford</surname><given-names>D.A.</given-names></name></person-group><article-title>Myocardial Lipidomics. Developments in myocardial nuclear lipidomics</article-title><source>Front. Biosci.</source><year>2007</year><volume>12</volume><fpage>2750</fpage><pub-id pub-id-type="doi">10.2741/2269</pub-id><pub-id pub-id-type="pmid">17127277</pub-id></element-citation></ref><ref id="B85-ijms-20-02167"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Gross</surname><given-names>R.W.</given-names></name></person-group><article-title>Plasmenylcholine and phosphatidylcholine membrane bilayers possess distinct conformational motifs</article-title><source>Biochemistry</source><year>1990</year><volume>29</volume><fpage>4992</fpage><lpage>4996</lpage><pub-id pub-id-type="doi">10.1021/bi00472a032</pub-id><?supplied-pmid 2364071?><pub-id pub-id-type="pmid">2364071</pub-id></element-citation></ref><ref id="B86-ijms-20-02167"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallner</surname><given-names>S.</given-names></name><name><surname>Schmitz</surname><given-names>G.</given-names></name></person-group><article-title>Plasmalogens the neglected regulatory and scavenging lipid species</article-title><source>Chem. Phys. Lipids</source><year>2011</year><volume>164</volume><fpage>573</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.chemphyslip.2011.06.008</pub-id><?supplied-pmid 21723266?><pub-id pub-id-type="pmid">21723266</pub-id></element-citation></ref><ref id="B87-ijms-20-02167"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandel</surname><given-names>H.</given-names></name><name><surname>Sharf</surname><given-names>R.</given-names></name><name><surname>Berant</surname><given-names>M.</given-names></name><name><surname>Wanders</surname><given-names>R.J.A.</given-names></name><name><surname>Vreken</surname><given-names>P.</given-names></name><name><surname>Aviram</surname><given-names>M.</given-names></name></person-group><article-title>Plasmalogen Phospholipids Are Involved in HDL-Mediated Cholesterol Efflux: Insights from Investigations with Plasmalogen-Deficient Cells</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1998</year><volume>250</volume><fpage>369</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1998.9321</pub-id><?supplied-pmid 9753636?><pub-id pub-id-type="pmid">9753636</pub-id></element-citation></ref><ref id="B88-ijms-20-02167"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munn</surname><given-names>N.J.</given-names></name><name><surname>Arnio</surname><given-names>E.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Zoeller</surname><given-names>R.A.</given-names></name><name><surname>Liscum</surname><given-names>L.</given-names></name></person-group><article-title>Deficiency in ethanolamine plasmalogen leads to altered cholesterol transport</article-title><source>J. Lipid Res.</source><year>2003</year><volume>44</volume><fpage>182</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1194/jlr.M200363-JLR200</pub-id><?supplied-pmid 12518037?><pub-id pub-id-type="pmid">12518037</pub-id></element-citation></ref><ref id="B89-ijms-20-02167"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;richon</surname><given-names>R.</given-names></name><name><surname>Moser</surname><given-names>A.B.</given-names></name><name><surname>Wallace</surname><given-names>W.C.</given-names></name><name><surname>Cunningham</surname><given-names>S.C.</given-names></name><name><surname>Roth</surname><given-names>G.S.</given-names></name><name><surname>Moser</surname><given-names>H.W.</given-names></name></person-group><article-title>Peroxisomal Disease Cell Lines with Cellular Plasmalogen Deficiency Have Impaired Muscarinic Cholinergic Signal Transduction Activity and Amyloid Precursor Protein Secretion</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1998</year><volume>248</volume><fpage>57</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1998.8909</pub-id><pub-id pub-id-type="pmid">9675085</pub-id></element-citation></ref><ref id="B90-ijms-20-02167"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Napolitano</surname><given-names>G.</given-names></name><name><surname>Ballabio</surname><given-names>A.</given-names></name></person-group><article-title>TFEB at a glance</article-title><source>J. Cell Sci.</source><year>2016</year><volume>129</volume><fpage>2475</fpage><lpage>2481</lpage><pub-id pub-id-type="doi">10.1242/jcs.146365</pub-id><pub-id pub-id-type="pmid">27252382</pub-id></element-citation></ref><ref id="B91-ijms-20-02167"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>D.L.</given-names></name><name><surname>Fraldi</surname><given-names>A.</given-names></name><name><surname>Bouche</surname><given-names>V.</given-names></name><name><surname>Annunziata</surname><given-names>F.</given-names></name><name><surname>Mansueto</surname><given-names>G.</given-names></name><name><surname>Spampanato</surname><given-names>C.</given-names></name><name><surname>Puri</surname><given-names>C.</given-names></name><name><surname>Pignata</surname><given-names>A.</given-names></name><name><surname>Martina</surname><given-names>J.A.</given-names></name><name><surname>Sardiello</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular Clearance</article-title><source>Dev. Cell</source><year>2011</year><volume>21</volume><fpage>421</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.07.016</pub-id><pub-id pub-id-type="pmid">21889421</pub-id></element-citation></ref><ref id="B92-ijms-20-02167"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nezich</surname><given-names>C.L.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Fogel</surname><given-names>A.I.</given-names></name><name><surname>Youle</surname><given-names>R.J.</given-names></name></person-group><article-title>MiT/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5</article-title><source>J. Cell Biol.</source><year>2015</year><volume>210</volume><fpage>435</fpage><lpage>450</lpage><pub-id pub-id-type="doi">10.1083/jcb.201501002</pub-id><pub-id pub-id-type="pmid">26240184</pub-id></element-citation></ref><ref id="B93-ijms-20-02167"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Settembre</surname><given-names>C.</given-names></name><name><surname>Di Malta</surname><given-names>C.</given-names></name><name><surname>Polito</surname><given-names>V.A.</given-names></name><name><surname>Arencibia</surname><given-names>M.G.</given-names></name><name><surname>Vetrini</surname><given-names>F.</given-names></name><name><surname>Erdin</surname><given-names>S.</given-names></name><name><surname>Erdin</surname><given-names>S.U.</given-names></name><name><surname>Huynh</surname><given-names>T.</given-names></name><name><surname>Medina</surname><given-names>D.</given-names></name><name><surname>Colella</surname><given-names>P.</given-names></name><etal/></person-group><article-title>TFEB Links Autophagy to Lysosomal Biogenesis</article-title><source>Science</source><year>2011</year><volume>332</volume><fpage>1429</fpage><lpage>1433</lpage><pub-id pub-id-type="doi">10.1126/science.1204592</pub-id><pub-id pub-id-type="pmid">21617040</pub-id></element-citation></ref><ref id="B94-ijms-20-02167"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Settembre</surname><given-names>C.</given-names></name><name><surname>Fraldi</surname><given-names>A.</given-names></name><name><surname>Medina</surname><given-names>D.L.</given-names></name><name><surname>Ballabio</surname><given-names>A.</given-names></name></person-group><article-title>Signals from the lysosome: a control centre for cellular clearance and energy metabolism</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2013</year><volume>14</volume><fpage>283</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1038/nrm3565</pub-id><pub-id pub-id-type="pmid">23609508</pub-id></element-citation></ref><ref id="B95-ijms-20-02167"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>A.R.A.</given-names></name><name><surname>Saftig</surname><given-names>P.</given-names></name></person-group><article-title>Lysosomal storage disorders &#x02013; challenges, concepts and avenues for therapy: beyond rare diseases</article-title><source>J. Cell Sci.</source><year>2019</year><volume>132</volume><fpage>jcs221739</fpage><pub-id pub-id-type="doi">10.1242/jcs.221739</pub-id><pub-id pub-id-type="pmid">30651381</pub-id></element-citation></ref><ref id="B96-ijms-20-02167"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thelen</surname><given-names>A.M.</given-names></name><name><surname>Zoncu</surname><given-names>R.</given-names></name></person-group><article-title>Emerging Roles for the Lysosome in Lipid Metabolism</article-title><source>Trends Cell Biol.</source><year>2017</year><volume>27</volume><fpage>833</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1016/j.tcb.2017.07.006</pub-id><pub-id pub-id-type="pmid">28838620</pub-id></element-citation></ref><ref id="B97-ijms-20-02167"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaishy</surname><given-names>B.</given-names></name><name><surname>Abel</surname><given-names>E.D.</given-names></name></person-group><article-title>Lipids, lysosomes, and autophagy</article-title><source>J. Lipid Res.</source><year>2016</year><volume>57</volume><fpage>1619</fpage><lpage>1635</lpage><pub-id pub-id-type="doi">10.1194/jlr.R067520</pub-id><?supplied-pmid 27330054?><pub-id pub-id-type="pmid">27330054</pub-id></element-citation></ref><ref id="B98-ijms-20-02167"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tapley</surname><given-names>E.C.</given-names></name><name><surname>Starr</surname><given-names>D.A.</given-names></name></person-group><article-title>Connecting the nucleus to the cytoskeleton by SUN&#x02013;KASH bridges across the nuclear envelope</article-title><source>Curr. Opin. Cell Biol.</source><year>2013</year><volume>25</volume><fpage>57</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2012.10.014</pub-id><pub-id pub-id-type="pmid">23149102</pub-id></element-citation></ref><ref id="B99-ijms-20-02167"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suntharalingam</surname><given-names>M.</given-names></name><name><surname>Wente</surname><given-names>S.R.</given-names></name></person-group><article-title>Peering through the Pore: Nuclear Pore Complex Structure, Assembly, and Function</article-title><source>Dev. Cell</source><year>2003</year><volume>4</volume><fpage>775</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1016/S1534-5807(03)00162-X</pub-id><pub-id pub-id-type="pmid">12791264</pub-id></element-citation></ref><ref id="B100-ijms-20-02167"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cascianelli</surname><given-names>G.</given-names></name><name><surname>Villani</surname><given-names>M.</given-names></name><name><surname>Tosti</surname><given-names>M.</given-names></name><name><surname>Marini</surname><given-names>F.</given-names></name><name><surname>Bartoccini</surname><given-names>E.</given-names></name><name><surname>Viola Magni</surname><given-names>M.</given-names></name><name><surname>Albi</surname><given-names>E.</given-names></name></person-group><article-title>Lipid Microdomains in Cell Nucleus</article-title><source>Mol. Biol. Cell</source><year>2008</year><volume>19</volume><fpage>5289</fpage><lpage>5295</lpage><pub-id pub-id-type="doi">10.1091/mbc.e08-05-0517</pub-id><pub-id pub-id-type="pmid">18923143</pub-id></element-citation></ref><ref id="B101-ijms-20-02167"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farooqui</surname><given-names>A.A.</given-names></name></person-group><article-title>Lipid mediators in the neural cell nucleus: Their metabolism, signaling, and association with neurological disorders</article-title><source>Neuroscientist</source><year>2009</year><volume>15</volume><fpage>392</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1177/1073858409337035</pub-id><pub-id pub-id-type="pmid">19666894</pub-id></element-citation></ref><ref id="B102-ijms-20-02167"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Gil</surname><given-names>M.</given-names></name><name><surname>Albi</surname><given-names>E.</given-names></name></person-group><article-title>Nuclear Lipids in the Nervous System: What they do in Health and Disease</article-title><source>Neurochem. Res.</source><year>2017</year><volume>42</volume><fpage>321</fpage><lpage>336</lpage><pub-id pub-id-type="doi">10.1007/s11064-016-2085-8</pub-id><?supplied-pmid 27766461?><pub-id pub-id-type="pmid">27766461</pub-id></element-citation></ref><ref id="B103-ijms-20-02167"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ledeen</surname><given-names>R.W.</given-names></name><name><surname>Wu</surname><given-names>G.</given-names></name></person-group><article-title>Thematic Review Series: Sphingolipids. Nuclear sphingolipids: metabolism and signaling</article-title><source>J. Lipid Res.</source><year>2008</year><volume>49</volume><fpage>1176</fpage><lpage>1186</lpage><pub-id pub-id-type="doi">10.1194/jlr.R800009-JLR200</pub-id><pub-id pub-id-type="pmid">18326892</pub-id></element-citation></ref><ref id="B104-ijms-20-02167"><label>104.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Takagi</surname><given-names>M.</given-names></name><name><surname>Imamoto</surname><given-names>N.</given-names></name></person-group><article-title>Control of Nuclear Size by NPC Proteins</article-title><source>Advances in Experimental Medicine and Biology</source><publisher-name>Springer</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>2014</year><fpage>571</fpage><lpage>591</lpage><isbn>978-1-4899-8031-1</isbn></element-citation></ref><ref id="B105-ijms-20-02167"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuvichkin</surname><given-names>V.V.</given-names></name></person-group><article-title>Lipid-nucleic acids interactions as base for organization and expression of cellular genome</article-title><source>Int. J. Quantum Chem.</source><year>2010</year><volume>110</volume><fpage>120</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1002/qua.22166</pub-id></element-citation></ref><ref id="B106-ijms-20-02167"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>F.</given-names></name><name><surname>Brenner</surname><given-names>S.</given-names></name><name><surname>Cuzin</surname><given-names>F.</given-names></name></person-group><article-title>On the Regulation of DNA Replication in Bacteria</article-title><source>Cold Spring Harb. Symp. Quant. Biol.</source><year>1963</year><volume>28</volume><fpage>329</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1101/SQB.1963.028.01.048</pub-id></element-citation></ref><ref id="B107-ijms-20-02167"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamann</surname><given-names>B.L.</given-names></name><name><surname>Blind</surname><given-names>R.D.</given-names></name></person-group><article-title>Nuclear phosphoinositide regulation of chromatin</article-title><source>J. Cell. Physiol.</source><year>2018</year><volume>233</volume><fpage>107</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1002/jcp.25886</pub-id><pub-id pub-id-type="pmid">28256711</pub-id></element-citation></ref><ref id="B108-ijms-20-02167"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benoit</surname><given-names>G.</given-names></name><name><surname>Cooney</surname><given-names>A.</given-names></name><name><surname>Giguere</surname><given-names>V.</given-names></name><name><surname>Ingraham</surname><given-names>H.</given-names></name><name><surname>Lazar</surname><given-names>M.</given-names></name><name><surname>Muscat</surname><given-names>G.</given-names></name><name><surname>Perlmann</surname><given-names>T.</given-names></name><name><surname>Renaud</surname><given-names>J.-P.</given-names></name><name><surname>Schwabe</surname><given-names>J.</given-names></name><name><surname>Sladek</surname><given-names>F.</given-names></name><etal/></person-group><article-title>International Union of Pharmacology. LXVI. Orphan Nuclear Receptors</article-title><source>Pharmacol. Rev.</source><year>2006</year><volume>58</volume><fpage>798</fpage><lpage>836</lpage><pub-id pub-id-type="doi">10.1124/pr.58.4.10</pub-id><pub-id pub-id-type="pmid">17132856</pub-id></element-citation></ref><ref id="B109-ijms-20-02167"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hazel</surname><given-names>J.</given-names></name></person-group><article-title>Thermal Adaptations in Biological Membranes: Is Homeoviscous Adaptation the Explanation?</article-title><source>Annu. Rev. Physiol.</source><year>1995</year><volume>57</volume><fpage>19</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1146/annurev.ph.57.030195.000315</pub-id><pub-id pub-id-type="pmid">7778864</pub-id></element-citation></ref><ref id="B110-ijms-20-02167"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koynova</surname><given-names>R.</given-names></name><name><surname>Caffrey</surname><given-names>M.</given-names></name></person-group><article-title>Phases and phase transitions of the phosphatidylcholines</article-title><source>Biochim. Biophys. Acta BBA - Rev. Biomembr.</source><year>1998</year><volume>1376</volume><fpage>91</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/S0304-4157(98)00006-9</pub-id></element-citation></ref><ref id="B111-ijms-20-02167"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>D.</given-names></name></person-group><article-title>Lateral Pressure Profile, Spontaneous Curvature Frustration, and the Incorporation and Conformation of Proteins in Membranes</article-title><source>Biophys. J.</source><year>2007</year><volume>93</volume><fpage>3884</fpage><lpage>3899</lpage><pub-id pub-id-type="doi">10.1529/biophysj.107.107938</pub-id><pub-id pub-id-type="pmid">17704167</pub-id></element-citation></ref><ref id="B112-ijms-20-02167"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frolov</surname><given-names>V.A.</given-names></name><name><surname>Shnyrova</surname><given-names>A.V.</given-names></name><name><surname>Zimmerberg</surname><given-names>J.</given-names></name></person-group><article-title>Lipid Polymorphisms and Membrane Shape</article-title><source>Cold Spring Harb. Perspect. Biol.</source><year>2011</year><volume>3</volume><fpage>a004747</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a004747</pub-id><pub-id pub-id-type="pmid">21646378</pub-id></element-citation></ref><ref id="B113-ijms-20-02167"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name></person-group><article-title>Membrane-lipid therapy: a new approach in molecular medicine</article-title><source>Trends Mol. Med.</source><year>2006</year><volume>12</volume><fpage>34</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2005.11.004</pub-id><pub-id pub-id-type="pmid">16325472</pub-id></element-citation></ref><ref id="B114-ijms-20-02167"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cockcroft</surname><given-names>S.</given-names></name><name><surname>Raghu</surname><given-names>P.</given-names></name></person-group><article-title>Phospholipid transport protein function at organelle contact sites</article-title><source>Curr. Opin. Cell Biol.</source><year>2018</year><volume>53</volume><fpage>52</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2018.04.011</pub-id><?supplied-pmid 29859321?><pub-id pub-id-type="pmid">29859321</pub-id></element-citation></ref><ref id="B115-ijms-20-02167"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>Y.</given-names></name><name><surname>Steck</surname><given-names>T.L.</given-names></name></person-group><article-title>Active membrane cholesterol as a physiological effector</article-title><source>Chem. Phys. Lipids</source><year>2016</year><volume>199</volume><fpage>74</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.chemphyslip.2016.02.003</pub-id><pub-id pub-id-type="pmid">26874289</pub-id></element-citation></ref><ref id="B116-ijms-20-02167"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endapally</surname><given-names>S.</given-names></name><name><surname>Frias</surname><given-names>D.</given-names></name><name><surname>Grzemska</surname><given-names>M.</given-names></name><name><surname>Gay</surname><given-names>A.</given-names></name><name><surname>Tomchick</surname><given-names>D.R.</given-names></name><name><surname>Radhakrishnan</surname><given-names>A.</given-names></name></person-group><article-title>Molecular Discrimination between Two Conformations of Sphingomyelin in Plasma Membranes</article-title><source>Cell</source><year>2019</year><volume>176</volume><fpage>1040</fpage><lpage>1053.e17</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.12.042</pub-id><pub-id pub-id-type="pmid">30712872</pub-id></element-citation></ref><ref id="B117-ijms-20-02167"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Infante</surname><given-names>R.E.</given-names></name><name><surname>Radhakrishnan</surname><given-names>A.</given-names></name></person-group><article-title>Continuous transport of a small fraction of plasma membrane cholesterol to endoplasmic reticulum regulates total cellular cholesterol</article-title><source>eLife</source><year>2017</year><volume>6</volume><pub-id pub-id-type="doi">10.7554/eLife.25466</pub-id><?supplied-pmid 28414269?><pub-id pub-id-type="pmid">28414269</pub-id></element-citation></ref><ref id="B118-ijms-20-02167"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>K.</given-names></name><name><surname>Ikonen</surname><given-names>E.</given-names></name></person-group><article-title>How cells handle cholesterol</article-title><source>Science</source><year>2000</year><volume>290</volume><fpage>1721</fpage><lpage>1726</lpage><pub-id pub-id-type="doi">10.1126/science.290.5497.1721</pub-id><?supplied-pmid 11099405?><pub-id pub-id-type="pmid">11099405</pub-id></element-citation></ref><ref id="B119-ijms-20-02167"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fairn</surname><given-names>G.D.</given-names></name><name><surname>Schieber</surname><given-names>N.L.</given-names></name><name><surname>Ariotti</surname><given-names>N.</given-names></name><name><surname>Murphy</surname><given-names>S.</given-names></name><name><surname>Kuerschner</surname><given-names>L.</given-names></name><name><surname>Webb</surname><given-names>R.I.</given-names></name><name><surname>Grinstein</surname><given-names>S.</given-names></name><name><surname>Parton</surname><given-names>R.G.</given-names></name></person-group><article-title>High-resolution mapping reveals topologically distinct cellular pools of phosphatidylserine</article-title><source>J. Cell Biol.</source><year>2011</year><volume>194</volume><fpage>257</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1083/jcb.201012028</pub-id><pub-id pub-id-type="pmid">21788369</pub-id></element-citation></ref><ref id="B120-ijms-20-02167"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Natarajan</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Hua</surname><given-names>Z.</given-names></name><name><surname>Graham</surname><given-names>T.R.</given-names></name></person-group><article-title>Drs2p-coupled aminophospholipid translocase activity in yeast Golgi membranes and relationship to in vivo function</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>10614</fpage><lpage>10619</lpage><pub-id pub-id-type="doi">10.1073/pnas.0404146101</pub-id><?supplied-pmid 15249668?><pub-id pub-id-type="pmid">15249668</pub-id></element-citation></ref><ref id="B121-ijms-20-02167"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alder-Baerens</surname><given-names>N.</given-names></name><name><surname>Lisman</surname><given-names>Q.</given-names></name><name><surname>Luong</surname><given-names>L.</given-names></name><name><surname>Pomorski</surname><given-names>T.</given-names></name><name><surname>Holthuis</surname><given-names>J.C.M.</given-names></name></person-group><article-title>Loss of P4 ATPases Drs2p and Dnf3p Disrupts Aminophospholipid Transport and Asymmetry in Yeast Post-Golgi Secretory Vesicles</article-title><source>Mol. Biol. Cell</source><year>2006</year><volume>17</volume><fpage>1632</fpage><lpage>1642</lpage><pub-id pub-id-type="doi">10.1091/mbc.e05-10-0912</pub-id><?supplied-pmid 16452632?><pub-id pub-id-type="pmid">16452632</pub-id></element-citation></ref><ref id="B122-ijms-20-02167"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tulodziecka</surname><given-names>K.</given-names></name><name><surname>Diaz-Rohrer</surname><given-names>B.B.</given-names></name><name><surname>Farley</surname><given-names>M.M.</given-names></name><name><surname>Chan</surname><given-names>R.B.</given-names></name><name><surname>Di Paolo</surname><given-names>G.</given-names></name><name><surname>Levental</surname><given-names>K.R.</given-names></name><name><surname>Waxham</surname><given-names>M.N.</given-names></name><name><surname>Levental</surname><given-names>I.</given-names></name></person-group><article-title>Remodeling of the postsynaptic plasma membrane during neural development</article-title><source>Mol. Biol. Cell</source><year>2016</year><volume>27</volume><fpage>3480</fpage><lpage>3489</lpage><pub-id pub-id-type="doi">10.1091/mbc.e16-06-0420</pub-id><pub-id pub-id-type="pmid">27535429</pub-id></element-citation></ref><ref id="B123-ijms-20-02167"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levental</surname><given-names>K.R.</given-names></name><name><surname>Surma</surname><given-names>M.A.</given-names></name><name><surname>Skinkle</surname><given-names>A.D.</given-names></name><name><surname>Lorent</surname><given-names>J.H.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Klose</surname><given-names>C.</given-names></name><name><surname>Chang</surname><given-names>J.T.</given-names></name><name><surname>Hancock</surname><given-names>J.F.</given-names></name><name><surname>Levental</surname><given-names>I.</given-names></name></person-group><article-title>$&#x000f8;mega$-3 polyunsaturated fatty acids direct differentiation of the membrane phenotype in mesenchymal stem cells to potentiate osteogenesis</article-title><source>Sci. Adv.</source><year>2017</year><volume>3</volume><fpage>eaao1193</fpage><pub-id pub-id-type="doi">10.1126/sciadv.aao1193</pub-id><pub-id pub-id-type="pmid">29134198</pub-id></element-citation></ref><ref id="B124-ijms-20-02167"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klose</surname><given-names>C.</given-names></name><name><surname>Surma</surname><given-names>M.A.</given-names></name><name><surname>Gerl</surname><given-names>M.J.</given-names></name><name><surname>Meyenhofer</surname><given-names>F.</given-names></name><name><surname>Shevchenko</surname><given-names>A.</given-names></name><name><surname>Simons</surname><given-names>K.</given-names></name></person-group><article-title>Flexibility of a Eukaryotic Lipidome &#x02013; Insights from Yeast Lipidomics</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e35063</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0035063</pub-id><?supplied-pmid 22529973?><pub-id pub-id-type="pmid">22529973</pub-id></element-citation></ref><ref id="B125-ijms-20-02167"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surma</surname><given-names>M.A.</given-names></name><name><surname>Klose</surname><given-names>C.</given-names></name><name><surname>Peng</surname><given-names>D.</given-names></name><name><surname>Shales</surname><given-names>M.</given-names></name><name><surname>Mrejen</surname><given-names>C.</given-names></name><name><surname>Stefanko</surname><given-names>A.</given-names></name><name><surname>Braberg</surname><given-names>H.</given-names></name><name><surname>Gordon</surname><given-names>D.E.</given-names></name><name><surname>Vorkel</surname><given-names>D.</given-names></name><name><surname>Ejsing</surname><given-names>C.S.</given-names></name><etal/></person-group><article-title>A Lipid E-MAP Identifies Ubx2 as a Critical Regulator of Lipid Saturation and Lipid Bilayer Stress</article-title><source>Mol. Cell</source><year>2013</year><volume>51</volume><fpage>519</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.06.014</pub-id><?supplied-pmid 23891562?><pub-id pub-id-type="pmid">23891562</pub-id></element-citation></ref><ref id="B126-ijms-20-02167"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michel</surname><given-names>V.</given-names></name><name><surname>Bakovic</surname><given-names>M.</given-names></name></person-group><article-title>Lipid rafts in health and disease</article-title><source>Biol. Cell</source><year>2007</year><volume>99</volume><fpage>129</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1042/BC20060051</pub-id><?supplied-pmid 17064251?><pub-id pub-id-type="pmid">17064251</pub-id></element-citation></ref><ref id="B127-ijms-20-02167"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>R.</given-names></name><name><surname>Rojo</surname><given-names>J.A.</given-names></name><name><surname>Fabelo</surname><given-names>N.</given-names></name><name><surname>Fernandez</surname><given-names>C.E.</given-names></name><name><surname>Diaz</surname><given-names>M.</given-names></name></person-group><article-title>Lipid raft disarrangement as a result of neuropathological progresses: A novel strategy for early diagnosis?</article-title><source>Neuroscience</source><year>2013</year><volume>245</volume><fpage>26</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.04.025</pub-id><pub-id pub-id-type="pmid">23618758</pub-id></element-citation></ref><ref id="B128-ijms-20-02167"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodman</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name></person-group><article-title>Membrane Lipids: Implication for Diseases and Membrane Trafficking</article-title><source>SM J. Biol.</source><year>2017</year><volume>3</volume><fpage>1016</fpage></element-citation></ref><ref id="B129-ijms-20-02167"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evangelisti</surname><given-names>E.</given-names></name><name><surname>Cecchi</surname><given-names>C.</given-names></name><name><surname>Cascella</surname><given-names>R.</given-names></name><name><surname>Sgromo</surname><given-names>C.</given-names></name><name><surname>Becatti</surname><given-names>M.</given-names></name><name><surname>Dobson</surname><given-names>C.M.</given-names></name><name><surname>Chiti</surname><given-names>F.</given-names></name><name><surname>Stefani</surname><given-names>M.</given-names></name></person-group><article-title>Membrane lipid composition and its physicochemical properties define cell vulnerability to aberrant protein oligomers</article-title><source>J. Cell Sci.</source><year>2012</year><volume>125</volume><fpage>2416</fpage><lpage>2427</lpage><pub-id pub-id-type="doi">10.1242/jcs.098434</pub-id><pub-id pub-id-type="pmid">22344258</pub-id></element-citation></ref><ref id="B130-ijms-20-02167"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>St. Clair</surname><given-names>J.R.</given-names></name><name><surname>London</surname><given-names>E.</given-names></name><name><surname>Raleigh</surname><given-names>D.P.</given-names></name></person-group><article-title>Islet Amyloid Polypeptide Membrane Interactions: Effects of Membrane Composition</article-title><source>Biochemistry</source><year>2017</year><volume>56</volume><fpage>376</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.6b01016</pub-id><pub-id pub-id-type="pmid">28054763</pub-id></element-citation></ref><ref id="B131-ijms-20-02167"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soria</surname><given-names>M.A.</given-names></name><name><surname>Cervantes</surname><given-names>S.A.</given-names></name><name><surname>Bajakian</surname><given-names>T.H.</given-names></name><name><surname>Siemer</surname><given-names>A.B.</given-names></name></person-group><article-title>The Functional Amyloid Orb2A Binds to Lipid Membranes</article-title><source>Biophys. J.</source><year>2017</year><volume>113</volume><fpage>37</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2017.05.039</pub-id><pub-id pub-id-type="pmid">28700922</pub-id></element-citation></ref><ref id="B132-ijms-20-02167"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>A.M.</given-names></name><name><surname>Bevan</surname><given-names>D.R.</given-names></name></person-group><article-title>Influence of sequence and lipid type on membrane perturbation by human and rat amyloid &#x003b2;-peptide (1&#x02013;42)</article-title><source>Arch. Biochem. Biophys.</source><year>2017</year><volume>614</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.abb.2016.11.006</pub-id><pub-id pub-id-type="pmid">27884599</pub-id></element-citation></ref><ref id="B133-ijms-20-02167"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunasekara</surname><given-names>L.</given-names></name><name><surname>Al-Saiedy</surname><given-names>M.</given-names></name><name><surname>Green</surname><given-names>F.</given-names></name><name><surname>Pratt</surname><given-names>R.</given-names></name><name><surname>Bjornson</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>A.</given-names></name><name><surname>Schoel</surname><given-names>W.M.</given-names></name><name><surname>Mitchell</surname><given-names>I.</given-names></name><name><surname>Brindle</surname><given-names>M.</given-names></name><name><surname>Montgomery</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Pulmonary surfactant dysfunction in pediatric cystic fibrosis: Mechanisms and reversal with a lipid-sequestering drug</article-title><source>J. Cyst. Fibros.</source><year>2017</year><volume>16</volume><fpage>565</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1016/j.jcf.2017.04.015</pub-id><pub-id pub-id-type="pmid">28599957</pub-id></element-citation></ref><ref id="B134-ijms-20-02167"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grassm&#x000e9;</surname><given-names>H.</given-names></name><name><surname>Henry</surname><given-names>B.</given-names></name><name><surname>Ziobro</surname><given-names>R.</given-names></name><name><surname>Becker</surname><given-names>K.A.</given-names></name><name><surname>Riethm&#x000fc;ller</surname><given-names>J.</given-names></name><name><surname>Gardner</surname><given-names>A.</given-names></name><name><surname>Seitz</surname><given-names>A.P.</given-names></name><name><surname>Steinmann</surname><given-names>J.</given-names></name><name><surname>Lang</surname><given-names>S.</given-names></name><name><surname>Ward</surname><given-names>C.</given-names></name><etal/></person-group><article-title>&#x003b2;1-Integrin Accumulates in Cystic Fibrosis Luminal Airway Epithelial Membranes and Decreases Sphingosine, Promoting Bacterial Infections</article-title><source>Cell Host Microbe</source><year>2017</year><volume>21</volume><fpage>707</fpage><lpage>718.e8</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2017.05.001</pub-id><?supplied-pmid 28552668?><pub-id pub-id-type="pmid">28552668</pub-id></element-citation></ref><ref id="B135-ijms-20-02167"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baenke</surname><given-names>F.</given-names></name><name><surname>Peck</surname><given-names>B.</given-names></name><name><surname>Miess</surname><given-names>H.</given-names></name><name><surname>Schulze</surname><given-names>A.</given-names></name></person-group><article-title>Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development</article-title><source>Dis. Model. Mech.</source><year>2013</year><volume>6</volume><fpage>1353</fpage><lpage>1363</lpage><pub-id pub-id-type="doi">10.1242/dmm.011338</pub-id><?supplied-pmid 24203995?><pub-id pub-id-type="pmid">24203995</pub-id></element-citation></ref><ref id="B136-ijms-20-02167"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cantley</surname><given-names>L.C.</given-names></name><name><surname>Neel</surname><given-names>B.G.</given-names></name></person-group><article-title>New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1999</year><volume>96</volume><fpage>4240</fpage><lpage>4245</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.8.4240</pub-id><?supplied-pmid 10200246?><pub-id pub-id-type="pmid">10200246</pub-id></element-citation></ref><ref id="B137-ijms-20-02167"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Ying</surname><given-names>H.</given-names></name><name><surname>Yan</surname><given-names>H.</given-names></name><name><surname>Kimmelman</surname><given-names>A.C.</given-names></name><name><surname>Hiller</surname><given-names>D.J.</given-names></name><name><surname>Chen</surname><given-names>A.-J.</given-names></name><name><surname>Perry</surname><given-names>S.R.</given-names></name><name><surname>Tonon</surname><given-names>G.</given-names></name><name><surname>Chu</surname><given-names>G.C.</given-names></name><name><surname>Ding</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>P53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation</article-title><source>Nature</source><year>2008</year><volume>455</volume><fpage>1129</fpage><lpage>1133</lpage><pub-id pub-id-type="doi">10.1038/nature07443</pub-id><?supplied-pmid 18948956?><pub-id pub-id-type="pmid">18948956</pub-id></element-citation></ref><ref id="B138-ijms-20-02167"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barcel&#x000f3;-Coblijn</surname><given-names>G.</given-names></name><name><surname>Martin</surname><given-names>M.L.</given-names></name><name><surname>de Almeida</surname><given-names>R.F.M.</given-names></name><name><surname>Noguera-Salv&#x000e0;</surname><given-names>M.A.</given-names></name><name><surname>Marcilla-Etxenike</surname><given-names>A.</given-names></name><name><surname>Guardiola-Serrano</surname><given-names>F.</given-names></name><name><surname>L&#x000fc;th</surname><given-names>A.</given-names></name><name><surname>Kleuser</surname><given-names>B.</given-names></name><name><surname>Halver</surname><given-names>J.E.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name></person-group><article-title>Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2011</year><volume>108</volume><fpage>19569</fpage><lpage>19574</lpage><pub-id pub-id-type="pmid">22106271</pub-id></element-citation></ref><ref id="B139-ijms-20-02167"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teres</surname><given-names>S.</given-names></name><name><surname>Llado</surname><given-names>V.</given-names></name><name><surname>Higuera</surname><given-names>M.</given-names></name><name><surname>Barcelo-Coblijn</surname><given-names>G.</given-names></name><name><surname>Martin</surname><given-names>M.L.</given-names></name><name><surname>Noguera-Salva</surname><given-names>M.A.</given-names></name><name><surname>Marcilla-Etxenike</surname><given-names>A.</given-names></name><name><surname>Garcia-Verdugo</surname><given-names>J.M.</given-names></name><name><surname>Soriano-Navarro</surname><given-names>M.</given-names></name><name><surname>Saus</surname><given-names>C.</given-names></name><etal/></person-group><article-title>2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2012</year><volume>109</volume><fpage>8489</fpage><lpage>8494</lpage><pub-id pub-id-type="doi">10.1073/pnas.1118349109</pub-id><?supplied-pmid 22586083?><pub-id pub-id-type="pmid">22586083</pub-id></element-citation></ref><ref id="B140-ijms-20-02167"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuya</surname><given-names>H.</given-names></name><name><surname>Shimizu</surname><given-names>Y.</given-names></name><name><surname>Kawamori</surname><given-names>T.</given-names></name></person-group><article-title>Sphingolipids in cancer</article-title><source>Cancer Metastasis Rev.</source><year>2011</year><volume>30</volume><fpage>567</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1007/s10555-011-9304-1</pub-id><?supplied-pmid 22005951?><pub-id pub-id-type="pmid">22005951</pub-id></element-citation></ref><ref id="B141-ijms-20-02167"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obeid</surname><given-names>L.M.</given-names></name><name><surname>Linardic</surname><given-names>C.M.</given-names></name><name><surname>Karolak</surname><given-names>L.A.</given-names></name><name><surname>Hannun</surname><given-names>Y.A.</given-names></name></person-group><article-title>Programmed cell death induced by ceramide</article-title><source>Science</source><year>1993</year><volume>259</volume><fpage>1769</fpage><lpage>1771</lpage><pub-id pub-id-type="doi">10.1126/science.8456305</pub-id><pub-id pub-id-type="pmid">8456305</pub-id></element-citation></ref><ref id="B142-ijms-20-02167"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venable</surname><given-names>M.E.</given-names></name><name><surname>Lee</surname><given-names>J.Y.</given-names></name><name><surname>Smyth</surname><given-names>M.J.</given-names></name><name><surname>Bielawska</surname><given-names>A.</given-names></name><name><surname>Obeid</surname><given-names>L.M.</given-names></name></person-group><article-title>Role of Ceramide in Cellular Senescence</article-title><source>J. Biol. Chem.</source><year>1995</year><volume>270</volume><fpage>30701</fpage><lpage>30708</lpage><pub-id pub-id-type="doi">10.1074/jbc.270.51.30701</pub-id><?supplied-pmid 8530509?><pub-id pub-id-type="pmid">8530509</pub-id></element-citation></ref><ref id="B143-ijms-20-02167"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hla</surname><given-names>T.</given-names></name></person-group><article-title>Physiological and pathological actions of sphingosine 1-phosphate</article-title><source>Semin. Cell Dev. Biol.</source><year>2004</year><volume>15</volume><fpage>513</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2004.05.002</pub-id><?supplied-pmid 15271296?><pub-id pub-id-type="pmid">15271296</pub-id></element-citation></ref><ref id="B144-ijms-20-02167"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Cheng</surname><given-names>J.C.</given-names></name><name><surname>Turner</surname><given-names>L.S.</given-names></name><name><surname>Elojeimy</surname><given-names>S.</given-names></name><name><surname>Beckham</surname><given-names>T.H.</given-names></name><name><surname>Bielawska</surname><given-names>A.</given-names></name><name><surname>Keane</surname><given-names>T.E.</given-names></name><name><surname>Hannun</surname><given-names>Y.A.</given-names></name><name><surname>Norris</surname><given-names>J.S.</given-names></name></person-group><article-title>Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy</article-title><source>Expert Opin. Ther. Targets</source><year>2009</year><volume>13</volume><fpage>1449</fpage><lpage>1458</lpage><pub-id pub-id-type="doi">10.1517/14728220903357512</pub-id><pub-id pub-id-type="pmid">19874262</pub-id></element-citation></ref><ref id="B145-ijms-20-02167"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirsch</surname><given-names>H.A.</given-names></name><name><surname>Iliopoulos</surname><given-names>D.</given-names></name><name><surname>Joshi</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Jaeger</surname><given-names>S.A.</given-names></name><name><surname>Bulyk</surname><given-names>M.</given-names></name><name><surname>Tsichlis</surname><given-names>P.N.</given-names></name><name><surname>Shirley Liu</surname><given-names>X.</given-names></name><name><surname>Struhl</surname><given-names>K.</given-names></name></person-group><article-title>A Transcriptional Signature and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse Human Diseases</article-title><source>Cancer Cell</source><year>2010</year><volume>17</volume><fpage>348</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2010.01.022</pub-id><pub-id pub-id-type="pmid">20385360</pub-id></element-citation></ref><ref id="B146-ijms-20-02167"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhajda</surname><given-names>F.P.</given-names></name><name><surname>Jenner</surname><given-names>K.</given-names></name><name><surname>Wood</surname><given-names>F.D.</given-names></name><name><surname>Hennigar</surname><given-names>R.A.</given-names></name><name><surname>Jacobs</surname><given-names>L.B.</given-names></name><name><surname>Dick</surname><given-names>J.D.</given-names></name><name><surname>Pasternack</surname><given-names>G.R.</given-names></name></person-group><article-title>Fatty acid synthesis: a potential selective target for antineoplastic therapy</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1994</year><volume>91</volume><fpage>6379</fpage><lpage>6383</lpage><pub-id pub-id-type="doi">10.1073/pnas.91.14.6379</pub-id><pub-id pub-id-type="pmid">8022791</pub-id></element-citation></ref><ref id="B147-ijms-20-02167"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilvo</surname><given-names>M.</given-names></name><name><surname>Denkert</surname><given-names>C.</given-names></name><name><surname>Lehtinen</surname><given-names>L.</given-names></name><name><surname>Muller</surname><given-names>B.</given-names></name><name><surname>Brockmoller</surname><given-names>S.</given-names></name><name><surname>Seppanen-Laakso</surname><given-names>T.</given-names></name><name><surname>Budczies</surname><given-names>J.</given-names></name><name><surname>Bucher</surname><given-names>E.</given-names></name><name><surname>Yetukuri</surname><given-names>L.</given-names></name><name><surname>Castillo</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression</article-title><source>Cancer Res.</source><year>2011</year><volume>71</volume><fpage>3236</fpage><lpage>3245</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-10-3894</pub-id><pub-id pub-id-type="pmid">21415164</pub-id></element-citation></ref><ref id="B148-ijms-20-02167"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crous-Bou</surname><given-names>M.</given-names></name><name><surname>Rennert</surname><given-names>G.</given-names></name><name><surname>Salazar</surname><given-names>R.</given-names></name><name><surname>Rodriguez-Moranta</surname><given-names>F.</given-names></name><name><surname>Rennert</surname><given-names>H.S.</given-names></name><name><surname>Lejbkowicz</surname><given-names>F.</given-names></name><name><surname>Kopelovich</surname><given-names>L.</given-names></name><name><surname>Lipkin</surname><given-names>S.M.</given-names></name><name><surname>Gruber</surname><given-names>S.B.</given-names></name><name><surname>Moreno</surname><given-names>V.</given-names></name></person-group><article-title>Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer</article-title><source>Mutagenesis</source><year>2012</year><volume>27</volume><fpage>169</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1093/mutage/ger066</pub-id><pub-id pub-id-type="pmid">22294764</pub-id></element-citation></ref><ref id="B149-ijms-20-02167"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dielschneider</surname><given-names>R.F.</given-names></name><name><surname>Henson</surname><given-names>E.S.</given-names></name><name><surname>Gibson</surname><given-names>S.B.</given-names></name></person-group><article-title>Lysosomes as Oxidative Targets for Cancer Therapy</article-title><source>Oxid. Med. Cell. Longev.</source><year>2017</year><volume>2017</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1155/2017/3749157</pub-id></element-citation></ref><ref id="B150-ijms-20-02167"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J.B.</given-names></name><name><surname>Lee</surname><given-names>C.S.</given-names></name><name><surname>Jang</surname><given-names>J.-H.</given-names></name><name><surname>Ghim</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>Y.-J.</given-names></name><name><surname>You</surname><given-names>S.</given-names></name><name><surname>Hwang</surname><given-names>D.</given-names></name><name><surname>Suh</surname><given-names>P.-G.</given-names></name><name><surname>Ryu</surname><given-names>S.H.</given-names></name></person-group><article-title>Phospholipase signalling networks in cancer</article-title><source>Nat. Rev. Cancer</source><year>2012</year><volume>12</volume><fpage>782</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1038/nrc3379</pub-id><pub-id pub-id-type="pmid">23076158</pub-id></element-citation></ref><ref id="B151-ijms-20-02167"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nomura</surname><given-names>D.K.</given-names></name><name><surname>Long</surname><given-names>J.Z.</given-names></name><name><surname>Niessen</surname><given-names>S.</given-names></name><name><surname>Hoover</surname><given-names>H.S.</given-names></name><name><surname>Ng</surname><given-names>S.-W.</given-names></name><name><surname>Cravatt</surname><given-names>B.F.</given-names></name></person-group><article-title>Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis</article-title><source>Cell</source><year>2010</year><volume>140</volume><fpage>49</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2009.11.027</pub-id><pub-id pub-id-type="pmid">20079333</pub-id></element-citation></ref><ref id="B152-ijms-20-02167"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joyce</surname><given-names>J.A.</given-names></name><name><surname>Pollard</surname><given-names>J.W.</given-names></name></person-group><article-title>Microenvironmental regulation of metastasis</article-title><source>Nat. Rev. Cancer</source><year>2009</year><volume>9</volume><fpage>239</fpage><lpage>252</lpage><pub-id pub-id-type="doi">10.1038/nrc2618</pub-id><pub-id pub-id-type="pmid">19279573</pub-id></element-citation></ref><ref id="B153-ijms-20-02167"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santolla</surname><given-names>M.F.</given-names></name><name><surname>Lappano</surname><given-names>R.</given-names></name><name><surname>Marco</surname><given-names>P.D.</given-names></name><name><surname>Pupo</surname><given-names>M.</given-names></name><name><surname>Vivacqua</surname><given-names>A.</given-names></name><name><surname>Sisci</surname><given-names>D.</given-names></name><name><surname>Abonante</surname><given-names>S.</given-names></name><name><surname>Iacopetta</surname><given-names>D.</given-names></name><name><surname>Cappello</surname><given-names>A.R.</given-names></name><name><surname>Dolce</surname><given-names>V.</given-names></name><etal/></person-group><article-title>G Protein-coupled Estrogen Receptor Mediates the Up-regulation of Fatty Acid Synthase Induced by 17&#x003b2;-Estradiol in Cancer Cells and Cancer-associated Fibroblasts</article-title><source>J. Biol. Chem.</source><year>2012</year><volume>287</volume><fpage>43234</fpage><lpage>43245</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.417303</pub-id><pub-id pub-id-type="pmid">23135268</pub-id></element-citation></ref><ref id="B154-ijms-20-02167"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Im</surname><given-names>S.-S.</given-names></name><name><surname>Yousef</surname><given-names>L.</given-names></name><name><surname>Blaschitz</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>J.Z.</given-names></name><name><surname>Edwards</surname><given-names>R.A.</given-names></name><name><surname>Young</surname><given-names>S.G.</given-names></name><name><surname>Raffatellu</surname><given-names>M.</given-names></name><name><surname>Osborne</surname><given-names>T.F.</given-names></name></person-group><article-title>Linking Lipid Metabolism to the Innate Immune Response in Macrophages through Sterol Regulatory Element Binding Protein-1a</article-title><source>Cell Metab.</source><year>2011</year><volume>13</volume><fpage>540</fpage><lpage>549</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2011.04.001</pub-id><pub-id pub-id-type="pmid">21531336</pub-id></element-citation></ref><ref id="B155-ijms-20-02167"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heusinkveld</surname><given-names>M.</given-names></name><name><surname>de Vos van Steenwijk</surname><given-names>P.J.</given-names></name><name><surname>Goedemans</surname><given-names>R.</given-names></name><name><surname>Ramwadhdoebe</surname><given-names>T.H.</given-names></name><name><surname>Gorter</surname><given-names>A.</given-names></name><name><surname>Welters</surname><given-names>M.J.P.</given-names></name><name><surname>van Hall</surname><given-names>T.</given-names></name><name><surname>van der Burg</surname><given-names>S.H.</given-names></name></person-group><article-title>M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells</article-title><source>J. Immunol.</source><year>2011</year><volume>187</volume><fpage>1157</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1100889</pub-id><?supplied-pmid 21709158?><pub-id pub-id-type="pmid">21709158</pub-id></element-citation></ref><ref id="B156-ijms-20-02167"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beloribi-Djefaflia</surname><given-names>S.</given-names></name><name><surname>Vasseur</surname><given-names>S.</given-names></name><name><surname>Guillaumond</surname><given-names>F.</given-names></name></person-group><article-title>Lipid metabolic reprogramming in cancer cells</article-title><source>Oncogenesis</source><year>2016</year><volume>5</volume><fpage>e189</fpage><pub-id pub-id-type="doi">10.1038/oncsis.2015.49</pub-id><pub-id pub-id-type="pmid">26807644</pub-id></element-citation></ref><ref id="B157-ijms-20-02167"><label>157.</label><element-citation publication-type="gov"><person-group person-group-type="author"><name><surname>Reference</surname><given-names>G.H.</given-names></name></person-group><article-title>Tay-Sachs Disease</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://ghr.nlm.nih.gov/condition/tay-sachs-disease">https://ghr.nlm.nih.gov/condition/tay-sachs-disease</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2019-04-25">(accessed on 25 April 2019)</date-in-citation></element-citation></ref><ref id="B158-ijms-20-02167"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcilla-Etxenike</surname><given-names>A.</given-names></name><name><surname>Mart&#x000ed;n</surname><given-names>M.L.</given-names></name><name><surname>Noguera-Salv&#x000e0;</surname><given-names>M.A.</given-names></name><name><surname>Garc&#x000ed;a-Verdugo</surname><given-names>J.M.</given-names></name><name><surname>Soriano-Navarro</surname><given-names>M.</given-names></name><name><surname>Dey</surname><given-names>I.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name><name><surname>Busquets</surname><given-names>X.</given-names></name></person-group><article-title>2-Hydroxyoleic Acid Induces ER Stress and Autophagy in Various Human Glioma Cell Lines</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e48235</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0048235</pub-id><pub-id pub-id-type="pmid">23133576</pub-id></element-citation></ref><ref id="B159-ijms-20-02167"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perona</surname><given-names>J.S.</given-names></name><name><surname>Vogler</surname><given-names>O.</given-names></name><name><surname>Sanchez-Dominguez</surname><given-names>J.M.</given-names></name><name><surname>Montero</surname><given-names>E.</given-names></name><name><surname>Escriba</surname><given-names>P.V.</given-names></name><name><surname>Ruiz-Gutierrez</surname><given-names>V.</given-names></name></person-group><article-title>Consumption of Virgin Olive Oil Influences Membrane Lipid Composition and Regulates Intracellular Signaling in Elderly Adults With Type 2 Diabetes Mellitus</article-title><source>J. Gerontol. A. Biol. Sci. Med. Sci.</source><year>2007</year><volume>62</volume><fpage>256</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1093/gerona/62.3.256</pub-id><pub-id pub-id-type="pmid">17389722</pub-id></element-citation></ref><ref id="B160-ijms-20-02167"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name><name><surname>Gonz&#x000e1;lez-Ros</surname><given-names>J.M.</given-names></name><name><surname>Go&#x000f1;i</surname><given-names>F.M.</given-names></name><name><surname>Kinnunen</surname><given-names>P.K.J.</given-names></name><name><surname>Vigh</surname><given-names>L.</given-names></name><name><surname>S&#x000e1;nchez-Magraner</surname><given-names>L.</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>A.M.</given-names></name><name><surname>Busquets</surname><given-names>X.</given-names></name><name><surname>Horv&#x000e1;th</surname><given-names>I.</given-names></name><name><surname>Barcel&#x000f3;-Coblijn</surname><given-names>G.</given-names></name></person-group><article-title>Membranes: a meeting point for lipids, proteins and therapies</article-title><source>J. Cell. Mol. Med.</source><year>2008</year><volume>12</volume><fpage>829</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.1111/j.1582-4934.2008.00281.x</pub-id><?supplied-pmid 18266954?><pub-id pub-id-type="pmid">18266954</pub-id></element-citation></ref><ref id="B161-ijms-20-02167"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wali</surname><given-names>R.K.</given-names></name><name><surname>Jaffe</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>D.</given-names></name><name><surname>Kalra</surname><given-names>V.K.</given-names></name></person-group><article-title>Alterations in Organization of Phospholipids in Erythrocytes as Factor in Adherence to Endothelial Cells in Diabetes Mellitus</article-title><source>Diabetes</source><year>1988</year><volume>37</volume><fpage>104</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.2337/diab.37.1.104</pub-id><?supplied-pmid 3335275?><pub-id pub-id-type="pmid">3335275</pub-id></element-citation></ref><ref id="B162-ijms-20-02167"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuel</surname><given-names>V.T.</given-names></name><name><surname>Shulman</surname><given-names>G.I.</given-names></name></person-group><article-title>Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases</article-title><source>Cell Metab.</source><year>2018</year><volume>27</volume><fpage>22</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2017.08.002</pub-id><pub-id pub-id-type="pmid">28867301</pub-id></element-citation></ref><ref id="B163-ijms-20-02167"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basseri</surname><given-names>S.</given-names></name><name><surname>Austin</surname><given-names>R.C.</given-names></name></person-group><article-title>Endoplasmic Reticulum Stress and Lipid Metabolism: Mechanisms and Therapeutic Potential</article-title><source>Biochem. Res. Int.</source><year>2012</year><volume>2012</volume><pub-id pub-id-type="doi">10.1155/2012/841362</pub-id></element-citation></ref><ref id="B164-ijms-20-02167"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Hofmann</surname><given-names>O.</given-names></name><name><surname>Dicker</surname><given-names>L.</given-names></name><name><surname>Hide</surname><given-names>W.</given-names></name><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Watkins</surname><given-names>S.M.</given-names></name><name><surname>Ivanov</surname><given-names>A.R.</given-names></name><name><surname>Hotamisligil</surname><given-names>G.S.</given-names></name></person-group><article-title>Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity</article-title><source>Nature</source><year>2011</year><volume>473</volume><fpage>528</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1038/nature09968</pub-id><?supplied-pmid 21532591?><pub-id pub-id-type="pmid">21532591</pub-id></element-citation></ref><ref id="B165-ijms-20-02167"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Handschin</surname><given-names>C.</given-names></name><name><surname>Spiegelman</surname><given-names>B.M.</given-names></name></person-group><article-title>Metabolic control through the PGC-1 family of transcription coactivators</article-title><source>Cell Metab.</source><year>2005</year><volume>1</volume><fpage>361</fpage><lpage>370</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2005.05.004</pub-id><pub-id pub-id-type="pmid">16054085</pub-id></element-citation></ref><ref id="B166-ijms-20-02167"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Settembre</surname><given-names>C.</given-names></name><name><surname>De Cegli</surname><given-names>R.</given-names></name><name><surname>Mansueto</surname><given-names>G.</given-names></name><name><surname>Saha</surname><given-names>P.K.</given-names></name><name><surname>Vetrini</surname><given-names>F.</given-names></name><name><surname>Visvikis</surname><given-names>O.</given-names></name><name><surname>Huynh</surname><given-names>T.</given-names></name><name><surname>Carissimo</surname><given-names>A.</given-names></name><name><surname>Palmer</surname><given-names>D.</given-names></name><name><surname>J&#x000fc;rgen Klisch</surname><given-names>T.</given-names></name><etal/></person-group><article-title>TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop</article-title><source>Nat. Cell Biol.</source><year>2013</year><volume>15</volume><fpage>647</fpage><lpage>658</lpage><pub-id pub-id-type="doi">10.1038/ncb2718</pub-id><?supplied-pmid 23604321?><pub-id pub-id-type="pmid">23604321</pub-id></element-citation></ref><ref id="B167-ijms-20-02167"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000f6;neberg</surname><given-names>J.</given-names></name><name><surname>Lehmann</surname><given-names>M.</given-names></name><name><surname>Ullrich</surname><given-names>A.</given-names></name><name><surname>Posor</surname><given-names>Y.</given-names></name><name><surname>Lo</surname><given-names>W.-T.</given-names></name><name><surname>Lichtner</surname><given-names>G.</given-names></name><name><surname>Schmoranzer</surname><given-names>J.</given-names></name><name><surname>Haucke</surname><given-names>V.</given-names></name><name><surname>No&#x000e9;</surname><given-names>F.</given-names></name></person-group><article-title>Lipid-mediated PX-BAR domain recruitment couples local membrane constriction to endocytic vesicle fission</article-title><source>Nat. Commun.</source><year>2017</year><volume>8</volume><fpage>15873</fpage><pub-id pub-id-type="doi">10.1038/ncomms15873</pub-id><pub-id pub-id-type="pmid">28627515</pub-id></element-citation></ref><ref id="B168-ijms-20-02167"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gray</surname><given-names>S.M.</given-names></name><name><surname>Aylor</surname><given-names>K.W.</given-names></name><name><surname>Barrett</surname><given-names>E.J.</given-names></name></person-group><article-title>Unravelling the regulation of insulin transport across the brain endothelial cell</article-title><source>Diabetologia</source><year>2017</year><volume>60</volume><fpage>1512</fpage><lpage>1521</lpage><pub-id pub-id-type="doi">10.1007/s00125-017-4285-4</pub-id><?supplied-pmid 28601906?><pub-id pub-id-type="pmid">28601906</pub-id></element-citation></ref><ref id="B169-ijms-20-02167"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trapani</surname><given-names>L.</given-names></name></person-group><article-title>Regulation and deregulation of cholesterol homeostasis: The liver as a metabolic &#x0201c;power station&#x0201d;</article-title><source>World J. Hepatol.</source><year>2012</year><volume>4</volume><fpage>184</fpage><pub-id pub-id-type="doi">10.4254/wjh.v4.i6.184</pub-id><pub-id pub-id-type="pmid">22761969</pub-id></element-citation></ref><ref id="B170-ijms-20-02167"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radic</surname><given-names>M.</given-names></name><name><surname>Pattanaik</surname><given-names>D.</given-names></name></person-group><article-title>Cellular and Molecular Mechanisms of Anti-Phospholipid Syndrome</article-title><source>Front. Immunol.</source><year>2018</year><volume>9</volume><fpage>969</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00969</pub-id><pub-id pub-id-type="pmid">29867951</pub-id></element-citation></ref><ref id="B171-ijms-20-02167"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asherson</surname><given-names>R.A.</given-names></name><name><surname>Cervera</surname><given-names>R.</given-names></name></person-group><article-title>Antiphospholipid antibodies and infections</article-title><source>Ann. Rheum. Dis.</source><year>2003</year><volume>62</volume><fpage>388</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1136/ard.62.5.388</pub-id><pub-id pub-id-type="pmid">12695147</pub-id></element-citation></ref><ref id="B172-ijms-20-02167"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahine</surname><given-names>A.</given-names></name><name><surname>Van Rhijn</surname><given-names>I.</given-names></name><name><surname>Cheng</surname><given-names>T.-Y.</given-names></name><name><surname>Iwany</surname><given-names>S.</given-names></name><name><surname>Gras</surname><given-names>S.</given-names></name><name><surname>Moody</surname><given-names>D.B.</given-names></name><name><surname>Rossjohn</surname><given-names>J.</given-names></name></person-group><article-title>A molecular basis of human T cell receptor autoreactivity toward self-phospholipids</article-title><source>Sci. Immunol.</source><year>2017</year><volume>2</volume><fpage>eaao1384</fpage><pub-id pub-id-type="doi">10.1126/sciimmunol.aao1384</pub-id><pub-id pub-id-type="pmid">29054999</pub-id></element-citation></ref><ref id="B173-ijms-20-02167"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palsuledesai</surname><given-names>C.C.</given-names></name><name><surname>Distefano</surname><given-names>M.D.</given-names></name></person-group><article-title>Protein prenylation: Enzymes, therapeutics, and biotechnology applications</article-title><source>ACS Chem. Biol.</source><year>2015</year><volume>10</volume><fpage>51</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1021/cb500791f</pub-id><?supplied-pmid 25402849?><pub-id pub-id-type="pmid">25402849</pub-id></element-citation></ref><ref id="B174-ijms-20-02167"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghomashchi</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Gelb</surname><given-names>M.H.</given-names></name></person-group><article-title>Binding of prenylated and polybasic peptides to membranes: affinities and intervesicle exchange</article-title><source>Biochemistry</source><year>1995</year><volume>34</volume><fpage>11910</fpage><lpage>11918</lpage><pub-id pub-id-type="doi">10.1021/bi00037a032</pub-id><pub-id pub-id-type="pmid">7547927</pub-id></element-citation></ref><ref id="B175-ijms-20-02167"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resh</surname><given-names>M.D.</given-names></name></person-group><article-title>Trafficking and signaling by fatty-acylated and prenylated proteins</article-title><source>Nat. Chem. Biol.</source><year>2006</year><volume>2</volume><fpage>584</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1038/nchembio834</pub-id><?supplied-pmid 17051234?><pub-id pub-id-type="pmid">17051234</pub-id></element-citation></ref><ref id="B176-ijms-20-02167"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>F.L.</given-names></name><name><surname>Casey</surname><given-names>P.J.</given-names></name></person-group><article-title>Protein Prenylation: Molecular Mechanisms and Functional Consequences</article-title><source>Annu. Rev. Biochem.</source><year>1996</year><volume>65</volume><fpage>241</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1146/annurev.bi.65.070196.001325</pub-id><pub-id pub-id-type="pmid">8811180</pub-id></element-citation></ref><ref id="B177-ijms-20-02167"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamiya</surname><given-names>Y.</given-names></name><name><surname>Sakurai</surname><given-names>A.</given-names></name><name><surname>Tamura</surname><given-names>S.</given-names></name><name><surname>Takahashi</surname><given-names>N.</given-names></name><name><surname>Abe</surname><given-names>K.</given-names></name><name><surname>Tsuchiya</surname><given-names>E.</given-names></name><name><surname>Fukui</surname><given-names>S.</given-names></name><name><surname>Kitada</surname><given-names>C.</given-names></name><name><surname>Fujino</surname><given-names>M.</given-names></name></person-group><article-title>Structure of rhodotorucine A, a novel lipopeptide, inducing mating tube formation in Rhodosporidiumtoruloides</article-title><source>Biochem. Biophys. Res. Commun.</source><year>1978</year><volume>83</volume><fpage>1077</fpage><lpage>1083</lpage><pub-id pub-id-type="doi">10.1016/0006-291X(78)91505-X</pub-id><pub-id pub-id-type="pmid">708426</pub-id></element-citation></ref><ref id="B178-ijms-20-02167"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farnsworth</surname><given-names>C.C.</given-names></name><name><surname>Wolda</surname><given-names>S.L.</given-names></name><name><surname>Gelb</surname><given-names>M.H.</given-names></name><name><surname>Glomset</surname><given-names>J.A.</given-names></name></person-group><article-title>Human lamin B contains a farnesylated cysteine residue</article-title><source>J. Biol. Chem.</source><year>1989</year><volume>264</volume><fpage>20422</fpage><lpage>20429</lpage><?supplied-pmid 2684976?><pub-id pub-id-type="pmid">2684976</pub-id></element-citation></ref><ref id="B179-ijms-20-02167"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolda</surname><given-names>S.L.</given-names></name><name><surname>Glomset</surname><given-names>J.A.</given-names></name></person-group><article-title>Evidence for modification of lamin B by a product of mevalonic acid</article-title><source>J. Biol. Chem.</source><year>1988</year><volume>263</volume><fpage>5997</fpage><lpage>6000</lpage><?supplied-pmid 3283116?><pub-id pub-id-type="pmid">3283116</pub-id></element-citation></ref><ref id="B180-ijms-20-02167"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berndt</surname><given-names>N.</given-names></name><name><surname>Hamilton</surname><given-names>A.D.</given-names></name><name><surname>Sebti</surname><given-names>S.M.</given-names></name></person-group><article-title>Targeting protein prenylation for cancer therapy</article-title><source>Nat. Rev. Cancer</source><year>2011</year><volume>11</volume><fpage>775</fpage><lpage>791</lpage><pub-id pub-id-type="doi">10.1038/nrc3151</pub-id><?supplied-pmid 22020205?><pub-id pub-id-type="pmid">22020205</pub-id></element-citation></ref><ref id="B181-ijms-20-02167"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pompliano</surname><given-names>D.L.</given-names></name><name><surname>Schaber</surname><given-names>M.D.</given-names></name><name><surname>Mosser</surname><given-names>S.D.</given-names></name><name><surname>Omer</surname><given-names>C.A.</given-names></name><name><surname>Shafer</surname><given-names>J.A.</given-names></name><name><surname>Gibbs</surname><given-names>J.B.</given-names></name></person-group><article-title>Isoprenoid diphosphate utilization by recombinant human farnesyl:protein transferase: Interactive binding between substrates and a preferred kinetic pathway</article-title><source>Biochemistry</source><year>1993</year><volume>32</volume><fpage>8341</fpage><lpage>8347</lpage><pub-id pub-id-type="doi">10.1021/bi00083a038</pub-id><?supplied-pmid 8347630?><pub-id pub-id-type="pmid">8347630</pub-id></element-citation></ref><ref id="B182-ijms-20-02167"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolence</surname><given-names>J.M.</given-names></name><name><surname>Cassidy</surname><given-names>P.B.</given-names></name><name><surname>Mathis</surname><given-names>J.R.</given-names></name><name><surname>Poulter</surname><given-names>C.D.</given-names></name></person-group><article-title>Yeast protein farnesyltransferase: steady-state kinetic studies of substrate binding</article-title><source>Biochemistry</source><year>1995</year><volume>34</volume><fpage>16687</fpage><lpage>16694</lpage><pub-id pub-id-type="doi">10.1021/bi00051a017</pub-id><pub-id pub-id-type="pmid">8527442</pub-id></element-citation></ref><ref id="B183-ijms-20-02167"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omer</surname><given-names>C.A.</given-names></name><name><surname>Gibbs</surname><given-names>R.A.</given-names></name></person-group><article-title>On the Stereochemical Course of Human Protein-Farnesyl Transferase</article-title><source>J. Am. Chem. Soc.</source><year>1996</year><volume>118</volume><fpage>1817</fpage><lpage>1823</lpage></element-citation></ref><ref id="B184-ijms-20-02167"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edelstein</surname><given-names>R.L.</given-names></name><name><surname>Weller</surname><given-names>V.A.</given-names></name><name><surname>Distefano</surname><given-names>M.D.</given-names></name><name><surname>Tung</surname><given-names>J.S.</given-names></name></person-group><article-title>Stereochemical Analysis of the Reaction Catalyzed by Yeast Protein Farnesyltransferase</article-title><source>J. Org. Chem.</source><year>1998</year><volume>63</volume><fpage>5298</fpage><lpage>5299</lpage><pub-id pub-id-type="doi">10.1021/jo980304s</pub-id></element-citation></ref><ref id="B185-ijms-20-02167"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clausen</surname><given-names>V.A.</given-names></name><name><surname>Edelstein</surname><given-names>R.L.</given-names></name><name><surname>Distefano</surname><given-names>M.D.</given-names></name></person-group><article-title>Stereochemical Analysis of the Reaction Catalyzed by Human Protein Geranylgeranyl Transferase &#x02020;</article-title><source>Biochemistry</source><year>2001</year><volume>40</volume><fpage>3920</fpage><lpage>3930</lpage><pub-id pub-id-type="doi">10.1021/bi002011a</pub-id><?supplied-pmid 11300771?><pub-id pub-id-type="pmid">11300771</pub-id></element-citation></ref><ref id="B186-ijms-20-02167"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>S.B.</given-names></name><name><surname>Casey</surname><given-names>P.J.</given-names></name><name><surname>Beese</surname><given-names>L.S.</given-names></name></person-group><article-title>Reaction path of protein farnesyltransferase at atomic resolution</article-title><source>Nature</source><year>2002</year><volume>419</volume><fpage>645</fpage><lpage>650</lpage><pub-id pub-id-type="doi">10.1038/nature00986</pub-id><?supplied-pmid 12374986?><pub-id pub-id-type="pmid">12374986</pub-id></element-citation></ref><ref id="B187-ijms-20-02167"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochocki</surname><given-names>J.D.</given-names></name><name><surname>Distefano</surname><given-names>M.D.</given-names></name></person-group><article-title>Prenyltransferase inhibitors: treating human ailments from cancer to parasitic infections</article-title><source>Med. Chem. Commun.</source><year>2013</year><volume>4</volume><fpage>476</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.1039/C2MD20299A</pub-id><?supplied-pmid 25530833?><pub-id pub-id-type="pmid">25530833</pub-id></element-citation></ref><ref id="B188-ijms-20-02167"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desnoyers</surname><given-names>L.</given-names></name><name><surname>Anant</surname><given-names>J.S.</given-names></name><name><surname>Seabra</surname><given-names>M.C.</given-names></name></person-group><article-title>Geranylgeranylation of Rab proteins</article-title><source>Biochem. Soc. Trans.</source><year>2015</year><volume>24</volume><fpage>699</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.1042/bst0240699</pub-id></element-citation></ref><ref id="B189-ijms-20-02167"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bos</surname><given-names>J.L.</given-names></name></person-group><article-title>Ras oncogenes in human cancer: a review</article-title><source>Cancer Res.</source><year>1989</year><volume>49</volume><fpage>4682</fpage><lpage>4689</lpage><pub-id pub-id-type="pmid">2547513</pub-id></element-citation></ref><ref id="B190-ijms-20-02167"><label>190.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bishop</surname><given-names>W.R.</given-names></name><name><surname>Doll</surname><given-names>R.</given-names></name><name><surname>Kirschmeier</surname><given-names>P.</given-names></name></person-group><article-title>Farnesyl Transferase Inhibitors</article-title><source>Enzymes</source><publisher-name>Academic Press</publisher-name><publisher-loc>Cambridge, MA, USA</publisher-loc><year>2011</year><fpage>275</fpage><lpage>303</lpage></element-citation></ref><ref id="B191-ijms-20-02167"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamad</surname><given-names>N.M.</given-names></name></person-group><article-title>Distinct requirements for Ras oncogenesis in human versus mouse cells</article-title><source>Genes Dev.</source><year>2002</year><volume>16</volume><fpage>2045</fpage><lpage>2057</lpage><pub-id pub-id-type="doi">10.1101/gad.993902</pub-id><pub-id pub-id-type="pmid">12183360</pub-id></element-citation></ref><ref id="B192-ijms-20-02167"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>A.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name><name><surname>Qian</surname><given-names>Y.</given-names></name><name><surname>Hamilton</surname><given-names>A.D.</given-names></name><name><surname>Sebti</surname><given-names>S.M.</given-names></name></person-group><article-title>The Geranylgeranyltransferase-I Inhibitor GGTI-298 Arrests Human Tumor Cells in G 0 /G 1 and Induces p21 WAF1/CIP1/SDI1 in a p53-independent Manner</article-title><source>J. Biol. Chem.</source><year>1997</year><volume>272</volume><fpage>27224</fpage><lpage>27229</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.43.27224</pub-id><pub-id pub-id-type="pmid">9341167</pub-id></element-citation></ref><ref id="B193-ijms-20-02167"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollinedo</surname><given-names>F.</given-names></name><name><surname>de la Iglesia-Vicente</surname><given-names>J.</given-names></name><name><surname>Gajate</surname><given-names>C.</given-names></name><name><surname>Estella-Hermoso de Mendoza</surname><given-names>A.</given-names></name><name><surname>Villa-Pulgarin</surname><given-names>J.A.</given-names></name><name><surname>Campanero</surname><given-names>M.A.</given-names></name><name><surname>Blanco-Prieto</surname><given-names>M.J.</given-names></name></person-group><article-title>Lipid raft-targeted therapy in multiple myeloma</article-title><source>Oncogene</source><year>2010</year><volume>29</volume><fpage>3748</fpage><lpage>3757</lpage><pub-id pub-id-type="doi">10.1038/onc.2010.131</pub-id><?supplied-pmid 20418917?><pub-id pub-id-type="pmid">20418917</pub-id></element-citation></ref><ref id="B194-ijms-20-02167"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e4;umer</surname><given-names>W.</given-names></name><name><surname>Wla&#x0017a;</surname><given-names>P.</given-names></name><name><surname>Jennings</surname><given-names>G.</given-names></name><name><surname>Rundfeldt</surname><given-names>C.</given-names></name></person-group><article-title>The putative lipid raft modulator miltefosine displays immunomodulatory action in T-cell dependent dermal inflammation models</article-title><source>Eur. J. Pharmacol.</source><year>2010</year><volume>628</volume><fpage>226</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2009.11.018</pub-id><pub-id pub-id-type="pmid">19917276</pub-id></element-citation></ref><ref id="B195-ijms-20-02167"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x000f6;lle</surname><given-names>S.</given-names></name><name><surname>Hoser</surname><given-names>D.</given-names></name><name><surname>Rasche</surname><given-names>C.</given-names></name><name><surname>Loddenkemper</surname><given-names>C.</given-names></name><name><surname>Maurer</surname><given-names>M.</given-names></name><name><surname>Zuberbier</surname><given-names>T.</given-names></name><name><surname>Worm</surname><given-names>M.</given-names></name></person-group><article-title>Long-term reduction in local inflammation by a lipid raft molecule in atopic dermatitis</article-title><source>Allergy</source><year>2010</year><volume>65</volume><fpage>1158</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1111/j.1398-9995.2010.02341.x</pub-id><?supplied-pmid 20337610?><pub-id pub-id-type="pmid">20337610</pub-id></element-citation></ref><ref id="B196-ijms-20-02167"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llad&#x000f3;</surname><given-names>V.</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>D.J.</given-names></name><name><surname>Ibarguren</surname><given-names>M.</given-names></name><name><surname>Alonso</surname><given-names>M.</given-names></name><name><surname>Soriano</surname><given-names>J.B.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name><name><surname>Busquets</surname><given-names>X.</given-names></name></person-group><article-title>Regulation of the cancer cell membrane lipid composition by NaCHOleate</article-title><source>Biochim. Biophys. Acta BBA - Biomembr.</source><year>2014</year><volume>1838</volume><fpage>1619</fpage><lpage>1627</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2014.01.027</pub-id><?supplied-pmid 24525074?><pub-id pub-id-type="pmid">24525074</pub-id></element-citation></ref><ref id="B197-ijms-20-02167"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>M.</given-names></name><name><surname>Price</surname><given-names>S.L.</given-names></name><name><surname>Fiol-deRoque</surname><given-names>M.A.</given-names></name><name><surname>Marcilla-Etxenike</surname><given-names>A.</given-names></name><name><surname>Ahyayauch</surname><given-names>H.</given-names></name><name><surname>Barcel&#x000f3;-Coblijn</surname><given-names>G.</given-names></name><name><surname>Ter&#x000e9;s</surname><given-names>S.</given-names></name><name><surname>Katsouri</surname><given-names>L.</given-names></name><name><surname>Ordinas</surname><given-names>M.</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>D.J.</given-names></name><etal/></person-group><article-title>Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer&#x02019;s disease</article-title><source>Biochim. Biophys. Acta BBA - Biomembr.</source><year>2014</year><volume>1838</volume><fpage>1680</fpage><lpage>1692</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2013.12.016</pub-id><?supplied-pmid 24374316?><pub-id pub-id-type="pmid">24374316</pub-id></element-citation></ref><ref id="B198-ijms-20-02167"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolson</surname><given-names>G.L.</given-names></name><name><surname>Ash</surname><given-names>M.E.</given-names></name></person-group><article-title>Lipid Replacement Therapy: A natural medicine approach to replacing damaged lipids in cellular membranes and organelles and restoring function</article-title><source>Biochim. Biophys. Acta BBA - Biomembr.</source><year>2014</year><volume>1838</volume><fpage>1657</fpage><lpage>1679</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2013.11.010</pub-id></element-citation></ref><ref id="B199-ijms-20-02167"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escriba</surname><given-names>P.V.</given-names></name><name><surname>Sastre</surname><given-names>M.</given-names></name><name><surname>Garcia-Sevilla</surname><given-names>J.A.</given-names></name></person-group><article-title>Disruption of cellular signaling pathways by daunomycin through destabilization of nonlamellar membrane structures</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>1995</year><volume>92</volume><fpage>7595</fpage><lpage>7599</lpage><pub-id pub-id-type="doi">10.1073/pnas.92.16.7595</pub-id><?supplied-pmid 7638236?><pub-id pub-id-type="pmid">7638236</pub-id></element-citation></ref><ref id="B200-ijms-20-02167"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Escriba</surname><given-names>P.V.</given-names></name><name><surname>Morales</surname><given-names>P.</given-names></name><name><surname>Smith</surname><given-names>A.</given-names></name></person-group><article-title>Membrane Phospholipid Reorganization Differentially Regulates Metallothionein and Heme Oxygenase by Heme&#x02013;Hemopexin</article-title><source>DNA Cell Biol.</source><year>2002</year><volume>21</volume><fpage>355</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1089/104454902753759762</pub-id><pub-id pub-id-type="pmid">12042074</pub-id></element-citation></ref><ref id="B201-ijms-20-02167"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vigh</surname><given-names>L.</given-names></name><name><surname>Maresca</surname><given-names>B.</given-names></name><name><surname>Harwood</surname><given-names>J.L.</given-names></name></person-group><article-title>Does the membrane&#x02019;s physical state control the expression of heat shock and other genes?</article-title><source>Trends Biochem. Sci.</source><year>1998</year><volume>23</volume><fpage>369</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1016/S0968-0004(98)01279-1</pub-id><pub-id pub-id-type="pmid">9810221</pub-id></element-citation></ref><ref id="B202-ijms-20-02167"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moulin</surname><given-names>M.</given-names></name><name><surname>Carpentier</surname><given-names>S.</given-names></name><name><surname>Levade</surname><given-names>T.</given-names></name><name><surname>Arrigo</surname><given-names>A.-P.</given-names></name></person-group><article-title>Potential roles of membrane fluidity and ceramide in hyperthermia and alcohol stimulation of TRAIL apoptosis</article-title><source>Apoptosis</source><year>2007</year><volume>12</volume><fpage>1703</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1007/s10495-007-0096-2</pub-id><?supplied-pmid 17610065?><pub-id pub-id-type="pmid">17610065</pub-id></element-citation></ref><ref id="B203-ijms-20-02167"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irvine</surname><given-names>R.F.</given-names></name></person-group><article-title>Nuclear lipid signalling</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2003</year><volume>4</volume><fpage>349</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1038/nrm1100</pub-id><pub-id pub-id-type="pmid">12728269</pub-id></element-citation></ref><ref id="B204-ijms-20-02167"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibarguren</surname><given-names>M.</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>D.J.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name></person-group><article-title>The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health</article-title><source>Biochim. Biophys. Acta BBA - Biomembr.</source><year>2014</year><volume>1838</volume><fpage>1518</fpage><lpage>1528</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2013.12.021</pub-id><?supplied-pmid 24388951?><pub-id pub-id-type="pmid">24388951</pub-id></element-citation></ref><ref id="B205-ijms-20-02167"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>A.D.</given-names></name><name><surname>Fesik</surname><given-names>S.W.</given-names></name><name><surname>Kimmelman</surname><given-names>A.C.</given-names></name><name><surname>Luo</surname><given-names>J.</given-names></name><name><surname>Der</surname><given-names>C.J.</given-names></name></person-group><article-title>Drugging the undruggable RAS: Mission Possible?</article-title><source>Nat. Rev. Drug Discov.</source><year>2014</year><volume>13</volume><fpage>828</fpage><lpage>851</lpage><pub-id pub-id-type="doi">10.1038/nrd4389</pub-id><pub-id pub-id-type="pmid">25323927</pub-id></element-citation></ref><ref id="B206-ijms-20-02167"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>R.A.</given-names></name><name><surname>Mendanha</surname><given-names>S.A.</given-names></name><name><surname>Hansen</surname><given-names>D.</given-names></name><name><surname>Alonso</surname><given-names>A.</given-names></name></person-group><article-title>Interaction of Miltefosine with the Lipid and Protein Components of the Erythrocyte Membrane</article-title><source>J. Pharm. Sci.</source><year>2013</year><volume>102</volume><fpage>1661</fpage><lpage>1669</lpage><pub-id pub-id-type="doi">10.1002/jps.23496</pub-id><?supplied-pmid 23457073?><pub-id pub-id-type="pmid">23457073</pub-id></element-citation></ref><ref id="B207-ijms-20-02167"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fern&#x000e1;ndez-Garc&#x000ed;a</surname><given-names>P.</given-names></name><name><surname>Rossell&#x000f3;</surname><given-names>C.A.</given-names></name><name><surname>Rodr&#x000ed;guez-Lorca</surname><given-names>R.</given-names></name><name><surname>Beteta-G&#x000f6;bel</surname><given-names>R.</given-names></name><name><surname>Fern&#x000e1;ndez-D&#x000ed;az</surname><given-names>J.</given-names></name><name><surname>Llad&#x000f3;</surname><given-names>V.</given-names></name><name><surname>Busquets</surname><given-names>X.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name><name><surname>Fern&#x000e1;ndez-Garc&#x000ed;a</surname><given-names>P.</given-names></name><name><surname>Rossell&#x000f3;</surname><given-names>C.A.</given-names></name><etal/></person-group><article-title>The Opposing Contribution of SMS1 and SMS2 to Glioma Progression and Their Value in the Therapeutic Response to 2OHOA</article-title><source>Cancers</source><year>2019</year><volume>11</volume><elocation-id>88</elocation-id><pub-id pub-id-type="doi">10.3390/cancers11010088</pub-id><?supplied-pmid 30646599?><pub-id pub-id-type="pmid">30646599</pub-id></element-citation></ref><ref id="B208-ijms-20-02167"><label>208.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez</surname><given-names>J.</given-names></name><name><surname>V&#x000f6;gler</surname><given-names>O.</given-names></name><name><surname>Casas</surname><given-names>J.</given-names></name><name><surname>Barcel&#x000f3;</surname><given-names>F.</given-names></name><name><surname>Alemany</surname><given-names>R.</given-names></name><name><surname>Prades</surname><given-names>J.</given-names></name><name><surname>Nagy</surname><given-names>T.</given-names></name><name><surname>Baamonde</surname><given-names>C.</given-names></name><name><surname>Kasprzyk</surname><given-names>P.G.</given-names></name><name><surname>Ter&#x000e9;s</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Membrane Structure Modulation, Protein Kinase C Activation, and Anticancer Activity of Minerval</article-title><source>Mol. Pharmacol.</source><year>2005</year><volume>67</volume><fpage>531</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1124/mol.104.000778</pub-id><?supplied-pmid 15531732?><pub-id pub-id-type="pmid">15531732</pub-id></element-citation></ref><ref id="B209-ijms-20-02167"><label>209.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erazo</surname><given-names>T.</given-names></name><name><surname>Lorente</surname><given-names>M.</given-names></name><name><surname>L&#x000f3;pez-Plana</surname><given-names>A.</given-names></name><name><surname>Mu&#x000f1;oz-Guardiola</surname><given-names>P.</given-names></name><name><surname>Fern&#x000e1;ndez-Nogueira</surname><given-names>P.</given-names></name><name><surname>Garc&#x000ed;a-Mart&#x000ed;nez</surname><given-names>J.A.</given-names></name><name><surname>Bragado</surname><given-names>P.</given-names></name><name><surname>Fuster</surname><given-names>G.</given-names></name><name><surname>Salazar</surname><given-names>M.</given-names></name><name><surname>Espadaler</surname><given-names>J.</given-names></name><etal/></person-group><article-title>The New Antitumor Drug ABTL0812 Inhibits the Akt/mTORC1 Axis by Upregulating Tribbles-3 Pseudokinase</article-title><source>Clin. Cancer Res.</source><year>2016</year><volume>22</volume><fpage>2508</fpage><lpage>2519</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-15-1808</pub-id><?supplied-pmid 26671995?><pub-id pub-id-type="pmid">26671995</pub-id></element-citation></ref><ref id="B210-ijms-20-02167"><label>210.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guardiola-Serrano</surname><given-names>F.</given-names></name><name><surname>Beteta-G&#x000f6;bel</surname><given-names>R.</given-names></name><name><surname>Rodr&#x000ed;guez-Lorca</surname><given-names>R.</given-names></name><name><surname>Ibarguren</surname><given-names>M.</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>D.J.</given-names></name><name><surname>Ter&#x000e9;s</surname><given-names>S.</given-names></name><name><surname>Alvarez</surname><given-names>R.</given-names></name><name><surname>Alonso-Sande</surname><given-names>M.</given-names></name><name><surname>Busquets</surname><given-names>X.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name></person-group><article-title>The Novel Anticancer Drug Hydroxytriolein Inhibits Lung Cancer Cell Proliferation via a Protein Kinase C&#x003b1;&#x02013; and Extracellular Signal-Regulated Kinase 1/2&#x02013;Dependent Mechanism</article-title><source>J. Pharmacol. Exp. Ther.</source><year>2015</year><volume>354</volume><fpage>213</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1124/jpet.114.222281</pub-id><?supplied-pmid 26065701?><pub-id pub-id-type="pmid">26065701</pub-id></element-citation></ref><ref id="B211-ijms-20-02167"><label>211.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menendez</surname><given-names>J.A.</given-names></name><name><surname>Vellon</surname><given-names>L.</given-names></name><name><surname>Lupu</surname><given-names>R.</given-names></name></person-group><article-title>Antitumoral actions of the anti-obesity drug orlistat (Xenical<sup>TM</sup>) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene</article-title><source>Ann. Oncol.</source><year>2005</year><volume>16</volume><fpage>1253</fpage><lpage>1267</lpage><pub-id pub-id-type="doi">10.1093/annonc/mdi239</pub-id><?supplied-pmid 15870086?><pub-id pub-id-type="pmid">15870086</pub-id></element-citation></ref><ref id="B212-ijms-20-02167"><label>212.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000f6;gler</surname><given-names>O.</given-names></name><name><surname>L&#x000f3;pez-Bellan</surname><given-names>A.</given-names></name><name><surname>Alemany</surname><given-names>R.</given-names></name><name><surname>Tof&#x000e9;</surname><given-names>S.</given-names></name><name><surname>Gonz&#x000e1;lez</surname><given-names>M.</given-names></name><name><surname>Quevedo</surname><given-names>J.</given-names></name><name><surname>Pereg</surname><given-names>V.</given-names></name><name><surname>Barcel&#x000f3;</surname><given-names>F.</given-names></name><name><surname>Escriba</surname><given-names>P.V.</given-names></name></person-group><article-title>Structure&#x02013;effect relation of C18 long-chain fatty acids in the reduction of body weight in rats</article-title><source>Int. J. Obes.</source><year>2008</year><volume>32</volume><fpage>464</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1038/sj.ijo.0803768</pub-id></element-citation></ref><ref id="B213-ijms-20-02167"><label>213.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teres</surname><given-names>S.</given-names></name><name><surname>Barcelo-Coblijn</surname><given-names>G.</given-names></name><name><surname>Benet</surname><given-names>M.</given-names></name><name><surname>Alvarez</surname><given-names>R.</given-names></name><name><surname>Bressani</surname><given-names>R.</given-names></name><name><surname>Halver</surname><given-names>J.E.</given-names></name><name><surname>Escriba</surname><given-names>P.V.</given-names></name></person-group><article-title>Oleic acid content is responsible for the reduction in blood pressure induced by olive oil</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2008</year><volume>105</volume><fpage>13811</fpage><lpage>13816</lpage><pub-id pub-id-type="doi">10.1073/pnas.0807500105</pub-id><pub-id pub-id-type="pmid">18772370</pub-id></element-citation></ref><ref id="B214-ijms-20-02167"><label>214.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J.C.</given-names></name><name><surname>Conklin</surname><given-names>S.M.</given-names></name><name><surname>Manuck</surname><given-names>S.B.</given-names></name><name><surname>Yao</surname><given-names>J.K.</given-names></name><name><surname>Muldoon</surname><given-names>M.F.</given-names></name></person-group><article-title>Long-Chain Omega-3 Fatty Acids and Blood Pressure</article-title><source>Am. J. Hypertens.</source><year>2011</year><volume>24</volume><fpage>1121</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1038/ajh.2011.120</pub-id><pub-id pub-id-type="pmid">21753804</pub-id></element-citation></ref><ref id="B215-ijms-20-02167"><label>215.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alemany</surname><given-names>R.</given-names></name><name><surname>Ter&#x000e9;s</surname><given-names>S.</given-names></name><name><surname>Baamonde</surname><given-names>C.</given-names></name><name><surname>Benet</surname><given-names>M.</given-names></name><name><surname>V&#x000f6;gler</surname><given-names>O.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name></person-group><article-title>2-Hydroxyoleic Acid</article-title><source>Hypertension</source><year>2004</year><volume>43</volume><fpage>249</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1161/01.HYP.0000107778.85528.b5</pub-id><pub-id pub-id-type="pmid">14662651</pub-id></element-citation></ref><ref id="B216-ijms-20-02167"><label>216.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alemany</surname><given-names>R.</given-names></name><name><surname>V&#x000f6;gler</surname><given-names>O.</given-names></name><name><surname>Ter&#x000e9;s</surname><given-names>S.</given-names></name><name><surname>Egea</surname><given-names>C.</given-names></name><name><surname>Baamonde</surname><given-names>C.</given-names></name><name><surname>Barcel&#x000f3;</surname><given-names>F.</given-names></name><name><surname>Delgado</surname><given-names>C.</given-names></name><name><surname>Jakobs</surname><given-names>K.H.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name></person-group><article-title>Antihypertensive action of 2-hydroxyoleic acid in SHRs via modulation of the protein kinase A pathway and Rho kinase</article-title><source>J. Lipid Res.</source><year>2006</year><volume>47</volume><fpage>1762</fpage><lpage>1770</lpage><pub-id pub-id-type="doi">10.1194/jlr.M500520-JLR200</pub-id><?supplied-pmid 16687663?><pub-id pub-id-type="pmid">16687663</pub-id></element-citation></ref><ref id="B217-ijms-20-02167"><label>217.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borchert</surname><given-names>G.H.</given-names></name><name><surname>Giggey</surname><given-names>M.</given-names></name><name><surname>Kolar</surname><given-names>F.</given-names></name><name><surname>Wong</surname><given-names>T.M.</given-names></name><name><surname>Backx</surname><given-names>P.H.</given-names></name><name><surname>Escriba</surname><given-names>P.V.</given-names></name></person-group><article-title>2-Hydroxyoleic acid affects cardiomyocyte [Ca2<sup>+</sup>]<sub>i</sub> transient and contractility in a region-dependent manner</article-title><source>Am. J. Physiol.-Heart Circ. Physiol.</source><year>2008</year><volume>294</volume><fpage>H1948</fpage><lpage>H1955</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01209.2007</pub-id><?supplied-pmid 18296566?><pub-id pub-id-type="pmid">18296566</pub-id></element-citation></ref><ref id="B218-ijms-20-02167"><label>218.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>M.</given-names></name><name><surname>Hossain</surname><given-names>S.</given-names></name></person-group><article-title>Neuroprotective and Ameliorative Actions of Polyunsaturated Fatty Acids Against Neuronal Diseases: Beneficial Effect of Docosahexaenoic Acid on Cognitive Decline in Alzheimer&#x02019;s Disease</article-title><source>J. Pharmacol. Sci.</source><year>2011</year><volume>116</volume><fpage>150</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1254/jphs.10R33FM</pub-id><pub-id pub-id-type="pmid">21606627</pub-id></element-citation></ref><ref id="B219-ijms-20-02167"><label>219.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>M.L.</given-names></name><name><surname>Barcel&#x000f3;-Coblijn</surname><given-names>G.</given-names></name><name><surname>de Almeida</surname><given-names>R.F.M.</given-names></name><name><surname>Noguera-Salv&#x000e0;</surname><given-names>M.A.</given-names></name><name><surname>Ter&#x000e9;s</surname><given-names>S.</given-names></name><name><surname>Higuera</surname><given-names>M.</given-names></name><name><surname>Liebisch</surname><given-names>G.</given-names></name><name><surname>Schmitz</surname><given-names>G.</given-names></name><name><surname>Busquets</surname><given-names>X.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name></person-group><article-title>The role of membrane fatty acid remodeling in the antitumor mechanism of action of 2-hydroxyoleic acid</article-title><source>Biochim. Biophys. Acta BBA - Biomembr.</source><year>2013</year><volume>1828</volume><fpage>1405</fpage><lpage>1413</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2013.01.013</pub-id></element-citation></ref><ref id="B220-ijms-20-02167"><label>220.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiol-deRoque</surname><given-names>M.A.</given-names></name><name><surname>Gutierrez-Lanza</surname><given-names>R.</given-names></name><name><surname>Ter&#x000e9;s</surname><given-names>S.</given-names></name><name><surname>Torres</surname><given-names>M.</given-names></name><name><surname>Barcel&#x000f3;</surname><given-names>P.</given-names></name><name><surname>Rial</surname><given-names>R.V.</given-names></name><name><surname>Verkhratsky</surname><given-names>A.</given-names></name><name><surname>Escrib&#x000e1;</surname><given-names>P.V.</given-names></name><name><surname>Busquets</surname><given-names>X.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>J.J.</given-names></name></person-group><article-title>Cognitive recovery and restoration of cell proliferation in the dentate gyrus in the 5XFAD transgenic mice model of Alzheimer&#x02019;s disease following 2-hydroxy-DHA treatment</article-title><source>Biogerontology</source><year>2013</year><volume>14</volume><fpage>763</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1007/s10522-013-9461-4</pub-id><?supplied-pmid 24114505?><pub-id pub-id-type="pmid">24114505</pub-id></element-citation></ref><ref id="B221-ijms-20-02167"><label>221.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila-Martin</surname><given-names>G.</given-names></name><name><surname>Galan-Arriero</surname><given-names>I.</given-names></name><name><surname>G&#x000f3;mez-Soriano</surname><given-names>J.</given-names></name><name><surname>Taylor</surname><given-names>J.</given-names></name></person-group><article-title>Treatment of Rat Spinal Cord Injury with the Neurotrophic Factor Albumin-Oleic Acid: Translational Application for Paralysis, Spasticity and Pain</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><elocation-id>e26107</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0026107</pub-id><?supplied-pmid 22046257?><pub-id pub-id-type="pmid">22046257</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="ijms-20-02167-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Several forms of triglycerides and phospholipids found in the cell. The left-most scheme is a triglyceride formed by a three-carbon glycerol backbone with a FA tail bound to each carbon. Second left-most scheme is a phospholipid bearing two FA tails with the third carbon of glycerol bound to a phosphate group. The middle scheme is an ether glycerolipid, who shares with the two previous structures the three-carbon glycerol backbone and is slightly modified with an ether group. In second right-most scheme, a sphingosine is shown as backbone instead of glycerol and first fatty acid tail of glycerol is modified slightly. This is a sphingophospholipid since it bears a phosphate group, it is called sphingomyelin. Right-most scheme shows the scheme of sphingolipids called glycolipids, since the phosphate group is replaced with a sugar (carbohydrate group).</p></caption><graphic xlink:href="ijms-20-02167-g001"/></fig><fig id="ijms-20-02167-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Lipids in organelle identity. For each organelle, the main lipid components are listed according to their contribution to the total lipid content of the organelle (in percentage, from the most abundant to the least abundant). Only lipids representing at least 5% of the total lipids for each organelle are shown. BmP: bis(monoacylglycero)phosphate; Chol: cholesterol; CL: cardiolipin; PtdCho: phosphatidylcholine; PtdEtn: phosphatidylethanolamine; PtdIns: phosphatidylinositol; PtdSer: phosphatidylserine; SM: sphingomyelin. Not to scale. Adapted from [<xref rid="B19-ijms-20-02167" ref-type="bibr">19</xref>].</p></caption><graphic xlink:href="ijms-20-02167-g002"/></fig><fig id="ijms-20-02167-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Membrane homeostasis and circuits of lipids between organelles. (<bold>a</bold>) Lipid bilayers can form a number of different structures upon their composition in PL species. Some examples of lipid shapes and their influence on membrane structure are shown. Lipids with a small polar head (blue), such as PtdEtn, have a molecular shape that resembles a truncated cone. They induce a negative curvature strain. Lipids with a bulky polar head and only one acyl chain (e.g., lysophospholipids, green) have a molecular shape similar to an inverted cone and induce a positive curvature strain in membranes. Lipids such as PtdCho have similar cross-sectional areas for the polar head and hydrophobic region and resemble cylinders (red). They form lamellar phases, with no curvature strain. Not to scale. Adapted from [<xref rid="B113-ijms-20-02167" ref-type="bibr">113</xref>]. (<bold>b</bold>) Mechanisms of lipid homeostasis maintenance between cell compartments. Chol: cholesterol; ER: endoplasmic reticulum; MCS: membrane contact sites; LTPs: lipid transfer proteins; PM: plasma membrane; PtdCho: phosphatidylcholine; PtdEtn: phosphatidylethanolamine.</p></caption><graphic xlink:href="ijms-20-02167-g003"/></fig><fig id="ijms-20-02167-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Lipid imbalances and human pathologies. Snapshot of the alterations in the lipidome which have been described in a variety of pathological situations. &#x025b2;, increased levels or pathway activity; PL: phospholipid; PtdIns(3,4,5)P3: phosphatidylinositol 3,4,5-trisphosphate; PtdEtn: phosphatidylethanolamine; SM: sphingomyelin; OLR1: Oxidized Low Density Lipoprotein Receptor 1; GLRX: Glutaredoxin; FASN: FA Synthase; ACC: acetyl-CoA carboxylase; INSIG1: Insulin induced gene 1; SREBP1: sterol regulatory element-binding protein 1; LSD: Lysosomal disorder; SL: sphingolipid; Chol: cholesterol; FA: fatty acid; PtdSer: phosphatidylserine; GPL: Glycerophospholipids.</p></caption><graphic xlink:href="ijms-20-02167-g004"/></fig><fig id="ijms-20-02167-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Molecular bases of Membrane-Lipid Therapy. Snapshot of the rationale behind targeting membrane composition or structure i.e., the drug-induced regulation of membrane lipid composition and structure.</p></caption><graphic xlink:href="ijms-20-02167-g005"/></fig><fig id="ijms-20-02167-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Membrane-Lipid Therapy molecules are currently being developed for several medical conditions.</p></caption><graphic xlink:href="ijms-20-02167-g006"/></fig></floats-group></article>